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The Role of Pharmacists and Emergency Contraception:
An Assessment of Pharmacy School Curricula in the U.S. and the
Knowledge, Attitudes, and Dispensing Practices of Florida Pharmacists.
Alice R Richman
ABSTRACT
Emergency contraception is a safe and effective form of contraception that is
75%-89% effective in preventing pregnancies within 120 hours of unprotected
intercourse. Emergency contraception is a type of hormonal contraception, containing
high doses of estrogen and progestin (ethinyl estradiol plus levonorgestrel) or progestin
only (levonorgestrel). Wider access to emergency contraception has the potential to
decrease the number of unintended pregnancies and abortions in the U.S. The Food and
Drug Administration (FDA) has previously denied any over-the-counter (OTC) access to
emergency contraception and only recently approved it for OTC status for women 18
years old and over; therefore, pharmacists continue to play a critical role in providing
access to emergency contraception. For example, pharmacists can answer women’s
questions, dispel misconceptions, advise medical colleagues, and provide important
information about the medication to clients. Although emergency contraception is a safe
and effective medication, many pharmacists and pharmacies throughout the U.S. have
either refused to fill prescriptions of emergency contraception or have refused to carry
and stock emergency contraception. Pharmacists’ perceptions and practice affect
whether women have access to this form of contraception and whether pharmacies carry
x

this medication. In addition, pharmacists’ behavior, professional conduct, and ethical
practice and training have major implications for public health and access to care for
women, children, and families.
This study has two purposes: First, because the attitudes and dispensing practices
among pharmacists may be related to their understanding of the medication, a review of
pharmacy school curricula in the U.S. was conducted, and involved (a) an assessment of
course content related to emergency contraception and (b) an analysis of how this content
is perceived by pharmacy students. The second purpose of the study is to assess
emergency contraception knowledge, attitudes, subjective norms, perceived behavioral
control, and dispensing practices of pharmacists and to determine if pharmacists’
emergency contraception knowledge, attitudes, subjective norms, and perceived
behavioral control are predictive of their dispensing practices. To reach these ends, a
mixed-methods study design was employed using mixed methods data analysis
techniques including coding methods, univariate, bivariate, and logistic regression.

xi

Chapter One: Introduction
Statement of the Problem
The prevalence of unintended pregnancy among women in the United States is
disturbingly high. Indeed, it is the highest among all industrialized nations (Grimes,
2002). Approximately half of all pregnancies in the United States are unintended, with
48% of all women aged 15-44 having at least one unintended pregnancy throughout their
lifetime (Henshaw, 1998). Unintended pregnancies result in consequences that have a
profound effect on the physical, mental, social, economic, and developmental well-being
of women, children, and their families (Misra, 2001).
Unintended pregnancy can be life-changing for all involved. Of the estimated
50% of pregnancies in the U.S. that are unintended (approximately three million
annually), almost half (47%) result in abortion, 40% result in an unplanned birth and 13%
result in miscarriage (Brown & Eisenberg, 1995). Although in the U.S. the medical risks
involved with abortion are relatively small, the psychological impact and the emotionally
taxing decision process can be great (Major et al., 2000).
In general, women with unintended pregnancies are more likely to receive
insufficient or delayed prenatal care, participate in unhealthy pregnancy behaviors like
smoking and drinking (Hellerstedt et al., 1998), and give birth to low birth weight infants
(Brown & Eisenberg, 1995) than women with intended pregnancies. Likewise, women
with unintended pregnancies are more likely to have a preterm delivery (Orr, Miller,
1

James, & Babones, 2000), report higher rates of maternal depression (Brown &
Eisenberg, 1995), and have a greater rate of infant mortality (Brown & Eisenberg, 1995)
than women with intended pregnancies. Furthermore, women with unintended
pregnancies have a greater risk of physical abuse and violence and are less likely to
achieve educational, financial, and careers goals (Brown & Eisenberg, 1995) than women
with intended pregnancies, all of which can result in poor pregnancy, birth, and health
outcomes.
If 40% of unintended pregnancies result in an unplanned birth in the U.S., 21% of
all pregnancies (both intended and unintended) will result in an unplanned birth.
Children from these pregnancies are more likely to exhibit poor health and development
and for many reasons are more likely to live apart from one or both parents, usually the
father (Brown & Eisenberg, 1995). Children who live with only one parent, usually the
mother, score lower on standardized tests, have lower grade point averages, more erratic
school attendance, behavioral problems, and consequently are more likely to drop out of
high school, never attend college, or drop out of college, if attended, as compared with
children from similar social class backgrounds and living arrangements (Brown &
Eisenberg, 1995).
The potentially negative health outcomes associated with unintended pregnancy
coupled with the disturbingly high rates of unintended pregnancy in the U.S. should
highlight the need for careful scrutiny of this public health problem. Healthy People
2010 is a set of health objectives for the nation to works towards throughout the first
decade of this century. Healthy People 2010 objectives are developed through scientific
knowledge and build on objectives pursued over the past two decades. Through Healthy
2

People 2010, the field of public health has identified a priority to decrease the rate of
unintended pregnancies from 70% to 30% by year 2010 (US Department of Health and
Human Services (DHHS), 2000).
Of the 50% of the pregnancies in the United States that are unintended, half are a
result of contraceptive failure (Henshaw, 1998). The high rate of unintended pregnancy
in this group highlights the need for additional methods of birth control. While waiting
for additional forms of birth control to be developed, a currently effective yet
underutilized method of preventing unintended pregnancy, emergency contraception, is
available.
Emergency contraception is a type of hormonal contraception, containing high
doses of estrogen and progestin (ethinyl estradiol plus levonorgestrel) or progestin only
(levonorgestrel). This medication is 75%-89% effective in preventing pregnancies when
taken within 72 hours (3days) after sexual intercourse (American Medical Women’s
Association (AMWA), 1996; Kaiser Family Foundation, 2000). Recent studies
conducted on the Yuzpe regimen of emergency contraception show that the 72 hour
window may be restrictive and have extended effectiveness up to 120 hours (5 days);
however the earlier a woman accesses emergency contraception, the more effective the
medication will be (ACOG News Release, 2003; Ellertson et al., 2003).
There is one dedicated product currently on the market that is packaged as
emergency contraception in the U.S. called Plan B, a progestin-only form of
contraception and is orally administered where one pill is taken within 120 hours of
unprotected intercourse and a second pill is taken 12 hours later. However, there are 20
other forms of birth control pills that the FDA has said are safe and effective to use as
3

emergency contraception (Princeton University & Reproductive Health Professionals,
2006). These pills and their dosing regimen are shown in Appendix A.
Post-coital contraception is typically taken orally in pill form although the
insertion of an intrauterine contraceptive device (IUD) by a trained medical provider can
be used as post-coital contraception as well (Princeton University & Reproductive Health
Professionals, 2006). Emergency contraception is not effective if the woman is already
pregnant (Trussell, Duran, Shochet, & Moore, 2000) and is a safe form of contraception
approved by the FDA in 1997 (FDA Federal Register, 1997), with no known
contraindications (Grimes & Raymond, 2002).
This form of contraception is important in that, unlike most forms of
contraception, it is effective post sexual intercourse; it can be used as a back-up method
of birth control when other birth control methods are not used appropriately, a condom
slips or breaks, a pill is forgotten, or in cases of rape. This post-coital feature of
emergency contraception is where it received its nickname as the “morning after pill”
because it is effective after sexual intercourse. Because half of all unintended
pregnancies are a result of contraception failure (Henshaw, 1998), and because this backup method of birth control that can be used post sexual intercourse but before pregnancy,
it is ideal for sexually active individuals.
According to the American College of Obstetrics and Gynecologists (ACOG),
wider access and acceptability of emergency contraception could reduce the number of
unintended pregnancies by half (ACOG, 2001) and could prevent one million abortions
annually (Trussell, Steward, Guest, & Hatcher, 1992). However, it is within the first 24
hours after unprotected intercourse that emergency contraception is the most effective in
4

preventing pregnancy (Downing, 2001); therefore, access is a critical issue for this type
of contraception. Women who have to wait for a doctor’s appointment or for the
workweek to begin may delay treatment and thus decrease the efficacy of the medication,
or may not be able to procure the medication at all. Because most pharmacies are open
late hours and are open on weekends, when most typical doctor’s offices and clinics are
not (Boonstra, 2002), pharmacies have been suggested as critical venues for emergency
contraception distribution (Van Riper & Hellerstedt, 2005).
There are three main barriers to emergency contraception access that seem to
perpetuate a lack of awareness and utilization of this method of birth control. First, there
are certain misunderstandings in the public’s perception that surround emergency
contraception. Second, health care providers and professionals do not prescribe it or
neglect to inform women of its availability and third, inadequate education is provided to
women about emergency contraception.
Misunderstandings in the public’s perception surround emergency contraception.
One common myth is that emergency contraception acts as an abortificient (Jackson,
Schwarz, Freddman, & Darney, 2003) or that it is the same as RU-486, a medical
abortion (Grimes & Raymond, 2002). These misconceptions represent one way in which
the definitional lines become blurred when abortion and emergency contraception are
discussed. Please see Appendix B for the package inserts of both Plan B and RU-486.
Health care providers and professionals may make emergency contraception
difficult to obtain, primarily due to the misconceptions discussed above. Women who are
seeking these contraceptive pills may be forced to go through long appointments,
unnecessary procedures such as physical exams, pregnancy tests and pelvic exams and
5

pay high prices (Trussell et al., 2000). In addition, physicians refuse to prescribe it; many
pharmacies refuse to stock it; and many pharmacists will not fill prescriptions of
emergency contraceptive pills (Henderson, 2000). In fact, up until March 3, 2006, WalMart pharmacies refused to stock emergency contraceptive pills. This policy was
particularly troublesome because Wal-Mart is the “world’s largest retailer and the
nation’s fifth largest distributor of pharmaceuticals” (AMWA, 1996, p. 1) and in the case
of some rural and poorer areas, may be the only pharmacy in town. Therefore, a policy
decision made by a private pharmacy can directly limit access and eliminate choice to
one of the most vulnerable populations (AMWA, 1996). Although long overdue, WalMart has finally begun carrying the medication due to claims that were filed against them
for refusing to fill prescriptions and from pressure from women’s rights groups
(CNN.com, 2006; Wal-Mart news releases, 2006)
Lastly, what Henderson (2000) calls the “paucity of prospective information
provided to reproductive age women” (p. 2) refers to the inadequate education women
receive about emergency contraception. If women have no knowledge about emergency
contraception, they cannot be expected to ask for it. Part of the reason that women have
an inadequate knowledge base regarding emergency contraception is that clinicians do
not inform women of this option on a regular basis (Trussell et al., 2000), and
pharmaceutical companies fail to adequately market it (Cates & Raymond, 1997).
These barriers to emergency contraception are troubling and should be examined
in greater detail. Because time is such a critical factor in terms of access and
effectiveness of emergency contraception, strategies to improve access to emergency
contraception have been primarily focused on collaborative drug therapy agreements with
6

pharmacists or through advocating for emergency contraception to go over-the-counter
(OTC). Collaborative drug therapy agreements with pharmacists refer to pharmacists’
prescribing privileges for specific medications while following a set protocol. Currently
44 states in the U.S. allow these types of agreements with pharmacists for certain
medications. Expansion access programs such as these allow non-physicians to prescribe
and distribute emergency contraception while working in conjunction with physicians
and advanced registered nurse practitioners, thereby expanding the range of providers
(Gardner, Hutchings, Fuller, & Downing, 2001).
In total, nine states allow pharmacists to dispense emergency contraception
without a doctor’s prescription under specific circumstances while following particular
guidelines (Alan Guttmacher Institute (AGI), 2006). Of those nine, seven states
(Washington, California, Alaska, Hawaii, New Hampshire, Massachusetts, and Vermont)
currently have collaborative drug therapy agreements where women can acquire
emergency contraception without a prescription from pharmacies under doctorpharmacist agreements, and three states (California, Maine, and New Mexico) allow
pharmacists to dispense emergency contraception without a prescription under a stateapproved protocol. In addition, only one state, Illinois, has mandated that pharmacies
that stock emergency contraception must fill prescriptions of the medication (AGI, 2006;
Tanne, 2005).
Conversely, while eight states have expanded access programs for emergency
contraception, eight states have adopted restrictions (AGI, 2006). Four states (Arkansas,
Georgia, Mississippi, and South Dakota) allow pharmacists to refuse to fill prescriptions
of contraception including prescriptions of emergency contraception. Two states
7

(Indiana and Texas) added language under their Medicaid coverage that excluded
emergency contraception services, and two states (Arkansas and North Carolina)
restricted emergency contraceptives from their contraception coverage mandate (AGI,
2006).
History of Emergency Contraception
A brief review of emergency contraception in the U.S. may provide further
background on this important issue (see Appendix C for a graphic representation of its
history). Emergency contraception pills have been administered to women since the
1960s. Packets of birth control pills were typically cut up to dispense the required dose
to women with instructions for use to avoid pregnancy after sex. These pills were
initially administered by feminist clinics, college health clinics, and a few Planned
Parenthood clinics (Castle & Coeytaux, 2000).
In 1996, one year prior to the FDA approval of emergency contraception, a
national campaign was created and sponsored by the Reproductive Health Technologies
Project and Princeton University to connect consumers and clinicians to useful
information on emergency contraception through an emergency contraception hotline (1888-NOT-2-LATE), an emergency contraception website (not-2-late.com), and
announcements and advertising in the media (radio, television, and outdoor events)
(Ellertson, Shochet, Blanchard, & Trussell, 2000). The national website and hotline are
still active today connecting consumers to providers at the local level anywhere in the
U.S.
Almost three decades after emergency contraceptive pills were first administered
to women, on February 25, 1997, the FDA approved six brands of oral contraceptives to
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be used as emergency contraception and deemed them both safe and effective when used
in prevention of a pregnancy (FDA Federal Register, 1997). Even after this approval,
there was no dedicated, labeled product manufacturer of emergency contraception until
September 1998 and therefore few marketing efforts were initiated before this time.
In 1997, the State of Washington began an innovative program where
collaborative prescription agreements allowed pharmacists to prescribe emergency
contraception to women (Wells et al., 1998). This two year project was funded by the
Packard Foundation, operated by the Program for Appropriate Technology in Health
(PATH) and worked in collaboration with the Washington State Board of Pharmacy,
Washington State Pharmacists Association, University of Washington Department of
Pharmacy and Elgin/DDB (a public relations firm that has worked with the Reproductive
Health Technologies Project) (Wells et al., 1998). Their goals were to educate
pharmacists, facilitate prescriptive protocols, help link clients with prescribers, increase
awareness of emergency contraception to women, and to evaluate the effectiveness of the
project.
The Washington State project evaluators estimate that after the first four months
of program initiation, 207 unintended pregnancies and 103 abortions have been prevented
through this service (Wells et al., 1998). In addition, program evaluation demonstrated
an increase in prescriptions written per week and an increase in the number of calls
inquiring about the medication after the initiation of this program (Wells et al., 1998).
This project has demonstrated that pharmacist collaborative prescription agreements such
as this one can play a vital role in making emergency contraception available and thus
decreasing unintended pregnancy and abortion in the U.S.
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In September 1998, Gynetics marketed Preven™, the first dedicated emergency
contraception product for women. In July 1999, Women’s Capital Corporation marketed
Plan B™, the first progestin-only form of emergency contraception.
Throughout this period, not only were researchers and pharmaceutical companies
supporting the need for increased access to emergency contraception through advanced
supply or OTC access, but many organizations in the field were supporting making
emergency contraception more readily available. The American College of Obstetrics
and Gynecologists (ACOG) have endorsed making emergency contraception available
OTC (2001) and the American Medical Association (AMA) has disseminated policy
statements in support of expanding access to emergency contraception to make the pills
“more readily available” (2002).
In 2001, a petition was filed by the Center for Reproductive Rights to the FDA on
behalf of over 70 organizations, including medical, public health, and others in support of
emergency contraception for OTC access (CRR, n. d.). In 2003, Women’s Capital
Corporation, the makers of Plan B (a type of emergency contraception), filed a second
petition to the FDA in support of OTC emergency contraception.
On December 16, 2003, the FDA’s Reproductive Health Drugs Advisory and
Nonprescription Drugs Panel supported making Plan B available OTC by a 27-4 vote—a
major success for public health and reproductive rights advocates in the United States.
However, on May 6th, 2004, the FDA struck down the recommendation from its own
committee. The rejection was based on the assumption that there was not enough
evidence that Plan B could be used safely by adolescent women under 16 years of age
without provider supervision.
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The FDA rejection letter states that “before this application can be approved, you
would have to provide data demonstrating that Plan B can be used safely by women
under 16 years of age without the professional supervision of a practitioner licensed by
law to administer the drug” (Galson, 2004, p. 2). The letter also stipulated that
alternatively, more information could be provided to support Plan B as a prescription
only product for women under 16 years of age and a nonprescription product for women
over 16 years of age.
After this decision was handed down by the FDA, the makers of Plan B submitted
an application for OTC access to emergency contraception for women 16 years and older.
Many feel that because unintended pregnancy among adolescent women is a concern in
the U.S., it is imperative that they too are provided with access to safe contraceptive
choices and that they are not excluded from future emergency contraception OTC
policies. In fact, teens younger than 18 years old have the highest percentage (82-83%)
of unintended pregnancy in the U.S. (Henshaw, 1998) and the U.S. has the highest teen
pregnancy rate of all industrialized nations (Feijoo, 2001).
For years, the FDA was criticized for dragging its feet in granting any proposals
for OTC access despite the fact that it fit all of the requirements for an OTC drug, and
then on August 24, 2006 to the surprise of many, the FDA approved OTC access for Plan
B. However, the approval of OTC access is for women 18 years and older with
prescriptions required for those 17 years old and under (FDA News, 2006). Plan B is to
be stocked and held at pharmacies behind the counter so that it may be dispensed with a
prescription for those less than 18 years of age or by proof of age for those over 17 years
of age (FDA News, 2006).
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Need for the Study
Although the decision by the FDA to approve OTC access to emergency
contraception for women over 17 years of age is a step forward, it is not enough.
Whether emergency contraception is dispensed through a prescription to women less than
18 years of age or OTC to women over 17 years of age, pharmacists will continue to play
a crucial role in access to this medication. For women over 17 years of age requesting
emergency contraception OTC, pharmacists may be the first contact to a health care
professional for these women as Stacie Garnett from the Emergency Contraception
Network stated the day emergency contraception went OTC, “Training for pharmacists
will be more important than ever as they become the first contact for women seeking EC”
(S. Garnett, personal communication, August 24, 2006).
In addition, for women who seek emergency contraception by prescription,
pharmacists can either aid or inhibit the doctor/patient relationship. Some pharmacists
have refused to fill prescriptions of emergency contraception. When a doctor writes a
patient a prescription for emergency contraception, it is the intention of the doctor to give
the patient the medication. If the patient then takes her prescription to a pharmacist to fill
the prescription and the pharmacist refuses to do so, the pharmacist is therefore inhibiting
this doctor/patient relationship. For example, in 2004, a pharmacist in Texas would not
fill a rape survivor’s prescription for emergency contraception, citing moral objections
for the refusal (Reuters, 2004). In October 2005, a pharmacist in Missouri who works at
a local Target store refused to fill a prescription of emergency contraception. Other
reports of pharmacist refusal have come from Ohio and New Hampshire (Cantor &
Baum, 2004).
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In addition to pharmacists refusing to fill prescriptions of emergency
contraception, some pharmacies refuse to stock this medication. Pharmacists’
knowledge, attitudes, and dispensing practices of emergency contraception may have an
affect on whether women have access to emergency contraception and whether
pharmacies carry the medication. Lack of access to emergency contraception can result
in unintended pregnancies, which may result in unplanned births or abortions. Therefore,
pharmacists’ behavior, professional conduct, and ethical practice and training all have
major implications for public health and access to care for women, children, and families.
Purpose of the Study
This study has two purposes: First, because the attitudes and dispensing practices
among pharmacists may be related to their understanding of the medication, a review of
pharmacy school curricula in the U.S. was conducted, and involved (a) an assessment of
course content related to emergency contraception and (b) an analysis of how this content
is perceived by pharmacy students. The second purpose of the study is to assess
emergency contraception knowledge, attitudes, subjective norms, perceived behavioral
control, and dispensing practices of pharmacists and to determine if pharmacists’
emergency contraception knowledge, attitudes, subjective norms, and perceived
behavioral control are predictive of their dispensing practices.
This project provides important state-level data for Florida, country-wide data on
curricula for the U.S., and helped to identify geographic and demographic trends in
pharmacist practices. This research advanced the state of knowledge, aided in
formulating baseline data on pharmacists’ knowledge and practice, and provided a venue
with which to make recommendations of ways to strengthen pharmacy school curricula.
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In addition, this research may work towards the goals of mainstreaming emergency
contraception and reducing unintended pregnancy and the need for abortion in the U.S.
Research Questions
Question 1: What do the 91 accredited schools of pharmacy in the U.S. teach about
emergency contraception?
Question 1a: What objectives, course assignments, course readings, and lectures
concerning emergency contraception are provided in the required courses at the
91 accredited schools of pharmacy in the U.S.?
Question 1b: What objectives, course assignments, course readings, and lectures
concerning emergency contraception are provided in the elective courses at the 91
accredited schools of pharmacy in the U.S.?
Question 2: How is emergency contraception course content taught at accredited schools
of pharmacy as perceived by fourth year pharmacy students at the four accredited schools
of pharmacy in Florida?
Question 2a: What did pharmacy students learn about emergency contraception in
their pharmacy school classes?
Question 2b: How was emergency contraception taught in their pharmacy school
classes?
Question 2c: What are the projected emergency contraception dispensing
practices of pharmacy students?
Question 3: What is the relationship among emergency contraception knowledge,
attitudes, subjective norms, perceived behavioral control, intention to dispense, and
dispensing practices of Florida pharmacists registered with the Board of Pharmacy?
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Question 3a: Is emergency contraception knowledge predictive of dispensing
practices of Florida pharmacists?
Question 3b: Are attitudes about emergency contraception predictive of
emergency contraception dispensing practices of Florida pharmacists?
Question 3c: Are subjective norms about emergency contraception (whether
important people such as colleagues, supervisors, corporate headquarters, and
peers think they should dispense emergency contraception) predictive of
emergency contraception dispensing practices of Florida pharmacists?
Question 3d: Is perceived behavioral control, the perceived ease or difficulty of
dispensing emergency contraception, predictive of dispensing practices of Florida
pharmacists?
Question 3e: Is intention to dispense emergency contraception predictive of
dispensing practices of Florida pharmacists?
Question 3f: Are emergency contraception knowledge, attitudes, subjective
norms, perceived behavioral control, and intention to dispense taken together,
predictive of emergency contraception dispensing practices of Florida
pharmacists?
Assumptions
1. The pharmacists will report their knowledge, attitudes, subjective norms,
perceived behavioral control, and dispensing practices accurately.
2. The pharmacy students will report their perceptions about the education they
received as well as their perceptions about future dispensing practices accurately.

15

3. The academic Deans of the accredited schools of pharmacy will report what is
covered in their curricula concerning emergency contraception accurately.
Delimitations
The following delimitations are imposed on this study:
1. Results are only generalizable to English literate pharmacists registered with the
Board of Pharmacy in the state of Florida.
2. Results from the quantitative data are generalizable to only accredited schools of
pharmacy in the U.S.
3. Results from the qualitative data by definition cannot be generalized to all
pharmacy students.
Limitations
The following are limitations of this study:
1. Pharmacists who respond to the survey may be motivated to respond due to their
attitudes about emergency contraception (both positive and negative attitudes).
2. Results of the study cannot be generalized to all pharmacists in the U.S. or all
pharmacy students in the U.S.
3. Results from the study are based upon self-reports which means that reported
behaviors and educational instruction may be a proxy for actual behavior and
instruction.
Definitions of Relevant Terms
Abortion: Termination of pregnancy before the fetus is viable and capable of extrauterine
existence, usually less than 20 weeks of gestation (or when the fetus weighs less than
500g) (Lowdermilk & Perry, 2004).
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Birth Control: Practices employed by couples that permit sexual intercourse with reduced
likelihood of conception and birth. The term birth control is often used synonymously
with such terms as contraception, fertility control, and family planning. Birth control
includes abortion to prevent a birth, whereas family planning methods explicitly do not
include abortion (Population Reference Bureau, n. d.).
Conception: Union of the sperm and ovum resulting in fertilization; formation of the onecelled zygote (Lowdermilk & Perry, 2004).
Contraception: Prevention of impregnation or conception (Lowdermilk & Perry, 2004).
Depression: An intense and pervasive sadness with severe and labile mood swings
(Lowdermilk & Perry, 2004).
Emergency Contraception: A type of hormonal contraception, containing high doses of
estrogen and progestin (ethinyl estradiol plus levonorgestrel) or progestin only
(levonorgestrel). Emergency contraception is 75%-89% effective in preventing
pregnancies when taken within 120 hours (5 days) after sexual intercourse (Planned
Parenthood, n. d.)
Family Planning: The conscious effort of couples to regulate the number and spacing of
births through artificial and natural methods of contraception. Family planning connotes
conception control to avoid pregnancy and abortion, but it also includes efforts of couples
to induce pregnancy (Population Reference Bureau, n. d.).
Infant Mortality: Number of deaths per 1000 children 1 year of age or younger
(Lowdermilk & Perry, 2004).
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Intended Pregnancy: Where the pregnancy is reported to have happened at the “right
time” or occurring later than desired due to infertility or other problems becoming
pregnant (Brown & Eisenberg, 1995; Santelli, et al., 2003).
Low Birth Weight (LBW): An infant birth weight of less than 2500g (Lowdermilk &
Perry, 2004).
Miscarriage: Spontaneous abortion; lay term usually referring to the loss of the fetus
(Lowdermilk & Perry, 2004).
Pharmacist: a health professional trained in the art of preparing and dispensing drugs
(Word Reference, n. d.).
Pharmacology: The science of drugs, including their composition, uses, and effects. The
characteristics or properties of a drug, especially those that make it medically effective
(The Free Dictionary n. d.).
Pregnancy: Period between conception through complete birth of the products of
conception. The usual duration of pregnancy in the human is 280 days, 9 calendar
months, or 10 lunar months (Lowdermilk & Perry, 2004).
Preterm Birth: Birth occurring before 37 weeks of gestation (Lowdermilk & Perry,
2004).
Plan B: Plan B consists of two white tablets, each contain glevonorgestrel .75mg. The
first tablet is taken within 72 hours of unprotected intercourse, and the second tablet is
taken 12 hours later (American Pharmaceutical Association (AphA) special report, 2000).
Preven: see Yupze Regimen of Emergency Contraception below.
Unintended Pregnancy: Unintended pregnancy is classified as either unwanted or
mistimed. Unwanted refers to where the current pregnancy occurred when no children or
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no more children were desired and mistimed refers to when the woman may have wanted
to be pregnant at some point in her life but that the current pregnancy occurred earlier
than desired (Brown & Eisenberg, 1995; Santelli, J et al., 2003).
Yupze Regimen of Emergency Contraception (AKA Preven): Preven or the Yupze
regimen consists of four blue tablets, each containing ethinyl estradiol 50ug and
levonorgestrel .25mg. Two tablets are taken initially, followed by a second dose of two
tablets 12 hours later (Apha special report, 2000).
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Chapter Two: Literature Review
Review of Related Research
This literature review examines the existing and current literature on emergency
contraception and specifically examines the literature on emergency contraception
knowledge, attitudes, and dispensing practices of pharmacists. The review begins with a
brief overview of emergency contraception including mechanism of action, side effects,
contraindications, and teratogenicity. Next, the review focuses on the current level of
knowledge and attitudes about emergency contraception among women followed by an
exploration of the research conducted on the knowledge, attitudes, and prescribing
practices of emergency contraception among health care professionals such as physicians,
nurses, and midwives. Because little research has been conducted on pharmacists
specifically, examining these relationships among other health care professionals will
help inform this study.
Next, the literature review examines the few studies that have been conducted on
the relationship between knowledge, attitudes, and dispensing practices of pharmacists.
Lastly, this review introduces the reader to the Theory of Reasoned Action and Theory of
Planned Behavior and will demonstrate how the concepts from these theories directly
inform the hypothesis and research questions of this study.
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Overview of Emergency Contraception
Emergency contraception is a type of hormonal contraception, containing high
doses of estrogen and progestin (ethinyl estradiol plus levonorgestrel) or progestin only
(levonorgestrel). This medication is 75%-89% effective in preventing pregnancies when
taken within 72 hours (3days) after sexual intercourse (American Medical Women’s
Association (AMWA), 1996; Kaiser Family Foundation, 2000). Recent studies
conducted on the Yuzpe regimen (estrogen and progestin) of emergency contraception
show that the 72 hour window may be restrictive and have extended effectiveness up to
120 hours (5 days); however the earlier a woman accesses emergency contraception, the
more effective the medication will be (ACOG News Release, 2003; Ellertson et al.,
2003).
The mechanism of action of emergency contraception is the same as oral
contraceptives that are administered daily. Emergency contraception works through
inhibiting events that are necessary for a pregnancy to occur. Emergency contraception
can work in a number of ways to inhibit:
1) Ovulation—can suppress luteinizing hormone that is needed for ovulation;
2) Fertilization—can inhibit movement of egg or sperm;
3) Transport—can inhibit the path of the fertilized egg to the uterus; or
4) Implantation—can change the endometrium so that the blastocyst is not able
to implant (American Pharmaceutical Association special report, 2000).
Emergency contraception is not effective if the woman is already pregnant and
therefore does not disrupt an existing pregnancy (Trussell, Duran, Shochet, & Moore,
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2000). It is a safe form of contraception approved by the FDA in 1997 (FDA Federal
Register, 1997).
Currently, there is only one dedicated product on the market that is packaged as
emergency contraception in the U.S. called Plan B. Plan B is a progestin-only form of
contraception and is orally administered and consists of two white pills containing .75 mg
of levonorgestrel, where one pill is taken within 120 hours of unprotected intercourse and
a second pill is taken 12 hours later. In the past, there was a product on the market called
Preven (also known as the Yuzpe regimen) that was packaged as emergency
contraception; however this product is no longer being manufactured. In addition, there
are 20 other forms of birth control pills that the FDA has said are safe and effective to use
as emergency contraception (Princeton University & Reproductive Health Professionals,
2006).
Whether a woman uses Plan B or one of the other 20 forms of birth control pills,
emergency contraceptives are safe to use with few side effects. Common side effects
include: nausea, vomiting, fatigue, breast tenderness, headache, abdominal pain, and
dizziness. If these side effects do occur when taking emergency contraceptives, they go
away within a few days of treatment (American Pharmaceutical Association (AphA)
special report, 2000).
The side effects listed above were much more common with Preven (estrogen and
progestin) and studies have shown that these side effects are lessened with the use of Plan
B (progestin only). For example, a study conducted by the World Health Organization
found that in comparing Plan B to Preven, Plan B caused less nausea (23% vs 51%), less
vomiting (6% vs 19%), less dizziness (11% vs 17%), and less fatigue (17% vs 29%) (n.
22

a., 1998). In addition to these adverse effects, irregular vaginal bleeding can occur after
use but the spotting is not serious. In addition, a woman’s menstrual period after using
emergency contraception may be lighter or heavier than usual depending on the woman
(American Pharmaceutical Association (AphA) special report, 2000).
Contraindications for the use of oral contraceptive combinations as emergency
contraception that include ethinyl estradiol (estrogen) include an increased risk of
thrombosis and ischemic stroke. However, the British Medicines Control Agency found
that over 13 years and approximately four million doses of emergency contraception,
only three cases of thromboembolism and three cases of stroke were detected (Vasilakis,
Jick, & Jick, 1999). Nonetheless, it is recommended that women with a history of
thromoembolic disease or stroke should not use emergency contraception as combined
estrogen and progesterone and it has been suggested that perhaps they should use Plan B
which is levonorgestrel only (American Pharmaceutical Association (AphA) special
report, 2000; Van Look & Stewart, 1998).
Contraindications for Plan B include: being pregnant, undiagnosed abnormal
genital bleeding, and an allergy to progesterone. Although being pregnant is listed as a
contraindication of emergency contraception, it is listed for the most part because it
would not be efficacious during a pregnancy rather than any ill effects that it may have on
an established pregnancy. In fact, using oral contraceptives during a pregnancy has not
been found to hurt the fetus (American Pharmaceutical Association (AphA) special
report, 2000). Overall, emergency contraception is a safe form of contraception with
very few side effects and contraindications.
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Epidemiology: Knowledge & Attitudes of Emergency Contraception
In order for emergency contraception to be used as a physician-prescribed, overthe-counter (OTC), or pharmacist-provided medication, women, men, and health care
professionals must know of its availability and must understand how it should be used.
Recent research findings have suggested a low but increasing level of knowledge about
emergency contraception among patients and health care providers (Conard & Gold,
2004).
Women’s Knowledge
Studies in many countries, including those in Europe, Asia, Africa, Middle East,
and North America have assessed women’s level of knowledge of emergency
contraception and found that these rates vary greatly. For example, in a study conducted
in India where participants were given a paper-based questionnaire, neither the abortion
clients surveyed (n=500) nor the college students surveyed (n=110) were familiar with
emergency contraception (Tripathi, Rathore, & Sachdeva, 2003). By contrast, a
nationally representative population-based study in Switzerland administered a
computerized questionnaire to 4,283 sexually active adolescents aged 16 to 20 years old
and found that 89% reported having heard of emergency contraception (Ottesen, Narring,
Renteria, & Michaud, 2002). Similarly, in the United Kingdom, 78% of the 78 women
who filled out a paper-based survey while attending an abortion clinic were familiar with
emergency contraception (Mathew & Urquhart, 2005). However, in Iran only 8% of the
250 married women ages 15-48 interviewed knew about emergency contraception
(Babaee, Jamali, & Ali, 2003). See Appendix D for a list of emergency contraception
knowledge and attitude studies in a comparative context.
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Not only do women’s levels of knowledge about emergency contraception vary
from place to place, but another striking finding and commonality among the knowledgebased studies is that in most studies, a larger percentage of women report having heard of
emergency contraception than the percentage of women who actually understand its
correct mechanism of action. For example, although Ottesen et al. (2002) found that 89%
of women in Switzerland had heard of emergency contraception, another prospective
study that employed a paper-based survey sampled women requesting emergency
contraception in Switzerland (n=365) and found that 42% of women incorrectly thought
that the pills had to be taken within 24 hours of unprotected intercourse and 13% of the
women incorrectly thought that emergency contraception was 100% effective in
preventing pregnancy (Nguyen, Bianchi-Demmicheli, & Ludicke, 2003).
Similarly, a U. S. study provided a paper-based survey to 297 Latina women
attending family planning clinics in Texas and found that 17% of Spanish-speaking
women and 41% of English-speaking Latina women had heard of emergency
contraception and 25% incorrectly believed that emergency contraception would end an
existing pregnancy (Romo, Berenson, & Wu, 2004). Also in the U.S., 77% of the 158
women surveyed an inner-city emergency department had heard of emergency
contraception, although only half of those who had heard of it knew how to use it. In
addition, of those who had heard of it, 26% were not aware of the correct timing, 24%
were not aware that it was available in the U.S., and 45% were not aware that a
prescription was required for use (Abbott, Feldhaus, Houry, & Lowenstein, 2004).
In a similar study, 82% of the 188 women sampled from a Boston community had
heard of emergency contraception but only about half of those women knew how
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emergency contraception worked (Chuang & Freund, 2005). Also, among a sample of
post-partum women from an inner-city public hospital (n=371) in the U.S., 36% of
women had heard of emergency contraception and only 7% understood the appropriate
timing for use (Jackson, Schwarz, Freedman, & Darney, 2000).
In countries where emergency contraception is available OTC such as Nigeria and
Sweden, 58% of the 880 Nigerian female undergraduate students sampled were familiar
with emergency contraception but only 18% knew the 72 hour protocol for use and 49%
believed that the pills needed to be taken within 24 hours of unprotected intercourse
(Aziken, Okonta, & Ande, 2003). In a study conducted in Sweden, 98% of the 800
women studied were aware of emergency contraception but 38% were not aware of the
effectiveness of emergency contraception when taken on the first day and 59% were not
aware of the effectiveness when taken on the third day (Larsson, Eurenius, Westerling, &
Tyden, 2004).
Although there is a disparity between the percentage of women who have heard of
emergency contraception and the percentage of women who understand its mechanism,
there is reason to believe that both of these percentages are increasing over time. A study
conducted in 1996 in the U.S. recruited women from a hospital-based clinic and drug
treatment center (n=133) and then recruited a different sample of women from the same
clinic in 2002 (n=139). Both groups of women were interviewed and guided by almost
identical questionnaires. The researchers found that between 1996 and 2002, the
percentage of clients who had ever heard of emergency contraception grew from 44% in
1996 to 73% in 2002 and comprehension of timing for use increased from 20% in 1996 to
51% in 2002 (Aiken, Gold, & Parker, 2005).
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Although overall knowledge about emergency contraception has been increasing
over the years, many misconceptions about emergency contraception still remain. One
U.S.-based study examined the knowledge and attitudes of emergency contraception
among women and men ages 18-21 (n=97) attending a university through the use of a 25item paper-based questionnaire. This study found that almost half of the participants
thought that emergency contraception was the same as RU-486, an abortifacient (Corbett,
Mitchell, Taylor, & Kemppainen, 2005). Similarly, another U.S.-based study conducted
a telephone survey among students attending Princeton University (n=550) and found
that study participants were confused between emergency contraception and RU-486
(Harper & Ellertson, 1995).
It is clear from these studies that although women’s knowledge of emergency
contraception varies, more women have heard of emergency contraception than know
how to use it. That is, women may be aware that emergency contraception exists;
however, they are not aware of the issues of timing, effectiveness, and how to obtain it.
This finding demonstrates the need for educational efforts to address these deficits.
Educational efforts should not only promote awareness of emergency contraception but
should present specific information about the medication such as correct timing for use,
availability, level of effectiveness, proper use, and possible side effects.
Women’s Attitudes
Much like knowledge, women’s attitudes towards emergency contraception vary.
In many studies, women tended to have positive attitudes about emergency contraception.
For example, in the study of Iranian women (n=250) where 8% of women had heard of
emergency contraception, 77% of the women surveyed were found to have a positive
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attitude about it and reported that they would be willing to use it in the future or tell other
people about it after they were informed of what the medication was and how it worked.
Because the percentage of women who had heard of emergency contraception was so
low, attitude was measured after each participant was read a paragraph explaining what it
was and how it worked (Babaee et al., 2003).
Positive attitudes were also found in other studies. Among the Swedish women
studied (n=800), 90% agreed that access to emergency contraception is positive (Larsson
et al., 2004). Of the 76 women surveyed in an abortion clinic in the UK, 90% of the
women said they would consider using emergency contraception in the future (Mathew &
Urquhart, 2005). And in the study of women recruited from a U.S. urban hospital and
drug treatment center (n=139), over half of the women thought that there may be a future
need to use emergency contraception, and of those that perceived a future need, 95%
reported that they would use it if needed (Aiken et al., 2005).
Although most studies found positive attitudes towards emergency contraception,
two studies found attitudes that were not as positive. In the study conducted in the inner
city emergency department in the U.S. (n=158), 51% of women reported that they would
think about using emergency contraception if they needed it; however 17% reported
moral or religious objections to its use (Abbott et al., 2004). Also, among the university
men and women that were surveyed in the U.S. study (n=97), 100% of the women who
reported to be unlikely to choose emergency contraception said that they would feel
judged or embarrassed if they had to ask for it (Corbett et al., 2005). Unfortunately, the
article did not mention how many women reported to be unlikely to choose emergency
contraception.
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Some researchers conducted further investigations into women’s attitudes about
emergency contraception and discovered a relationship between approval of emergency
contraception and political and religious views. Harper and Ellertson (1995) found that
political and religious affiliations were significant predictors of student attitudes.
Specifically, they found that Democrats (86%) were more approving of emergency
contraception than Republicans (71%) or Independents (63.5%). Also, highly religious
students were less likely to recommend emergency contraception to women than those
who were not religious.
Harper and Ellertson (1995) also found a positive correlation between emergency
contraception knowledge and attitudes, that is, when the level of knowledge about
emergency contraception increased, so did the positive attitudes about its use. In fact, the
odds of the favorable attitudes of emergency contraception were 148% higher among
participants that understood the side effects when compared to those who did not. This
relationship between knowledge and attitudes was also demonstrated among Latina
women surveyed in the U.S. (n=297). These researchers found that only half of women
who have heard of emergency contraception said that they would be willing to use it in
the future and those who did not comprehend the action of emergency contraception were
even less likely to say that they would use it in the future (Romo et al., 2004).
In contrast to these findings, the U.S. based study of 371 post-partum women
from an inner-city public hospital found that while two-thirds of these women reported a
willingness to use emergency contraception in the future, only 7% understood the correct
timing for use (Jackson et al., 2000). This finding that willingness to use the medication
was high even though comprehension of timing was low seems to conflict with the
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previous study that found that the willingness to use emergency contraception decreased
as the comprehension of action decreased.
In summary, women’s attitudes about emergency contraception vary. However,
in most studies, women held positive attitudes about emergency contraception. In
addition, there seems to be little consistency in the relationship between knowledge and
attitudes. For example, some studies showed high knowledge and positive attitudes,
some studies showed low knowledge and positive attitudes for future use, while other
studies showed low knowledge and negative attitudes towards emergency contraception.
However, one thing that can be surmised is that education should be provided to women
who are willing to use emergency contraception but are unfamiliar with it. It is important
to note that in some studies approval of the birth control pill was related to political or
religious views. These views may account for the studies that found high knowledge and
low attitudes about emergency contraception; however more research is needed to
uncover these relationships.
Healthcare Professionals’ Knowledge, Attitudes, and Practice
of Emergency Contraception
Several studies have assessed healthcare professionals’ knowledge, attitudes, and
prescribing practices of emergency contraception. For the purposes of this literature
review and study, the research conducted on healthcare professionals is reported
separately from the research conducted on pharmacists. This section will focus on
studies conducted on all other healthcare professionals except for pharmacists and the
next section will focus solely on pharmacists. In addition, the terms health care
professionals and providers will be used interchangeably.
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Provider Knowledge
Overall, provider studies on knowledge about emergency contraception have
found that while most providers have general knowledge about emergency contraception,
detailed knowledge is low. For example, one U.S.-based study mailed a questionnaire to
236 pediatricians and 121 surveys were returned. They found that all but one doctor
responded that they had heard of emergency contraception but around half of the
pediatricians did not know the timing of emergency contraception or that it was FDAapproved (Sills, Chamberlain, & Teach, 2000). See Appendix E for a list of provider
knowledge, attitude, and prescribing practice studies in a comparative context.
In another U.S.-based study, 954 pediatricians were mailed a five-page survey and
233 responded. Findings indicated that pediatricians had a lack of detailed knowledge
about emergency contraception. For example, 72.9% of respondents could not identify
the FDA-approved methods for emergency contraception and roughly 72% of
respondents could not identify the correct timing for the drug (Golden et al., 2001).
Low levels of knowledge were also found in a study conducted on 180 family
planning providers in Turkey where only half of the providers knew the correct timing
and dose interval of emergency contraception. In addition to this lack of detailed
knowledge, these providers had major misconceptions about emergency contraception
(Uzuner et al., 2005). Over 39% of respondents believed that emergency contraception
causes abortion and 31.1% thought that it was harmful for the fetus. In addition, almost
79% of respondents incorrectly thought that pill use may increase unprotected intercourse
and 75% thought that use will lead to men giving up on condom use. Interestingly,
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female providers had more negative impressions regarding the above statements than
male providers (Uzuner et al., 2005).
Another U.S.-based study conducted on 78 providers consisting of family
physicians and nurse providers explored provider perceived knowledge and actual
knowledge. Among the 78 providers, 96% reported that they were knowledgeable on the
indications for use and 78% reported that they understood the protocols for prescribing
emergency contraception, although knowledge inaccuracies were found between
perceived and actual knowledge. Also, 44% of providers inaccurately thought that
emergency contraception was an abortifacient (Wallace, Wu, Weinstein, Gorenflo, &
Fetters, 2004).
Another U.S.-based study gave self-administered questionnaires to 102 providers
including physicians, registered nurse practitioners, certified nurse midwives, and
physician assistants and measured level of knowledge, attitudes, and practices of
emergency contraception before and after an educational program. The educational
program involved a training of providers through a lecture presentation and a review of a
clinical manual. The clinical manual included pertinent information about emergency
contraception and each provider was given a clinical manual to keep. At baseline, onethird of the sample did not know the correct timing for emergency contraception. At
follow-up, one year later, knowledge about emergency contraception significantly
increased. However, at follow-up, providers still maintained limited knowledge about the
medication’s side effects and modes of action. Overall this study found that an
educational training for providers can help increase knowledge about emergency
contraception; however the finding that there were still a few gaps in knowledge suggests
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a need for even more education and training (Beckman, Harvey, Sherman, & Petitti,
2001).
In contrast to these studies where the general knowledge is high, some non-U.S.
based studies found that even general provider knowledge about emergency
contraception was absent. One study conducted in Turkey found low levels of
knowledge among 72 health care providers which included general practitioners, nurses,
and midwives (Sevil, Yanikkerem, & Hatipoglu, 2006). These researchers used face-toface interviews as well as paper-based self administered questionnaires. They found that
almost one in ten providers surveyed was unfamiliar with the words ‘emergency
contraception’ and they concluded that knowledge about emergency contraception among
health care providers is inadequate. In addition, a study conducted on the knowledge,
attitudes and practice of family planning among community health extension workers
(n=232) in Nigeria found an absence of knowledge about emergency contraception
(Onwuhafua, Kantiok, Olafimihan, & Shittu, 2005).
Provider Attitudes
In addition to low levels of knowledge and major misconceptions about
emergency contraception, several studies identified negative attitudes towards emergency
contraception. Golden et al. (2000) surveyed 233 practicing pediatricians and found that
68% of respondents felt uncomfortable prescribing emergency contraception, with
inexperience cited as the most common reason (70%). Seventeen percent did not
prescribe due to perceived teratogenic effects and 12% did not prescribe due to moral or
religious reasons. In addition, 22% agreed that emergency contraception provision
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encourages adolescent risk-taking behavior and 52% said they would place restrictions on
how many times they would dispense the drug to a patient (Golden et al., 2000).
Another U.S.-based study conducted on 78 providers consisting of family
physicians and nurse providers found generally positive attitudes towards prescribing
emergency contraception, although the actual rates of prescribing were low. Of the 78
providers studied, 90% thought that the pill was an appropriate topic of discussion at
women’s exams and felt that the benefits of emergency contraception outweighed the
risks. However, due to fear of repeated pill use, 59% of providers said they would
restrict how many times they prescribed emergency contraception to a woman. Also,
14% thought that emergency contraception use would discourage regular contraceptive
use, 16% were uncomfortable prescribing emergency contraception for religious or
ethical reasons, and 7% said that they would not prescribe emergency contraception
under any circumstances (Wallace, et al., 2004).
Interestingly, in a 2001 in the U.S.-based study that surveyed 102 providers and
measured levels of knowledge, attitudes, and practices of emergency contraception before
and after an educational program, follow-up knowledge and prescribing practices
increased while attitudes about emergency contraception showed little change (Beckman
et al., 2001). This finding may indicate the difficulty of producing a change in provider
attitudes.
Provider Prescribing Practices
In general, research conducted on provider prescribing practices of emergency
contraception has shown prescribing frequency among providers to be low, regardless of
specialty. That is, most providers have prescribed emergency contraception at one point
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or another, but report prescribing the medication less than five times per year (Delbanco
et al. 1998; Gold, Schein, & Coupey, 1997; Sills et al., 2000; Chuang, Waldman, Freund,
& Ash, 2004). Unlike the low rates of prescribing among U.S. providers, a national study
of British health authorities found that the majority of physicians surveyed report that
they prescribe emergency contraception a few times per week (Webb & Morris, 1993).
A mail-based survey conducted in the northeast region of the U.S. sought to
compare emergency contraception prescribing practices among 282 providers and found
that 94% of obstetricians/gynecologists, 76% of family practitioners, and 63% of general
internists had ever prescribed emergency contraception. This study found that being
female was a positive predictor (OR: 9.6, 95% CI: 3.2-29.1) and the Catholic religion was
a negative predictor (OR: .39, 95% CI: .19-.79) for prescribing emergency contraception.
In addition, 75% of the physicians surveyed (86% of general internists, 82% of family
physicians, and 57% of obstetricians-gynecologists) reported infrequent prescribing of
emergency contraception (less than five times a year), regardless of their specialty
(Chuang, et al., 2004).
A study conducted in India found a very low level of prescribing of emergency
contraception. Researchers found that 84% of gynecologists and 41% of general
practitioners were vaguely familiar with emergency contraception, although among those
who had some knowledge, most were unsure of how to prescribe it. In fact, 51% of
gynecologists and 17% of practitioners reported ever prescribing it (Tripathi et al., 2003).
It is interesting to note that in both of these studies discussed above the
prescribing frequency among providers is low; however, women health care providers
like gynecologists tended to have a higher level of knowledge and a higher prescribing
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frequency of emergency contraception than non-women specific health care providers
such as pediatrics or general practitioners.
An additional U.S.-based study conducted on 78 providers consisting of family
physicians and nurse providers, also found low prescribing practices (Wallace et. Al.,
2004). Of the 78 providers studied, 74% reported that they have prescribed emergency
contraception in the past, with an average of 3.2 times in the past year.
In a U.S.-based study that surveyed 102 providers and measured level of
knowledge, attitudes, and practices of emergency contraception before and after an
educational program, at baseline only 7% of providers reported prescribing emergency
contraception once a month. At follow-up, prescribing frequency of emergency
contraception significantly increased (Beckman et al., 2001). For example, providers
who prescribed emergency contraception at least once per year rose from 30% to 49%
and providers who reported prescribing emergency contraception at least once a month
rose from 7% at baseline to 26% at follow-up. These findings indicate that an
educational program may help increase the frequency of provider prescription writing.
Although many of these studies discussed measured knowledge, attitudes, and
prescribing practices independently, very few studies have evaluated provider practices in
relation to provider knowledge and attitudes. One study found that knowledge about
emergency contraception was significantly related to prescribing practice whereas
attitudes about emergency contraception were not found to be significant predictors of
prescribing it (Sills et al., 2000). For example, two of the knowledge variables,
knowledge of the timing of emergency contraception and knowledge that it is FDAapproved, were predictive of emergency contraception counseling and prescribing. In
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contrast, none of the attitude variables including, (a) whether they thought emergency
contraception causes a risk of congenital malformation, (b) concern about giving or
prescribing the medication, (c) whether it should be used in rape cases, or (d) whether a
provider thought that the side effects of were serious, were predictive of prescribing
writing or counseling. This study suggests that knowledge, not attitudes, is a significant
predictor of emergency contraception prescribing. However, another study found just the
opposite. Gold et al. (1997) found that four out of the eight negative attitude variables
did correlate to failure to prescribe emergency contraception. In addition, another study
performed a cross-sectional survey of 96 faculty physicians and found that 42% of
physicians intended to prescribe emergency contraception for teenagers, whereas 65-77%
of the sample intended to prescribe to other identified groups. This study also found that
intention to prescribe was associated with positive attitudes but physicians’ knowledge
about emergency contraception was not found to be significant (Sable, Schwartz, Kelly,
Lisbon & Hall, 2006). This discrepancy in research findings merits further inquiry into
determining the predictors of emergency contraception prescription writing.
Pharmacists’ Knowledge, Attitudes, & Dispensing Practices of Emergency Contraception
In the only study of its kind, Van Riper and Hellerstedt (2005) assessed
pharmacist knowledge, attitudes, and dispensing practices of emergency contraception
among South Dakota pharmacists. A 14-item survey was mailed to all registered
pharmacists (n=810) in South Dakota to assess their attitudes, knowledge, and dispensing
practices of emergency contraception and 62% responded. Among respondents, only
54% of pharmacists worked in pharmacies that carried emergency contraception. For
those that carried the medication, 67% of pharmacists had dispensed emergency
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contraception in 2003 but 24% reported that they were not comfortable providing
counseling to clients about the medication. Dispensing practices did not vary by gender.
Findings also suggested that there was low knowledge about emergency
contraception among South Dakota pharmacists, as 37% were unaware that the
medication is similar in its mechanism to oral contraceptives. In addition, 74% of
pharmacists either incorrectly agreed or were uncertain about whether emergency
contraception can cause birth defects when administered to pregnant women and 85% of
respondents either incorrectly agreed or were uncertain about the statement that repeated
use of the medication can pose health risks. Only 5% of the sample correctly answered
all five of the knowledge questions on the survey (Van Riper & Hellerstedt, 2005). In
contrast to dispensing behaviors, knowledge and attitudes about emergency contraception
did vary by sex where more female pharmacists opposed making emergency
contraception over-the-counter.
One limitation of this study is that the researchers did not include enough
questions about attitudes towards emergency contraception and did not question whether
the pharmacist had personal or moral objections about dispensing the medication. In
addition, this study did not ask questions about knowledge of other contraceptive
medications to assess whether there was a lack of knowledge about all contraceptives or
just emergency contraception.
Although there have been no other published state-wide studies on the knowledge,
attitudes, and dispensing practices of pharmacists, there have been, however, a handful of
studies that assessed pharmacists’ knowledge and attitudes about emergency
contraception and one study that assessed pharmacists’ knowledge, attitudes, and beliefs
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towards prescribing emergency contraception. These five studies will be discussed
below in chronological order. Please see Appendix F to view these studies in a
comparative context.
In 1999, a study was conducted by the Planned Parenthood of New York City.
They conducted a phone survey of 100 retail pharmacists who practiced in New York
City and only 3 out of 100 pharmacists surveyed provided correct information about
emergency contraception, while 38 pharmacists did not know it was available in the U.S.
(Draut, 1999). In their article, Planned Parenthood compiled some interesting quotes
provided by pharmacists upon being called and asked about emergency contraception.
They are as follows: “…never heard of the morning-after pill…”, “Don’t have it…don’t
know anything about it”, “There’s no morning-after pill available in this country.”,
“…it’s used to induce periods and it starts contractions..it is abortion”, “It must be taken
within one day, that’s why it’s called the morning-after pill.” (p. 2-3).
The second study, conducted by Bennett, Petraitis, D’Anella, and Marcella in
2003, randomly selected pharmacies in Pennsylvania and assessed pharmacist knowledge
(accuracy of information provided to client) and availability of emergency contraception
through employing “mystery callers”. These mystery callers called the pharmacy and
spoke to 315 pharmacists. They asked questions that assessed knowledge and assessed
whether the particular pharmacy could dispense emergency contraception that day. The
findings from the study indicated that knowledge about and access to emergency
contraception was limited. In fact, 30% of the pharmacists surveyed did not provide the
correct timing required for emergency contraception administration where 23% thought it
needed to be taken within 24 hours and 7% thought it needed to be taken within 48 hours.
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In addition, 13% of the pharmacists said that emergency contraception would cause an
abortion (Bennett et al. 2003). Sixty-five percent of the pharmacists sampled reported
that they would not be able to fill a prescription of emergency contraception that day. Of
those who reported that the medication could not be filled that day, 79% said the
medication was not in stock, 6% replied that it was against store policy, 7% reported that
it conflicted with personal beliefs, and 8% did not provide a reason.
A potential limitation of this study is that attitude of the pharmacist was measured
by the mystery caller recording the attitude she felt from the pharmacist toward her after
the call ended. This variable was measured on a 5-point graded scale, from very
unpleasant to most pleasant (Bennett et al., 2003).
The third study, conducted in Indiana, mailed a survey to chief pharmacists
(n=948) at 1361 pharmacies and assessed pharmacists’ attitudes towards practice with
adolescents (Conard, Fortenberry, Blythe, & Orr, 2003). The study’s main goal was to
address pharmacists’ attitudes and practice with adolescents concerning all medications,
and although emergency contraception wasn’t the focus of the study, it was included in
the list of medications.
One interesting finding from this study was that although the majority of
pharmacists dispensed medication to adolescents, 57% reported feeling inadequately
trained for handling adolescent-related issues. Another important finding was that 48%
of the pharmacists surveyed did not dispense emergency contraception. Age was found
to be a significant factor in that pharmacists under 45 years of age were more likely to
report dispensing emergency contraception; however no differences were found for sex
(Conard et al., 2003).
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Of the 59% of pharmacists who have dispensed emergency contraception to
adolescents, 83% said that they felt uncomfortable dispensing it. There were no
differences in feelings of comfort based on age or sex (Conard et al, 2003). These
findings that emergency contraception is unavailable at pharmacies and that pharmacists
either don’t dispense or are uncomfortable dispensing emergency contraception to
adolescents is of concern in that it places barriers to access to emergency contraception
for adolescents.
A fourth study, conducted in Sweden, where emergency contraception is sold
both over-the-counter and in clinics and hospitals, assessed attitudes towards emergency
contraception and its OTC availability among pharmacists and pharmacy staff (n=237)
and nurse-midwifes (n=163) through a mail-based survey (Aneblom, Lundborg, Carlsten,
Eurenisu, & Tyden, 2004). The reason this study chose to survey pharmacists, pharmacy
staff, and nurse-midwives is because these individuals represent the professionals in
Sweden that are the main providers and counselors of emergency contraception.
The findings showed that both study groups had positive attitudes towards
emergency contraception and towards the OTC administration of emergency
contraception; however nurse midwives demonstrated more favorable attitudes than the
pharmacist group. In addition, verbal information and counseling to clients on issues of
emergency contraception was more commonly reported by the nurse-midwife group than
by the pharmacist group and both groups reported that they wanted more collaboration
between health care providers (Aneblom et al., 2004).
The fifth study, conducted in New Mexico, sought to describe pharmacists’
knowledge, attitudes, and beliefs towards prescribing emergency contraceptives through
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a mail-based questionnaire (Borrego et al., 2006). Of the 1392 questionnaires that were
delivered, 555 (40%) were returned but only 523 (38%) could be used. Overall, they
found that although New Mexico pharmacists had positive attitudes and beliefs about
prescribing emergency contraception, their knowledge about the medication was average.
In addition, 40% of the sample had an interest in becoming certified to prescribe
emergency contraception in their state-approved emergency contraception prescribing
training program.
New Mexico is one of three states (California, Maine, and New Mexico) that
allow pharmacists to dispense emergency contraception without a prescription under a
state-approved protocol. Pharmacists who had an interest in becoming certified to
prescribe emergency contraception were more likely to be male, non-Hispanic, nonChristian, to report liberal or moderate political views, and to say that they had employer
approval, time, and privacy at their pharmacy to prescribe emergency contraception.
New Literature
Since the original writing of this literature review, a few pertinent studies have
been published and will be addressed here. One study has been published describing the
knowledge, attitudes, and practices among pharmacists in Puerto Rico (Fuentes & AzizeVargas, 2007). Pharmacists attending a national conference were surveyed. Although it
was found that emergency contraception knowledge was low among these pharmacists,
they were in support of a non-prescription emergency contraception policy.
Another study assessed student pharmacist knowledge and attitudes surrounding
emergency contraception (Evans, Patel, & Stranton, 2007). A group of pharmacy
students were sent an electronic survey measuring knowledge, attitudes, and
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demographics. Researchers found that religious and political views played a role in
determining student attitudes about emergency contraception. They also found that high
levels of knowledge equates to more support and fewer concerns regarding use of
emergency contraception. This study aids in strengthening the results of this study in
terms of need for effective teaching and efficient learning.
Another few provider studies were published since this literature review, one
concerning a cross-sectional survey faculty physicians about intention to educate patients
about emergency contraception at four U.S. universities (Kelly, Sable, Schwartz, Lisbon,
& Hall, 2008), and one study that assessed provider knowledge, attitudes, practice, and
barriers at a military treatment facility in the U.S. (Chung-Park, 2008). The first study
found that attitudes and peer expectations around educating predicted intention to educate
patients about emergency contraception among faculty physicians. The second study
found low knowledge among the sample of providers such that there was a discrepancy
between what providers perceived knowing and actual knowledge. The first study
concludes that attitudes and beliefs should be addressed when creating interventions and
the second study calls for better education among providers.
Summary & Recommendations for Future Research
Women’s Knowledge & Attitudes
Overall, women’s knowledge and attitudes about emergency contraception vary.
In terms of women’s knowledge, more women are aware that emergency contraception
exists; however, they are not aware of the issues of timing, effectiveness, and how to
obtain it. This finding demonstrates the need for educational efforts to address these
deficits. Educational efforts should not only promote awareness of emergency
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contraception but should present specific information about the medication such as
correct timing for use, availability, level of effectiveness, proper use, and possible side
effects.
In terms of women’s attitudes towards emergency contraception, most women
had positive attitudes about the medication and these attitudes were not dependent on
level of knowledge. In fact, there was little consistency in the relationship between
knowledge and attitudes of emergency contraception. For example, some studies showed
high knowledge and positive attitudes, some studies showed low knowledge and positive
attitudes for future use, while other studies showed low knowledge and negative attitudes
towards the medication. Future research could examine the relationship between
emergency contraception knowledge and attitudes among women and determine what
causes these inconsistencies. However, one thing that can be surmised is that education
should be provided to women who are willing to use emergency contraception but are
unfamiliar with it. Another interesting finding was that in some studies, approval of the
pill was related to political or religious views. These views may account for the studies
that found high knowledge and low attitudes about emergency contraception; however
more research is needed to uncover these relationships.
Health Care Professionals’ Knowledge, Attitudes, & Practice
When comparing the provider studies, it becomes evident there is a paucity of
detailed knowledge about emergency contraception among providers and there are major
misconceptions that seem to persist. It seems that providers, specifically those who work
with women of childbearing age and whose duty it is to care for the health of women,
should have both salient and specific knowledge about emergency contraception.
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Unfortunately, these studies show that precise knowledge among healthcare professionals
is inadequate. Therefore, these findings suggest that training is needed for healthcare
professionals. Healthcare providers need more detailed information about emergency
contraception which would most likely increase the rate of knowledge and use by clients,
decrease the misconceptions held by providers, and increase provider prescribing
frequencies. Future research could test these hypotheses.
Although the knowledge that providers have about emergency contraception is
generally consistent in the literature, provider attitudes tend to vary with some reporting
positive and some reporting negative attitudes. This finding may be due to the fact that
people are different and there may be as many varying attitudes as there are people.
However, more research is needed in this area.
Another interesting finding was the gender differences detected in three of the
health care provider studies. One study found that women health care providers were
more likely than male health care providers to have negative attitudes towards emergency
contraception, the second study found that they were more likely than their male
counterparts to say that emergency contraception should not go over-the-counter (OTC),
and the third study found that being female was a positive predictor of prescribing
emergency contraception. The first two studies point towards female providers having
more negative attitudes towards emergency contraception than male providers but the
third study demonstrates that women providers are more likely to prescribe the
medication. These gender differences are noteworthy and should be explored in greater
detail.
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In general, results from studies show low prescribing rates of emergency
contraception among health care providers in the U.S. One study found that being female
was a positive predictor and being Catholic was a negative predictor of prescribing
emergency contraception. Two other studies found that knowledge was a predictor of
prescribing emergency contraception but conflicted on whether provider attitude was a
significant predictor of emergency contraception prescription writing. More research is
needed to uncover these relationships and inconsistencies and to determine what predicts
prescribing practices. Also, given the high abortion rate in this country, efforts should be
taken to increase the number of emergency contraception prescriptions that are written
which may aid in a decrease in abortion and unintended pregnancy rates in the U.S.
Pharmacists’ Knowledge, Attitudes, & Dispensing Practices
A major finding from the pharmacist studies is that many pharmacies in the U.S.
do not carry emergency contraception. This finding is troublesome in that access is
certainly limited if pharmacies do not carry the medication. Another major finding is that
there are many pharmacists that do not feel comfortable dispensing emergency
contraception to adolescents and also do not feel confident in counseling women about
emergency contraception. Perhaps future research could test if comfort levels in
counseling women and dispensing the medication would increase if knowledge about
emergency contraception was increased and misconceptions were dispelled.
Much like the health care provider literature, when viewing the pharmacist studies
it becomes apparent that there is a lack of detailed knowledge and understanding about
emergency contraception among pharmacists and major misconceptions persist as a
result. These studies show that precise knowledge among pharmacists is inadequate
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suggesting that training is needed for pharmacists. Pharmacists need more detailed
information about emergency contraception which may result in an increased rate of
knowledge and use by clients, a decrease in the misconceptions held by pharmacists,
increased provider dispensing frequencies, as well as increased comfort in counseling
about emergency contraception. Future research is needed to test these hypotheses.
Although studies have shown that the knowledge that pharmacists have about
emergency contraception is generally low, more research is needed in determining the
attitudes of pharmacists as they tended to vary with some reporting positive and some
reporting negative attitudes. In addition, given that there is only one study that measured
the self-reported emergency contraception dispensing practices of pharmacists, more
research is needed to understand the prescribing practices of pharmacists.
It is also important to note that there is limited research on emergency
contraception and pharmacists as there have only been five U.S.-based studies concerning
these topics. In addition, no other study except the Van Riper and Hellerstedt (2005)
South Dakota study, assessed pharmacists’ attitudes, knowledge, and dispensing practices
of emergency contraception. However, Van Riper and Hellerstedt (2005) failed to
determine whether pharmacist knowledge and attitudes about emergency contraception
predict dispensing practices. The proposed study will be the first to test these
relationships.
Given the low levels of knowledge detected among pharmacists in the few studies
conducted, it is imperative to find out what pharmacists are learning about emergency
contraception in school. Therefore, this study proposes to perform a curricula review of
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all 91 accredited schools of pharmacy in the U.S. to determine what is being taught about
emergency contraception to pharmacy students.
This study has two purposes: First, because the attitudes and dispensing practices
among pharmacists may be related to their understanding of the medication, a review of
pharmacy school curricula in the U.S. will be conducted, and will involve (a) an
assessment of course content related to emergency contraception and (b) an analysis of
how this content is perceived by pharmacy students. The second purpose of the study is
to assess emergency contraception knowledge, attitudes, subjective norms, perceived
behavioral control, and dispensing practices of pharmacists and to determine if
pharmacists’ emergency contraception knowledge, attitudes, subjective norms, and
perceived behavioral control are predictive of their dispensing practices.
The Theory of Reasoned Action
The theory that will guide this research, the Theory of Planned Behavior (TPB), is
an extension of the earlier Theory of Reasoned Action (TRA) which was developed by
Ajzen and Fishbein (1980; Fishbein & Ajzen, 1975). The Theory of Reasoned Action
was first introduced in 1967 (Fishbein, 1967), and is based on the assumption that people
are rational beings who make informed decisions based on available information. Thus,
the theory is called the Theory of Reasoned Action because it assumes that people
consider the implications of their actions before deciding whether to perform a particular
behavior (Ajzen & Fishbein, 1980).
The Theory of Reasoned Action’s primary purpose is to both predict and
understand behavior. The Theory also postulates that behavioral intention is the most
important predictor of behavior. That is, people typically behave in line with their
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intentions. Therefore, a secondary purpose of the TRA is to understand the determinants
of intentions. Following in line with the theory, behavioral intention is determined by
two factors, (a) personal attitudes toward the behavior and (b) social influence or
subjective norms. Personal attitudes toward a behavior refer to a person’s judgment in
performing the behavior. For example, whether a person believes performing a behavior
is good or bad is a personal judgment towards a particular behavior. Social influence or
social norms, the second determinant of intention, refers to the perceived social pressures
to perform or not perform a particular behavior. In general, a person intends to perform a
behavior when they have a positive attitude towards the behavior and when they perceive
that important people think they should engage in the behavior (Ajzen & Fishbein, 1980).
See Figure 1 for a graphic representation of the Theory of Reasoned Action.
The TRA also postulates that both attitude and social norms play a role in
behavioral intention; however the relative weights of these factors in terms of influencing
intention differ from person to person (Ajzen & Fishbein, 1980). For example, take two
women who are deciding whether or not to use birth control pills. Both women have the
same attitudes and social norms towards using the pill; they both want to use the pill
(attitude towards behavior) but feel social pressure not to use the pill (social norms),
however, one woman decides to use the pill and the other does not. This difference could
be because one woman places more emphasis on her attitudes to determine her intention
to use the pill and the other woman places more emphasis on social pressures to
determine her intention to use the pill. Either way, both of their attitudes and perception
of social pressures were the same but the relative weights of the attitudes and social
factors varied and thus the behavior was different (Ajzen & Fishbein, 1980).
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Figure 1. Theory of Reasoned Action
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Intention

Behavior
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Norm
The Theory of Planned Behavior
The Theory of Planned Behavior (TPB), which was developed after the Theory of
Reasoned Action (TRA), includes an additional construct, perceived behavioral control.
Whereas the Theory of Reasoned Action was developed to deal with volitional behaviors,
the Theory of Planned Behavior was developed to incorporate behaviors that are not
altogether volitional. For example, a smoker may intend to quit smoking but when tries
to quit, is unable to do so. Control over behavior is thus viewed on a continuum with one
extreme including something such as voting for a particular candidate in a voting booth
where the selection is performed at will and the other extreme includes actions like
sneezing or decreasing one’s blood pressure where people have limited control (Ajzen,
1988). Although these examples are extremes, the point is that many factors can interfere
with the relationship between intention and behavior.
Ajzen’s Theory of Planned Behavior was developed in an attempt to present a
conceptual framework that addresses this incomplete volitional control (Ajzen, 1985;
Ajzen & Madden, 1986; Schifter & Ajzen, 1985). The TPB postulates that there are three
(rather than the two addressed in the TRA) determinants of intention. The two that were
addressed in the Theory of Reasoned Action, (a) attitude toward behavior and (b)
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subjective norms, are still present and then a third determinant, (c) perceived behavioral
control is addressed in the Theory of Planned Behavior. Perceived behavioral control
refers to how difficult or easy the behavior is to perform and according to Ajzen, this
difficulty or ease of the behavior is “assumed to reflect past experience as well as
anticipated impediments and obstacles” (1988, p. 132). See Figure 2 for a graphic
representative of the Theory of Planned Behavior. In general, there is a direct positive
relationship between the three determinants. That is, as attitude and subjective norms
towards the behavior become more favorable, the perceived behavioral control becomes
greater and the intention to perform a particular behavior increases as a result (Ajzen,
1988).
Figure 2. Theory of Planned Behavior
Attitude
toward the
behavior
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Norm
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Intention

Behavior
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Control
There are two important features of perceived behavioral control. The first is that
it has motivational implications for intentions. That is, individuals who do not have the
resources or the opportunities to perform a behavior and not likely to develop strong
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behavioral intentions even though they may have favorable attitudes toward the behavior
and feel that people important to them would approve of the behavior. This is why there
is a straight line from perceived behavioral control to intention shown in figure 2,
because attitude and subjective norm may not mediate the relationship between perceived
behavioral control and intention (Ajzen, 1988).
The second important feature of perceived behavioral control is that it may have a
direct link to behavior as shown in figure 2. Perceived behavioral control can help
predict behavior or it can bypass behavioral intention altogether which reflects the idea
that perceived behavioral control can be a measure for actual control. Therefore,
perceived behavioral control can predict behavior through intentions and can also predict
behavior directly as a proxy measure for actual control (Ajzen, 1988).
This third determinant of intention is particularly relevant to the proposed study
because a pharmacists’ emergency contraception dispensing practices may vary based on
the perceived difficulty or ease of dispensing the medication. That is, emergency
contraception dispensing practices of pharmacists may not be under their volitional
control and therefore this third determinant of intention may be relevant for the study.
For example, if a pharmacist does not want to fill a prescription of emergency
contraception but perceives that if she or he refuses that they may be fired, the
pharmacists may decide to dispense the medication anyway.
Taking from the concepts, assumptions, and propositions of the TPB, it is
hypothesized that if pharmacists intend to dispense emergency contraception then they
will have a positive attitudes towards dispensing the medication and will perceive that
important people think they should dispense the medication. In addition, there will be a
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positive relationship between attitudes, subjective norms, and perceived behavioral
control. For example, if positive attitudes towards dispensing are high and if subjective
normative beliefs are high (perception that important people think they should dispense
the medication), than perceived control over the dispensing will also increase. As a
result, the intention to dispense emergency contraception will increase which will
increase the actual behavior of dispensing. Likewise, if pharmacists do not intend to
dispense emergency contraception, they will have negative attitudes towards dispensing
the medication and will perceive that important people think they should not dispense
emergency contraception. In addition, if the attitudes and subjective norms are low, the
perceived control over dispensing the medication should also be low. This way, the
intentions to dispense will be low and the actual behavior of dispensing emergency
contraception will be low as a result. See Figure 3 for a graphic representation of how
this theory may be applied to the research study.
Although the Theory of Planned Behavior does not explicitly include knowledge
as a predictor of behavior, it will be included in this study. Ajzen (1988) states, “at the
most basic level of explanation, behavior is assumed to be a function of salient
information, or beliefs, relevant to the behavior” (p. 132). The theory follows that
attitude toward a behavior is determined by beliefs about that behavior. Therefore if a
person thinks that a certain behavior will lead to favorable outcomes, then the person will
have a positive attitude toward the behavior and likewise, a person thinks that a certain
behavior will lead to a negative outcome, then the person will have negative attitudes
toward performing the behavior. In addition, a few of the provider studies found that
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knowledge, not attitudes, were predictive of emergency contraception prescribing
practices and therefore, knowledge will be added to the model as shown in Figure 3.

*Figure 3: Modified Theory of Planned Behavior Applied to Research Study
Knowledge
about EC
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dispensing EC
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*EC=Emergency Contraception
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Chapter Three: Methods
This chapter describes the methods that were used to conduct this study and has
been divided into eight sections: (1) purpose of the study, (2) research questions, (3)
overview of study design, (4) pharmacy school curricula review, (5) pharmacy student
focus groups, (6) pharmacist questionnaire, (7) data collection, and (8) data analysis.
Purpose of the Study
This study has two purposes: First, because the attitudes and dispensing practices
among pharmacists may be related to their understanding of the medication, a review of
pharmacy school curricula in the U.S. was conducted, and involved (a) an assessment of
course content related to emergency contraception and (b) an analysis of how this content
is perceived by pharmacy students. The second purpose of the study was to assess
emergency contraception knowledge, attitudes, subjective norms, perceived behavioral
control, and dispensing practices of pharmacists and to determine if pharmacists’
emergency contraception knowledge, attitudes, subjective norms, and perceived
behavioral control are predictive of their dispensing practices.
This project provided important state-level data for Florida, national data on
curricula for the U.S., and helped to identify geographic and demographic trends in
pharmacist practices. Since no other studies have been conducted on these variables and
on this topic, this research advances the state of knowledge, aided in formulating baseline
data on pharmacists’ knowledge and practice, and provided a venue with which to make
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recommendations of ways to strengthen pharmacy school curricula. In addition, this
research works towards the goals of mainstreaming emergency contraception and
reducing unintended pregnancy and the need for abortion in the U.S.
Research Questions
After a thorough review of the literature on emergency contraception knowledge,
attitudes, and dispensing practices, a review of behavioral theories, and an understanding
of the future recommendations suggested in the existing literature, the following research
questions emerged:
Question 1: What do the 91 accredited schools of pharmacy in the U.S. teach about
emergency contraception?
Question 1a: What objectives, course assignments, course readings, and lectures
concerning emergency contraception are provided in the required courses at the
91 accredited schools of pharmacy in the U.S.?
Question 1b: What objectives, course assignments, course readings, and lectures
concerning emergency contraception are provided in the elective courses at the 91
accredited schools of pharmacy in the U.S.?
Question 2: How is emergency contraception course content taught at accredited schools
of pharmacy as perceived by third or fourth year pharmacy students at the four accredited
schools of pharmacy in Florida?
Question 2a: What did pharmacy students learn about emergency contraception in
their pharmacy school classes?
Question 2b: How was emergency contraception taught in their pharmacy school
classes?
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Question 2c: What are the projected emergency contraception dispensing
practices of pharmacy students?
Question 3: What is the relationship among emergency contraception knowledge,
attitudes, subjective norms, perceived behavioral control, intention to dispense, and
dispensing practices of Florida pharmacists registered with the Board of Pharmacy?
Question 3a: Is emergency contraception knowledge predictive of dispensing
practices of Florida pharmacists?
Question 3b: Are attitudes about emergency contraception predictive of
emergency contraception dispensing practices of Florida pharmacists?
Question 3c: Are subjective norms about emergency contraception (whether
important people think they should dispense emergency contraception) predictive
of emergency contraception dispensing practices of Florida pharmacists?
Question 3d: Is perceived behavioral control, the perceived ease or difficulty of
dispensing emergency contraception, predictive of dispensing practices of Florida
pharmacists?
Question 3e: Is intention to dispense emergency contraception predictive of
dispensing practices of Florida pharmacists?
Question 3f: Are emergency contraception knowledge, attitudes, subjective
norms, perceived behavioral control, and intention to dispense taken together,
predictive of emergency contraception dispensing practices of Florida
pharmacists?
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Overview of Study Design
This research study employed a mixed methods study design involving both
survey and focus group methods. The study involved three major research questions with
sub-questions included within each of the three main questions. Each major research
question contains three separate methods crafted to address each individual but related
research question. Question #1 was addressed through a brief web-based survey emailed
to the Academic Deans of the 91 accredited schools of pharmacy in the U.S. Question #2
was addressed through focus groups with third and fourth year Doctor of Pharmacy
(Pharm. D.) students at the four accredited schools of pharmacy in Florida and Question
#3 was addressed through a mixed-mode survey administered to a randomly selected
group of pharmacists registered with the Florida Board of Pharmacy.
Taken together, findings demonstrated what is intended to be taught to pharmacy
students, what is actually being learned by pharmacy students, and how practicing
pharmacists’ perceptions of emergency contraception are associated with their dispensing
practices. This research study examined both the education and practice of pharmacists.
All activities were approved by the University of South Florida Institutional
Review Board. All records were stored in locked filing cabinets in a locked room. It was
assumed that all study participants in this study including Deans, practicing pharmacists,
and fourth year pharmacy students were able to both read and speak English and were
able to complete the questionnaires presented to them without aid.
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Pharmacy School Curricula Review
Target Population & Sampling Frame
The first research question, what do the 91 accredited schools of pharmacy in the
U.S. teach about emergency contraception, was addressed through a short web-based
survey to the Deans at the 91 accredited schools of pharmacy in the U.S. The target
population is Academic Deans at accredited schools of pharmacy in the U.S. In this case,
the target population, the sampling frame, and the sample are the same because the
survey will act as a census. Academic Deans were chosen as the target population for
this research question as they are the individuals who are most knowledgeable and
responsible for their school curricula. In addition accredited schools of pharmacy were
chosen as the target population because students must graduate from an accredited school
of pharmacy in order to become a licensed pharmacist in the U.S.
Sampling Plan
The following four letters were constructed and emailed to all 91 Deans: (a) a prenotice, (b) an abbreviated informed consent form, (c) a cover letter and questionnaire, and
(d) a thank you/reminder letter. Please see Appendix G for a copy of the Academic Dean
email pre-notice, Appendix H for a copy of the abbreviated informed consent form,
Appendix I for a copy of the Academic Dean cover letter and questionnaire, and
Appendix J for a copy of the Academic Dean thank you/reminder letter.
In addition to the survey and the informed consent form, all three letters, a prenotice, cover letter, and thank you/reminder, were added to the survey process as
recommended by the Dillman tailored design method (Dillman, 2000). According to
Dillman, the pre-notice email message should be delivered two to three days before the
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questionnaire is emailed out. The pre-notice has been shown to be important for email
surveys as it alerts the recipient that the survey will be arriving shortly and to not discard
it when it does arrive (Dillman, 2000).
After the pre-notice is delivered, the questionnaire followed a few days later.
Dillman (2000) suggests that a brief cover letter should be included directly before the
survey. It has been shown that brevity for the cover letter is best as people are more
likely to read an email that is shorter given the mass quantities of email that people have
to sift through on a daily basis (Dillman, 2000). In addition to a pre-notice and cover
letter, all email contacts were personalized as studies show that an individual is more
likely to respond to an email addressed directly to them rather than a mass email, group,
or listserve mailing (Dillman, 2000).
In addition to a pre-notice and cover letter, the third letter that should be included
in an online survey is a thank you/reminder email. This email is designed to both thank
individuals as well as remind them to fill out the survey. Attached to the thank
you/reminder letter is a replacement electronic questionnaire. Providing a replacement
questionnaire with the follow-up thank you/reminder letter has been shown to increase
survey response rates (Dillman, 2000).
A link to the web-based survey was emailed to all 91 Deans. Email addresses
were retrieved from school websites or by phone. The web-based survey was held on the
University of South Florida Ultimate Surveyor program. Ultimate Surveyor is an
electronic survey response program. It was employed to ensure confidentiality so that the
Academic Deans felt more comfortable providing accurate and truthful information about
their programs. Because this survey is electronic, a wavier of consent was requested and
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granted from the IRB as well as a waiver of written documentation. According to the
IRB, a one page document including the basic elements provided in a longer informed
consent form is all that is required for a study of this nature.
The survey asked Dean’s questions pertaining to the curricula offered in their
Pharm. D. programs, identified appropriate course numbers and titles, and requested an
electronic copy of every syllabus in both required and elective courses that included
objectives, course assignments, course readings, and/or lectures concerning emergency
contraception. These syllabi were retrieved, reviewed, totaled, and summarized by the
research investigator. The gathered data was entered into an EXCEL spreadsheet for
analysis and reporting purposes. Names of the particular schools and Academic Deans
were kept confidential and were not linked to the data. In addition, where applicable,
curricula information was searched for and retrieved from the school websites to amplify
and cross check the information provided by the Academic Deans. Course content is
assumed to be up-to-date, however it will only be as up-to-date as the faculty that create
the content and syllabi for the courses.
To more fully understand the feasibility of this survey, five Academic Deans from
schools of pharmacy in the U.S. were contacted by email prior to sending out the actual
survey. The email explained the study and inquired as to whether they would respond to
a survey of this nature. Three out of five Academic Deans reported that they would
respond to a survey of this nature, yielding a 60% response rate. The response from these
emails provided an estimate of the feasibility of this survey.
The Academic Deans survey was piloted to the Academic Dean of the USF
College of Public Health, and she said that she would complete it if it was sent to her;
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however it is not known how Academic Deans for schools of pharmacy will respond. A
30% return rate was expected from the Academic Deans (N=24). This percentage was
estimated from a review of email surveys which both reviewed and estimated response
rates of email surveys over time (Sheehan, 2001). In addition, preparations were made to
use curricula information provided on their school websites to search for emergency
contraception course content had we not received a good response rate from Deans.
Pharmacy Student Focus Groups
Target Population & Sampling Frame
The second research question, how is emergency contraception course content
taught at accredited schools of pharmacy as perceived by fourth year pharmacy students
at the four accredited schools of pharmacy in Florida, was answered through focus
groups conducted at all four accredited Schools of Pharmacy in Florida: Florida
Agricultural and Mechanical University, Nova Southeastern University, Palm Beach
Atlantic University, and University of Florida. These focus groups provided insight into
how the curricula in pharmacy schools are operationalized and perceived by pharmacy
students.
For this research question, the target population was fourth year Pharm. D.
students at accredited schools of pharmacy in the U.S. The sampling frame was fourth
year Pharm. D. students at the four accredited schools of pharmacy in the Florida and the
samples for the focus groups were created through non-probability quota sampling.
Focus Group Discussion Guide
A focus group topical guide was created by an expert panel to (a) understand what
pharmacy students learned about emergency contraception in their pharmacy school
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classes, (b) discover how they were taught about emergency contraception in their
pharmacy school classes, and (c) find out what their projected emergency contraception
dispensing practices will be upon becoming a pharmacist.
The topical guide was developed prior to the focus group discussions by the
researcher and panel of experts. The panel of experts consisted of pharmacy faculty,
recent pharmacy school graduates, practicing pharmacists, and a focus group expert. A
list of topic areas was generated that began with non-threatening issues leading into more
specific questions. Topical areas and probing questions for the focus groups included but
were not limited to the following:
•

Knowledge (What do you know about emergency contraception? Where
did you learn this information? What did you learn about emergency
contraception in your pharmacy classes? Which classes talked about
emergency contraception? Were these classes required or offered as an
elective? How does what you learned in course instruction vary from
what you learned or what you know from outside of class?)

•

Instruction (What were you taught about emergency contraception in your
pharmacy classes? How were you taught about emergency contraception?
What kinds of methods of instruction taught you about emergency
contraception (e. g. lectures, class discussions, course readings,
assignments)?

•

Practice (How do you feel about dispensing emergency contraception?
Do you feel any differently about dispensing emergency contraception
than you do dispensing any other medications? Where do your feelings
about dispensing come from? Do you think you will dispense the
medication upon becoming a pharmacist? What do you think about the
recent move to allow emergency contraception to be administered overthe-counter for women over 17 years of age? Does this change in
administration status change your views about emergency contraception?
Have your classes discussed the dispensing issues surrounding emergency
contraception? Have your classes brought up the new over-the-counter
status of emergency contraception?)
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The qualitative methods employed in this study best address the issue of cognitive
understanding or perceptions of course instruction on emergency contraception in their
pharmacy school classes because qualitative research is able to capture complex human
behaviors such as cognitive processes. Partnering the Academic Deans survey with the
findings from the pharmacy student focus groups allowed for an enhanced understanding
of pharmacy school curricula in the U.S. Not only did this study review emergency
contraception pharmacy school curricula but these focus groups provided insight into
how the curriculum is operationalized or translated to the pharmacy students it aims to
teach.
A limitation of focus group data in general, and this research question in
particular is that the information received from the pharmacy students is based solely on
self-reporting, meaning that what pharmacy students report learning about in their classes
may not be reflective of actual classroom instruction. No two students will learn the
same way or remember the same material exactly the same and therefore eliciting
pharmacy students’ perceptions about what they learned or were taught in pharmacy
school is subjective. However, the focus groups provided an accurate picture of what
these pharmacy students remember learning about emergency contraception and how
they remember being taught this information.
Sampling Plan
Each of the four accredited schools of pharmacy in Florida were contacted and
asked if focus groups could be conducted at their institutions. In addition, space to
conduct the focus groups was requested. One focus group per institution was conducted,
equaling a total of four focus groups. Both flyers as well as an email were disseminated
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to pharmacy students in an attempt to recruit study participants. If a school of pharmacy
did not have a listserve of pharmacy students to email, then only flyers were used for
recruitment. Flyers were placed into students’ mailboxes and places in convenient
locations around the school. The flyer and email announced the focus group date and
time and students had the ability to contact the researcher either by email or phone to sign
up to participate. All four schools participated in the dissemination of the flyer to aid in
the recruitment of students (see Appendix K for a sample of the recruitment flyer).
The researcher held one focus group at each of the four institutions and each focus
group attempted to recruit 8-10 students. If more than 10 students applied for any one
focus group, the first 10 students to make contact with the researcher were recruited for
the focus group. Individuals were excluded from the study if they were first or second
year students and if they were not working towards their Pharm. D. degree. These
criteria were selected because the Pharm. D. degree is the only degree that allows
students to become practitioners or pharmacists in various practice settings and this study
sought to understand the relationships between emergency contraception practices and
pharmacists. In addition, first and second year Pharm. D. students were excluded from
this study because they may not have had the course instruction that the focus groups
explore. The Pharm. D. degree is typically a four year and full-time program where the
first three years are dedicated to course work and then the last year is dedicated to an
advanced pharmacy practicum where the students apply their class room training to
clinical settings such as hospitals, outpatient facilities, and community clinics. Therefore,
third and fourth year Pharm. D. students were chosen so that they will have already had
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most of the course instruction for their degree which makes them able to answer the focus
group questions.
Study participants who met the eligibility criteria were asked to sign an informed
consent form prior to participation in the focus group. Please see Appendix L for a copy
of the focus group informed consent form. Students were given a $10 gift certificate to
Starbucks for their participation. Gift certificates were provided to study participants in
an envelope directly before the focus group discussions. Participants received
compensation before participation to show that they could leave the study at any time for
any reason, as waiting until the end of the focus group to distribute the gift certificate
could appear coercive.
Focus groups were conducted for approximately one hour and were tape recorded.
Participants sat in a circle for the focus group discussions. Two personnel were present
throughout the focus group discussions, a moderator and a note taker. The moderator
was the researcher and the note taker was an individual who has at least an undergraduate
degree and was screened by the researcher to ensure that the individual can take notes. In
addition, the note taker was trained by the researcher to understand the focus group
topical guide and how to take notes properly.
In total, 21 third and fourth year Pharm. D. students participated in the focus
group discussions (8 from UF, 4 from FAMU, 5 from PBA, 4 from NOVA). Study
participants met in a closed room, refreshments were served, and participants read and
signed the informed consent form prior to participation in the focus group. After
informed consent was procured, the paper and pencil survey was administered. Focus
groups were conducted for approximately one hour and were tape recorded. Participants
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sat in a circle at a table for the discussions. Two study personnel (a moderator and notetaker) were present throughout the focus group discussions. After each focus group, the
note taker presented a summary of the main ideas that had been identified in each
question and asked if participants had any changes or additions they would like to make
to the summary; when changes or additions were made, this information was included.
Debriefing between the note-taker and the moderator occurred directly after each focus
group discussion.
All data, audiotape, notes, and any other pertinent materials collected during focus
groups were kept confidential. The materials were stored in locked filing cabinets and no
personal identifiers were used. It should be noted that a limitation of the focus groups is
that there was a high potential for leading and researcher bias since the moderator was
also the researcher. In order to reduce this bias, the moderator stayed close to the topical
guide created by the panel of experts. In addition, the process of self-reflexivity was
performed where the researcher becomes aware of her own beliefs and how these beliefs
may be impacting the interaction and interpretation of the research.
Pharmacist Questionnaire
Target Population & Sampling Frame
The third research question, what is the relationship among emergency
contraception knowledge, attitudes, subjective norms, perceived behavioral control, and
dispensing practices of Florida pharmacists registered with the Board of Pharmacy, was
addressed through a 58-item, mixed-mode (paper or web-based) questionnaire
administered to a randomly selected group of Florida pharmacists. This research
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question will determine what variables, if any, are predictive of pharmacist emergency
contraception dispensing practices.
The target population for this research question was all pharmacists in Florida and
the sampling frame was all pharmacists registered with the Florida Board of Pharmacy.
Although national organizations such as the American Pharmaceutical Association
(AphA) have an impact on pharmacies and pharmacists, most pharmacists are regulated
more by state law and by their local state Board of Pharmacies. Therefore, although the
target population was all pharmacists in the U.S., it is better to perform research on a
state-by-state basis because state policies and regulations vary from state-to-state. The
target sample was 552 Florida pharmacists that were randomly selected from all
pharmacists (N= 29,896) registered with the Florida Board of Pharmacy. The
determination of the target sample size of pharmacists (N=552) for this study is discussed
in the power analysis section below.
Power Analysis—Sample Size
Target sample size (N) is determined by a confluence of factors including the
significance criterion (α), statistical power, and population effect size (ES). In statistical
modeling, the relationships between these four factors are a function of each other
(Cohen, 1992). The significance criterion (α) equals the acknowledged risk of falsely
rejecting the null hypothesis also referred to as Type I error. Typically α is set at .05 and
therefore in this study, α will set at .05 as well (Cohen, 1992).
Statistical power is the probability of rejecting the null hypothesis when it is false.
If the null hypothesis is false, failing to reject it is an error. This error, failing to reject a
false null hypothesis, is referred to as Type II error. The probability of committing a
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Type II error (β) is 1-power. Cohen (1992) recommends target power of .80 for general
use as a value smaller than .80 represents excessive risk of Type II error. Conversely,
power larger than .80 would require an N that would possibly be unattainable given the
resources of the researcher (Cohen, 1992).
Population effect size is the most difficult of all four components to determine.
Effect size is the degree to which the null hypothesis is false. Cohen (1992) has proposed
criteria for small, medium, and large effect size values based on a given statistical test.
Since the proposed research sought a medium effect size and for most of the statistical
tests employed in this research, an effect size of .30 will be adequate. An effect size of
.30 is able to detect an effect that can be visible to the naked eye of an observer (Cohen,
1992). This effect size is adequate for this research.
Given these three pieces of information, α=.05, statistical power=.80, and ES=.30,
both Cohen’s power tables of N for small, medium, and large effect sizes as well as a
power analysis program (performed in SAS) were employed in order to determine sample
size (N). First, it was necessary to determine the correct statistical tests to use. Given the
research questions and the levels of measurement of the survey questions, three statistical
tests were identified: Chi-square, significant tests of a sample r, and logistic regression.
Once the statistical tests were defined, the sample size required to get adequate power for
a medium ES could be determined. Each statistical test yielded a different N and the test
with the largest N was chosen as the appropriate sample size. Please see Table 1 for
sample size (N) determined by the statistical test with a medium ES.
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Table 1. Sample Size (N) for Medium ES at Power = .80 for α=.05
Test

Measure

Sample Size (N)

Sig r

r = .30

n = 85

Chi-square (6df)

w = .30

n = 151

Logistic Regression

tolerance=.5

n = 331

In order to find the sample size for Chi-square and significant tests of a sample r,
Cohen’s power tables were employed (1992). However, in order to determine the sample
size required for logistical regression, a power analysis was performed in SAS (SAS
Institute Inc, Cary, NC). The SAS program code used is a test of a single predictor in a
logistic model.
Tolerance is the extent to which the predictor variable is independent of the other
predictors. Tolerance set at 1 means that the predictor is completely independent of the
other predictor variables and if tolerance is smaller than 1, it means that the predictor
variable is related to the other predictors, and therefore a larger sample size is needed.
Tolerance was tested from 1 to .5. These values are represented in Table 2 below.
Table 2. Sample Size Required for Each Level of Tolerance (1 to .5) in Logistic Regression,
α=.05.
pi

OR
0.1
0.1
0.1
0.1
0.1
0.1

Tolerance
2
2
2
2
2
2

1
0.9
0.8
0.7
0.6
0.5

N
166
184
207
237
276
331

The model was set for power at .80, α=.05, and was set for the smallest odds ratio
that is cared about finding (OR=2) if the predictor is unrelated to the other predictors. It
is preferred that a tolerance of .5 is unique meaning that half of the variability of each
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predictor is independent of the other predictors. This is why a sample size of 331 was
chosen as this sample will maintain enough power to detect any differences. However, in
determining any sample size, response rates must be taken into consideration. Because
there is not a known response rate of pharmacists in existing literature, an expected
response rate was calculated by taking the mean of response rates from the other
pharmacist studies discussed in the literature review. Borrego et al (2006) had a 40%
return rate, Van Riper & Hellerstedt (2005) received a 67% response rate, and Conard et
al (2003) had a 75% response rate. Taking the mean of these three studies, a response
rate of 60% is expected for this survey which means that a sample of 552 pharmacists
will be required.
Sampling Plan
The power analysis determined that a target sample size of 331 would maintain
enough power to detect any differences and a response rate of 60% was established based
upon response rates from other studies that surveyed pharmacists. Therefore, it was
determined that 552 surveys should be mailed out to procure a sample of 331.
The sample was selected through a simple random sampling method. First,
information on all pharmacists who were registered with the Florida Board of Pharmacy
was downloaded from the Department of Health webpage (N=29,896) in EXCEL format.
Both active and inactive pharmacists living in Florida and outside of Florida were
contained in these files. Inactive pharmacists as well as pharmacists living outside of
Florida were sorted out of the total, leaving 17,310 pharmacists who were active and who
lived in Florida. A random number table was employed to generate 552 random numbers
from 1 to 17,310. The numbers in a number table are listed through a pure random
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process which allows any number the equal chance of being placed in any position. After
the beginning number was selected, this random sampling technique chose 552
pharmacists as participants for this study. This procedure is described in Neuman (2003)
as one way to approximate randomness and thus be able to yield a sample that is
representative of the total population. Finally, contact information on each of the 552
pharmacists was removed from the larger list and was entered into an additional EXCEL
spreadsheet which made up the sample.
A sample of 552 pharmacists was randomly selected for participation in this
study. Each pharmacist was mailed (a) a pre-notice postcard, (b) an abbreviated
informed consent form, (c) a cover letter (d) a questionnaire with an envelope with return
postage included, and (e) a thank you/reminder postcard as suggested to improve
response rates by the tailored design method (Dillman, 2000). Please see Appendix M
for a copy of the pre-notice postcard, Appendix N for a copy of an abbreviated informed
consent form, Appendix O for a copy of the cover letter, Appendix P for a copy of the
questionnaire, and Appendix Q for a copy of the thank you/reminder postcard.
Three separate mailings occurred for this portion of the research study, one for the
pre-notice, one for the actual questionnaire, and one for a thank you/reminder mailing
with online survey-mode option. Postal addresses of all pharmacists registered with the
Florida Board of Pharmacy were obtained from the Florida Department of Health
website. The pre-notice letter was mailed to pharmacists a few days before the
questionnaire was mailed. The pre-notice alerts the pharmacist to be on the look out for
an important survey that will be arriving within the near future and indicates that a
response would be appreciated. The pre-notice should be brief and personalized and is
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not meant to provide detail about the study but just to provide notice of the upcoming
request to complete a survey (Dillman, 2000).
A few days after the pre-notice was mailed, another mailing was sent out which
will included the informed consent form, cover letter, paper-based questionnaire, and a
return envelope. The return envelope was addressed and real stamps were usedinstead of
a business reply as using stamps has been shown to improve study response rates
(Dillman, 2000). The cover letter was no longer than one page and included pertinent
information about the study. The cover letter explained why the study is important.
Because this survey is a mail survey with follow-up internet survey option, a wavier of
consent was requested and granted from the IRB as well as a waiver of written
documentation. According to the IRB, a one page document including the basic elements
provided in a longer informed consent form is all that is required for a study of this
nature.
Regardless of whether the study participant returned the questionnaire, they
received a thank you/reminder postcard approximately one week after the delivery of the
questionnaire. The main purpose of this postcard is to jog the memories of the
individuals and increase the study response rate (Dillman, 2000). Included in the thank
you/reminder postcard was a link to the same survey on-line. Each participant may
choose to fill out the paper-based survey they received in the second mailing or an online version they received a link to in the follow-up post-card. Like the Academic Dean
survey, the pharmacist web-based survey was held on the USF Ultimate Surveyor
program. If pharmacists choose to complete their survey online, the informed consent
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form was the same as the paper-based informed consent except that participants clicked
the check box at the bottom of the screen signifying consent to participate in the study.
According to Dillman (2000), the type of mixed-mode format where one mode is
used at first contact and then another mode is used at final contact only to prompt the
completion of a survey, will improve coverage and reduce non-response rates. Dillman
(2000) notes, “introducing a new mode at this stage of the data collection may allow
information to be collected that will improve coverage…it is also likely it improve
response rates to the other mode significantly” (p. 222). In addition, potential
measurement differences that are found in other mixed-mode situations may be avoided
by introducing another survey mode this way (Dillman, 2000).
This type of mixed-mode survey design was chosen for this study as it improves
response rates while limiting measurement differences found in other mixed survey
modes. It was originally thought desirable to send respondents a choice between a paper
and pencil survey and an online version; however in practice this has not shown to
increase response rates (Dillman, 2000). Therefore, the current mixed-mode survey
design with the first mode being paper-based and the follow-up or final mode being
online was chosen for this research study.
Originally, it was thought that a comparison of critical variables to estimate nonrespondent bias could be performed. That is, answers from first responders were going to
be compared to answers from those who responded after the follow-up post card to
measure any differences in the two groups. However, due to the low number of
responders from the follow-up postcard (n=8), this type of bias could not be estimated.
In an additional attempt to understand the characteristics of non-responders, the Florida
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Board of Pharmacy was contacted to see if they collect basic demographic information on
Florida pharmacists. However, they do not, meaning that the demographic information
from the responders cannot be compared to the demographic information of nonresponders and therefore the characteristics of the non-responders cannot be known.
The pharmacist survey was developed, piloted, and tested for readability,
reliability, and validity among a group of pharmacists. The questionnaire inquire about
six main variables, (1) level of knowledge about Plan B, (2) personal attitudes held about
Plan B and about Plan B dispensing, (3) perceived social pressures around issues of
dispensing, (4) perceived behavioral control over the behavior of dispensing Plan B, (5)
intention or likelihood of dispensing Plan B, and (6) emergency contraception dispensing
practices. In addition to questions that measure these six variables, the instrument will
include questions on basic demographics and background such as age, gender, ethnicity,
marital status, religious and political party affiliation, type of pharmacy, and length of
time in practice.
Data Collection
Instrument Development
To guide the questionnaire development and focus group topical guide for this
study, interviews were conducted with a panel of experts in which practicing pharmacists
were asked general questions about being a pharmacist, their schooling and curricula, and
their emergency contraception knowledge, attitudes, subjective norms, and perceived
behavioral control. Please see Appendix R to review the questions and responses from
the expert interviews.
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It is from these interviews as well as from the literature review and the theoretical
underpinnings of the Theory of Planned Behavior, that instruments were developed for
this study. The literature review in particular brought three important studies to light that
were influential in the creation of the pharmacist questionnaire. Permission was
requested to utilize parts of instruments that were employed in these studies. Questions
were selected from these three studies and combined to form one questionnaire however
some questions were taken and altered to fit the proposed study. The pharmacist survey
instrument was developed from the surveys used in the following three studies:
1)

The most influential study in terms of survey development assessed
pharmacist knowledge, attitudes, and dispensing practices of emergency
contraception among South Dakota pharmacists. A 14-item survey was
mailed to all registered pharmacists (n=810) in South Dakota to assess
their attitudes, knowledge, and dispensing practices of emergency
contraception and 62% responded (Van Riper & Hellerstedt, 2005). Many
of the practice and workplace as well as knowledge and attitudes questions
were taken and adapted from the survey instrument employed in the
pharmacist survey.

2)

Another U.S.-based study examined emergency contraception knowledge,
attitudes, and behaviors among women and men ages 18-21 (n=97)
attending a university through the use of a 25-item paper-based
questionnaire (Corbett, Mitchell, Taylor, & Kemppainen, 2006).
Although this questionnaire was read to aid in the development of ideas
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for the pharmacist survey, the only questions taken from this instrument
were the demographic questions.
3)

A third study performed a cross-sectional survey of 96 faculty physicians
from four universities to measure prescribing intention of emergency
contraception (Sable, Schwartz, Kelly, Lisbon, & Hall, 2006). Many of
the prescribing practice and perceived behavioral control questions were
taken from the survey instrument, adapted, and employed for use in the
pharmacist survey.

The pharmacist survey was piloted among a group of pharmacists not eligible for
participation in the Florida pharmacist survey. The Academic Deans survey was piloted
among the Academic Dean of the USF College of Public Health as she was not eligible
for the pharmacy school curricula review. The feedback from this pilot was helpful in
not only adjusting the survey but also for understanding the feasibility of the survey.
After reviewing the survey, the Academic Dean of the USF College of Public Health
indicated that she would respond to the survey if it had been emailed to her. In order to
better understand the feasibility of the Academic Deans survey, five Academic Deans
were randomly selected and sent an email asking if they would respond to a three item
questionnaire of this nature. The final pharmacist and Academic Dean surveys were
developed from the feedback provided through the pilots.
Both instruments, the pharmacist questionnaire and the Academic Dean
questionnaire, were tested for validity and reliability. The focus group topical guide will
be discussed in greater detail later in the paper. Reliability refers to the dependability or
consistency of the instrument and validity implies truthfulness and refers to how well the
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construct and measure fit together (Neuman, 2003). There are three types of reliability
that are of concern: stability reliability, representative reliability, and equivalence
reliability.
Stability reliability is a measure of dependability across time. That is, will this
instrument yield the same answers over varying time periods? Stability reliability can be
measured through a test-retest method where the instrument is re-administered to the
same group of people to see if the same results are produced multiple times (Neuman,
2003).
Representative reliability is dependability across different groups of individuals.
It answers the question; will the instrument yield the same answers when administered to
different groups? Representative reliability can be measured through a subpopulation
analysis in which the instrument is measured among different groups of people such as
people of varying ages, sexes, and ethnicities. The instrument is said to have
representative reliability if the groups maintain the same error rate (Neuman, 2003).
Equivalence reliability is dependability when multiple indicators are used to
measure a construct. It answers the question; does the construct yield consistent findings
across the various indicators or survey items? Cronbach’s alpha is a statistical measure
that can determine equivalence reliability. Cronbach’s alpha is a numerical coefficient of
reliability ranging from 0 to 1 and the higher the score, the more reliable the scale. A
reliability coefficient of .7 is viewed as acceptable; however some literature has accepted
lower coefficients (Nunnaly, 1978).
Not only will the test-retest method, a subpopulation analysis, and Cronbach’s
alpha be employed to test for reliability but other ways to increase reliability include: (a)
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conceptualizing constructs clearly, (b) employing multiple indicators, and (c) running
pilot tests (Neuman, 2003).
Validity or more specifically, measurement validity indicates how conceptual and
operational definitions fit with each other. The greater the fit, the more measurement
validity is achieved. Validity answers the question: does the indicator measure the
construct it is trying to measure? There are two types of measurement validity that are of
concern for this study: face and construct validity. Face validity is a consensus measure
of validity which demonstrates that people agree that the indicator measures the
construct. Face validity answers the question; do people think that there is a fit between
the definition and the method of measurement? Construct validity is employed when
measures have multiple indicators. Construct validity answers the question, are the
various indicators consistent? Face validity was measured through a survey pilot test and
construct validity was calculated through factor analysis procedures, all of which will be
discussed in the results section below.
Measures
There are six main constructs measured in the survey of pharmacists, (1)
knowledge (2) attitudes, (3) subjective norms, (4) perceived behavioral control, (5)
intention to dispense, and (6) dispensing practices. Each of these six constructs is
measured by multiple indicators or survey questions. All independent, dependent, and
socio-demographic variables, survey questions, response options, and variable level of
measurement are represented in Appendix S.
1) The first construct, knowledge, is measured by 10 separate questions and is
measured on the nominal level. Knowledge is operationalized through a
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comprehension of emergency contraception effectiveness, number of pills
dispensed in Plan B packaging, mechanism of action, and health risks.
Individual variables include: # of pills in package, hours of effectiveness,
mechanism of action, timing for effectiveness, comprehension about OTC
sales, health risks, birth defects, and abortifacient.
2) The second construct, attitudes, is measured by 8 separate questions and is
measured at the nominal and ordinal levels. An attitude is defined by Ajzen
(1988) as “…a disposition to respond favorably or unfavorably to an object,
person, institution, or event.” (p. 4). Therefore survey questions about
attitudes measure self-reported feelings or beliefs that are positive and
negative about emergency contraception use and dispensing. Variables
include: feelings about benefits and risks, beliefs about maintenance of
contraception, feelings about promiscuity, feelings about prescribing and
religion/ethics, feelings about repeated use, feelings about comfort level in
dispensing, feelings about dispensing to adolescents, feelings about dispensing
for clients, beliefs about lifetime use of emergency contraception.
3) The third construct, subjective norms, refers to the perceived social pressures
to perform or not perform a particular behavior. Subjective norms are
measured through 6 questions that query about how the participant perceives
what important people think about emergency contraception dispensing and is
measured at the interval level. Variables include: partners/colleagues
perception of emergency contraception dispensing, professional organization
perception of emergency contraception dispensing, boss perception of
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emergency contraception dispensing, and close friends and family perception
of emergency contraception dispensing. Additionally, two questions were
asked regarding their pharmacy culture (i. e. if there is anyone who refuses to
dispense the medication at their pharmacy and if there is a policy in place at
their pharmacy if someone refuses to dispense Plan B).
4) The fourth construct, perceived behavioral control is measured by 4 questions
and refers to how difficult or easy the behavior is to perform and in this case,
the behavior is emergency contraceptive dispensing. Therefore, perceived
behavioral control is measured by four questions that inquire about the ease or
difficulty involved in dispensing emergency contraception and is measured at
the ordinal level. Variables include: perceived ease of counseling clients,
perceived ease of dispensing, perceived ease of refuse to dispense, perceived
ease of educating clients.
5) The fifth construct, intention or likelihood to dispense Plan B, is measured by
8 questions that query pharmacists about their intention to dispense Plan B to
varying groups of people. For example, pharmacists answer whether they are
likely or unlikely to dispense Plan B to women who are raped, women who
have experienced a problem with their birth control method etc. to test for
differences in intention to dispense based on the situation of the woman
requesting the medication. Intention to dispense is divided by OTC and by
prescription to account for any differences.
6) The sixth construct, dispensing practices, is measured by 13 questions that
query pharmacists about their emergency contraception dispensing practices
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in general and by prescription and over-the-counter to varying groups of
people. Variables are measured on both the nominal and ordinal levels and
include: pharmacy stock of birth control products, pharmacy dispensing of
emergency contraception, ever filled a prescription, # of prescriptions filled in
past 12 months, likelihood of dispensing over-the-counter to various groups,
and likelihood of dispensing by prescription to various groups. However, in
the analysis, dispensing practices are only measured by two questions that ask
pharmacists if they have ever dispensed Plan B by prescription or OTC.
In addition to these measures, demographic information such as age, gender,
ethnicity, marital status, religious and party affiliation, type of pharmacy, and length of
time in practice will be collected on study participants and these variables are measured
on the nominal, ordinal, and ratio levels. The first five constructs, knowledge, attitudes,
subjective norms, perceived behavioral control, and intention to dispense are the
independent variables and dispensing practices is the dependent variable. See Figure 4
below for a graphic representation of these variables. This design will aid in
understanding which independent variables, if any, predict emergency contraception
dispensing practices of pharmacists.
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Figure 4: Independent and Dependent Variables
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Reliability and Validity Measures
The pharmacist survey was developed, piloted, and tested for readability, validity,
and reliability among a group of pharmacists. After the pilot and tests, the survey was
finalized as a 58 item questionnaire.
Validity: Face, Content, and Construct
The pharmacist survey was piloted among a panel of experts (n=5) including
practicing pharmacists, pharmacy faculty, and pharmacy students for face and content
validity. Participants were asked to rate each question on the instrument as to whether it
looks as if it is measuring the designated topic (face validity) and were asked to provide
comments on how to fix questions that were given low ratings. In addition, participants
were asked if there were important aspects of each question of the designated topic that
the instrument was not measuring (content validity). See Appendix T for a sample
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review guide that was distributed to measure face and content validity. It was from this
pilot among a panel of experts that the pharmacist questionnaire was fully developed (see
appendix N for the finalized pharmacist survey).
Construct validity of scores was measured by exploratory factor analysis. Survey
questions naturally divided into the predefined construct areas of knowledge, attitudes,
subjective norms, perceived behavioral control, and dispensing practices. Factor analysis
was conducted separately for each construct area to see if content area questions are only
measuring that one factor. Factor analysis was performed using SAS statistical
packaging (SAS Institute Inc, Cary, NC). Eigenvalues (the proportion of variance
determined by each factor) were used to help decide on the number of factors (via the
scree plot). In addition, squared multiple correlations were used as prior communality
estimates, principal factor analysis was used to extract factors, and an oblique rotation
was employed. A scree test was also used to determine meaningful factors and an item
was said to load on a factor if the pattern coefficient was above .30.
Knowledge: The eigenvalues and scree plot suggested that one factor was present
among the 10 questions aimed at measuring knowledge of emergency contraception
(Questions 22-31) as only one factor maintained an eigenvalue over 1. The factor
represented 22.5% of the total item variance in the set of questions. Given the criteria of
.30, all variables loaded at .30 or higher except for questions 24 and 25 (see Table 3).
However, after a closer look at questions 24 and 25 in the survey, it was determined that
they would need to stay in the analysis as they measured understanding of the mechanism
of action and percentage of effectiveness, both of which are critical to knowledge of the
medication.
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Table 3. Factor Pattern matrix for Knowledge Items
Item
Q22. Number of pills in Plan B package
Q23. Timing of administration
Q24. Mechanism of action
Q25. Percentage of effectiveness
Q26. Who can sell Plan B to consumers
Q27. How to sell OTC to women (in advance of need)
Q28. How to sell OTC to men
Q29. Plan B can cause birth defects (True/False)
Q30. Plan B can act as an abortifacient (True/False)
Q31. The sooner a woman takes Plan B, the more effective it will be
(True/False)

Factor 1
0.52
0.64
0.28
0.20
0.53
0.38
0.55
0.50
0.58
0.37

Attitudes: The eigenvalues and scree plot suggested that one factor was present
among the 8 questions aimed at measuring attitudes about emergency contraception
(Questions 32-39) as only one factor maintained an eigenvalue even over 0. The factor
represented 86.6% of the total item variance in the set of questions. All items maintained
very high loadings on the one factor with the lowest loading at 0.75 and the highest at
0.99 (see Table 4).
Table 4. Factor Pattern matrix for Attitude Items
Item
Q32. Easy availability of Plan B will discourage regular contraceptive use
Q33. Easy availability of Plan B promotes promiscuity
Q34. I feel uncomfortable dispensing Plan B because of my
religious/ethnical beliefs
Q35. Repeated use of Plan B is wrong
Q36. I feel comfortable dispensing Plan B to adult women
Q37. I feel comfortable dispensing Plan B to adolescents (teens <18 yrs old)
Q38. I feel comfortable dispensing Plan B to men
Q39. Should Plan B be offered to women who are raped in all hospital
emergency rooms, regardless of hospital affiliation?

Factor 1
0.99
0.89
0.99
0.81
0.99
0.99
0.99
0.75

Subjective Norms: Much like knowledge and attitudes, the eigenvalues and scree
plot suggested that one factor was present among the 4 questions aimed at measuring
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subjective norms (Questions 40-43) as only one factor maintained an eigenvalue over 0.
The factor represented 78.5% of the total item variance in the set of questions. As
demonstrated in Table 5, all items maintained very high loadings on the one factor
ranging from 0.83 to 0.94.
Table 5. Factor Pattern Matrix for Subjective Norm Items
Item
Q40. My partners/business colleagues think I should dispense Plan B
Q41. The professional organization I am most active in recommends
that I dispense Plan B
Q42. My supervisor thinks that I should dispense Plan B
Q43. My close friends and family think I should dispense Plan B

Factor 1
0.94
0.83
0.86
0.91

Perceived Behavioral Control: The eigenvalues and scree plot suggested that one
factor was present among the 4 questions aimed at measuring perceived behavioral
control (Questions 46-49) as only one factor maintained an eigenvalue over 0. The factor
represented 96.5% of the total item variance in the set of questions. All items maintained
very high loadings on the one factor ranging from 0.93 to 1.00 (see Table 6).
Table 6. Factor Pattern Matrix for Perceived Behavioral Control Items
Item
Q46. How easy is it for you to counsel clients about Plan B
Q47. How easy is it for you refuse to dispense Plan B
Q48. How easy is it for you educate clients about Plan B
Q49. How easy is it for you dispense Plan B

Factor 1 Pattern
Loadings
1.00
0.93
1.00
1.00

Dispensing Practices: Dispensing practices includes the two separate constructs of
actual dispensing practices and intention to dispense emergency contraception. Actual
dispensing practices of emergency contraception is measured by two items (Questions 8
and 11). Question 8 asks if a respondent has ever filled a prescription of Plan B and
question 11 asks if they have ever sold Plan B OTC. Because the variable, actual
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dispensing practices, is only measured by two questions, factor analysis does not
conceptually make sense. Instead, a cross tabulation, Pearson Chi-Square test of
association, and Phi coefficient statistic was run to determine the relationship between the
two questions. The Chi-Square test revealed a direct and significant relationship (ChiSquare value 91.33, p<0.001) between the two questions. The Phi coefficient which is
the measure of association between the two variables was significant (Phi=0.585,
p<0.0001). These findings provide enough evidence to combine them into one construct
measuring actual dispensing practices.
As for intention to dispense emergency contraception, the eigenvalues and scree
plot suggested that one factor was present among the 8 questions aimed at measuring this
construct (Questions 14-21) as only one factor maintained an eigenvalue over 0. The
factor represented 80.5% of the total item variance in the set of questions. All items
maintained very high loadings on the one factor ranging from 0.70 to 1.00 (see Table 7).
Table 7. Factor Pattern Matrix for Intention to Dispense Items
Item
Q14. Likelihood of dispensing OTC to women who have experienced
incest or rape
Q15. Likelihood of dispensing OTC to women who have experienced a
problem with their birth control method
Q16. Likelihood of dispensing OTC to women who request the method
after having unprotected sexual intercourse
Q17. Likelihood of dispensing OTC to a person other than the ultimate
consumer of the product such as parents or a boyfriend
Q18. Likelihood of dispensing by prescription to women who have
experienced incest or rape
Q19. Likelihood of dispensing by prescription to women who have
experienced a problem with their birth control method
Q20. Likelihood of dispensing by prescription to women who request the
method after having unprotected sexual intercourse
Q21. Likelihood of dispensing by prescription to sexually active teens
under age 18
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Factor 1
0.73
0.99
0.71
0.98
0.99
1.00
1.00
0.70

In summary, exploratory factor analysis provides evidence of construct validity of
scores for the pharmacist survey.
Reliability: Stability and Equivalence
Reliability refers to the dependability or consistency of an instrument and validity
implies truthfulness and refers to how well the construct and measure fit together
(Neuman, 2003). There are two types of reliability that are of concern: stability and
equivalence reliability.
Stability reliability is a measure of dependability across time. That is, will this
instrument yield the same answers over varying time periods? Stability reliability was
measured through a test-retest method where the instrument was re-administered to the
same group of people to see if the same results were produced multiple times (Neuman,
2003). The pharmacist survey was administered online to a group of 18 pharmacists at
one point in time and then again about one week later. The sample of pharmacists who
participated did not practice pharmacy in Florida, so not to impact study results. Survey
data were stored in an EXCEL database and were analyzed using SPSS statistical
analysis software (SPSS 16.0, SPSS Inc., Chicago). Percentage agreements and Pearson
product-moment correlation coefficients were calculated to measure the relationship
between the variables over the two time periods. Percentage agreements measure the
proportion of all occasions at which the variables agree across time and are primarily
used with nominal level data. A percentage of 80% or higher was deemed as acceptable.
Pearson product-moment correlation coefficients (represented as r) assess the relationship
between variables and range from -1 to zero to +1 and are typically employed with rato or
interval levels of measurement. A correlation of -1 demonstrates a perfect negative linear
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relationship, 0 means that there is no relationship, and +1 demonstrates a perfect positive
linear relationship between variables. A Pearson correlation of 0.60 or higher was
deemed as acceptable.
The survey was tested and was found to have acceptable reliability of scores. The
results support dependability of scores that will be procured from the survey. The results
are discussed below and have been categorized by survey construct: background
characteristics, dispensing practices, knowledge, attitudes, subjective norms, and
perceived behavioral control.
Background Characteristics.

Background characteristics are comprised of

13 variables including gender, age, ethnicity, years in practice, type of pharmacy, marital
status, religion, religiosity, political affiliation, employment status, pharmacy school
attended, year of graduation, and job title. Percentage agreement tests were performed on
all 13 variables. A Table depicting the results for the demographic variables is provided
below.
Table 8. Percentage Agreements for Background Characteristics
Variable
Percentage Agreement
Gender
100%
Age
83%
Ethnicity
100%
Years in practice
83%
Type of pharmacy
100%
Marital status
100%
Religion
94%
Religiosity*
72%
Political affiliation
100%
Employment status
100%
Pharmacy school attended
94%
Year of graduation
100%
Job title
94%
*Did not meet the 80% cut off value.
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All variables except for one (religiosity) met the percentage agreement cut off
value of 80%. The percentage agreement for religiosity was 72% in that five out of the
eighteen participants changed their answer over time. The question on religiosity asked,
How would you describe yourself (choose only one). The answer choices were 1)
Religious, 2) Spiritual, 3) Religious and spiritual, 4) Undecided, 5) None of the above,
and 6) Prefer not to respond. Of the five respondents that changed their answer from one
administration to the other, the first respondent changed their answer from religious to
prefer not to respond, two participants changed from religious and spiritual to religious,
one changed from none of the above to religious and spiritual, and the last respondent
changed from prefer not to respond to none of the above. The inconsistency in the
answers of these five participants seems to be a result of the personal nature of the
question.
Dispensing Practices. Dispensing practices is measured by 17 questions of which
percentage agreements were performed on nine questions and Pearson correlations were
performed for the other eight questions. Of the nine that received percentage agreements,
the questions queried about pharmacy stocking of condoms, spermicide, oral
contraceptive pills, stocking of Plan B, dispensing of Plan B and inquired about how
many times within the past year that they dispensed it both OTC and by prescription (see
questions 5-13 in pharmacist survey Appendix N). All nine questions received
percentage agreements above the 80% cut off value and are therefore reliable. In fact, all
but two questions received 100% agreements across the two survey administrations. The
two questions that received less than 100% agreements were the open ended questions
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querying about how many times they have sold Plan B OTC and by prescription in the
past 12 months and yielded 88% and 83% agreements, respectively.
Pearson correlations were run on the eight questions measuring dispensing
practices. Specifically, these questions measure to what extent pharmacists are likely to
sell Plan B OTC or dispense Plan B by prescription to women in varying circumstances
such as women who were raped, women who had a problem with their birth control
method etc. (see questions 14-21 on the pharmacist survey Appendix N). These
questions employ a 4-point Likert scale ranging from very unlikely to very likely.
Correlations were run for each individual item at time one and time two. In addition, the
responses were combined to create a new variable and the combined variable was run at
time one and time two. All individual questions received a Pearson correlation of
r=0.686 or higher, demonstrating a positive relationship and all analyses were significant
at the p=0.01 level. In addition, the combined score for dispensing practices yielded a
Pearson correlation coefficient of r=0.820, with significance at the p=0.01 level.
Knowledge.

Knowledge of emergency contraception is measured by 10

questions querying on the basic properties and mechanisms of action of Plan B as well as
questions that measure if pharmacists have knowledge around issues of dispensing Plan B
OTC (see questions 22-31 in pharmacist survey Appendix N). For knowledge, each item
was awarded one point if the participant responded correctly and zero if they responded
incorrectly. The points were added up for each participant yielding a knowledge score
for each participant at time one and time two. Then, Pearson correlations were run on
these knowledge scores. The Pearson Correlation was r=0.849, demonstrating a positive
relationship and was significant at the p=0.01 level.
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Attitudes. Attitudes is measured by eight questions querying about how
pharmacists personally feel about dispensing and about women using Plan B (see
questions 32-39 in pharmacist survey Appendix N). Seven of the questions are Likert
scale questions (questions 32-28) and therefore employed Pearson correlations and one of
the questions is a nominal level question (question 39) and therefore a percentage
agreement was calculated. Of the seven questions employing a 4-point Likert scale,
responses ranged from completely disagree to completely agree. First scores had to be
adjusted such that a higher score demonstrated a more positive attitude towards Plan B.
The response scale for these items was reflected. After this process, correlations were
run for each individual item at time one and time two. In addition, the responses were
combined to create a new variable and the combined variable was run at time one and
time two. All individual questions received a Pearson correlation of r=0.727 or higher,
demonstrating a positive relationship and all analyses were significant at the p=0.01 level.
In addition, the combined score for attitudes yielded a high Pearson correlation
coefficient of r=0.950, with significance at the p=0.01 level. The one nominal level
question received a percentage agreement of 100% and is reliable.
Subjective Norms. The construct subjective norms is measured by six questions
pertaining to the way people, groups, and pharmacy policy may be associated with
pharmacist dispensing of Plan B (see questions 40-45 in pharmacist survey Appendix N).
Pearson correlations were run on four of the questions measured on a 4-point likert scale
(interval data) and percentage agreements were calculated for the other two questions that
were measured at the nominal level. For the analysis of the four likert scale questions
(questions 40-43), the answers were combined and Pearson correlations were calculated.
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The Pearson Correlation was 0.820 and were significant at the p=0.01 level,
demonstrating a positive relationship. The two questions that were measured at the
nominal level (questions 44-45) maintained 100% agreement between time one and time
two.
Perceived Behavioral Control. Perceived behavioral control is measured by four
questions on a 4-point likert scale depicting how difficult or easy it is to dispense Plan B
(see questions 46-49 in pharmacist survey Appendix N). Questions queried about how
difficult or easy it is to counsel and educate clients, to dispense and refuse to dispense
Plan B. Responses to the questions were added up and Pearson correlations were
calculated. The Pearson Correlation was 0.831, demonstrating a positive relationship and
all analyses were significant at the p=0.01 level.
In summary, the statewide pharmacist survey was found to have stability
reliability and thus these results support dependability of scores that will be procured
from the survey.
Equivalence reliability assesses how well variables measure a latent construct.
Cronbach’s alpha is a statistical measure that can determine equivalence reliability. This
measure is a numerical coefficient of reliability ranging from 0 to 1 and the higher the
score, the more reliable the scale. A reliability coefficient of .70 is typically viewed as
acceptable (Nunnaly, 1978). Reliability analysis through Cronbach’s alpha was
performed on the four constructs that contained interval and ordinal level data (attitudes,
subjective norms, perceived behavioral control, and dispensing practices) and all
coefficients exceeded the acceptable value of .70. In fact, all reliability coefficients
exceeded .90. Given that the construct of knowledge is based on nominal level data in
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which a composite knowledge score was calculated for each individual, it did not make
sense to assess scale reliability through Cronbach’s alpha. Instead, the equivalence
reliability measure for knowledge will rely on the stability reliability measure and high
Pearson correlation that was determined through the test-retest method. However, for the
other four constructs, reliability estimates were .98 for attitudes, .94 for subjective norms,
.99 for perceived behavioral control, and .95 for dispensing practices. Therefore, the
variables are measuring each construct and the scale is shown to have equivalence
reliability. In sum, reliability tests resulted in adequate values and the statewide
pharmacist survey was found to have stability and equivalence reliability.
Data Analysis
Because the proposed research is employing a mixed methods study design, the
data analysis for this proposal included both qualitative and quantitative techniques.
Although the first main research question, what do the 91 accredited schools of pharmacy
in the U.S. teach about emergency contraception, is answered through an electronic
survey of Deans, the responses from this survey only required basic descriptive statistics
(frequencies, mean, median, mode) and categorization into typologies. Frequency
calculations measure numbers and percentages of schools that teach about emergency
contraception and a typology categorizes and quantifies the courses that teach this
content.
The second major research question, how is emergency contraception course
content taught at accredited schools of pharmacy as perceived by third or fourth year
pharmacy students at the four accredited schools of pharmacy in Florida, was explored
through focus groups with pharmacy students and this information required qualitative
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analysis techniques. In addition, the third major research question, what is the
relationship among emergency contraception knowledge, attitudes, subjective norms,
perceived behavioral control, and dispensing practices of Florida pharmacists registered
with the Board of Pharmacy, was measured through a survey of a random sample of
pharmacists and required quantitative analysis techniques. Therefore, both the qualitative
data analysis methods used to analyze the focus group data and the quantitative data
analysis methods used to analyze the pharmacist survey are outlined below.
Qualitative Data Analysis Plan
Qualitative data includes focus group transcripts, observation notes, debriefing
session notes, participant demographic information, and any other pertinent documents.
Ethnograph version 5 computer software program was used to help with coding, and
thematic and content analysis. The reason an ethnographic computer program was
chosen is because it can handle project data files in multiple forms such as transcripts,
field notes, and any other text based documents. In addition, Ethnograph has a large
storage capacity that will be good to use with focus group transcripts.
An editing type of qualitative analysis was employed where the editor begins with
the text and then from this text develops codes, themes, and concepts. Preliminary and
thematic analyses were employed to create a range of themes, typologies, propositions
and concepts. A coding template was developed where categories were created from
questions and from the topical guide. Each code was defined in the code book including
the parameters involved in assigning the code. Later, the data was checked against the
code template to see if it fit. The codes were adjusted and new codes were added as they
emerge.
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Open coding, axial coding, and selective coding allowed for data reduction and
categorization of data into themes. Open coding is the first look at the collected data
where themes are located and assigned initial codes or labels. Open coding brings
themes within the data to the surface. Axial coding is the second look at the data where
the researcher already has an organized set of initial codes and focuses more on the coded
themes than on the data. In axial coding, the initial codes are reviewed and examined to
establish linkages between themes and raise new questions. Selective coding is the last
look at the data. With selective coding, the researcher scans the data and previous codes
and looks to compare and contrast cases. Selective coding is performed when all or most
of the data is collected.
Analytic memos were written and kept throughout the coding process. Analytic
memos are thoughts or ideas written down throughout the coding process. The memos
contain thoughts and reflections about the data, coding, and coding process. Each code
contained a separate memo discussing the theme. The purpose of an analytic memo is to
provide a bridge between the raw data and abstract or theoretical thinking.
In order to check for coding consistency, trustworthy or consistency checks were
performed where the data was reviewed several times to ensure consistency of the coding
system. In addition, a single coder performed most of the analysis but another coder
analyzed at least 10% of the data to ensure consistency of the data and inter-rater
reliability. The second coder was trained to understand the codebook prior to coding and
analysis. The same limitation of having the researcher as the moderator of the focus
groups exists in having the researcher analyze the data for the focus group discussions;
however employing two people for qualitative coding limited the researcher bias. After
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initial data analysis was performed, the analysis moved into an interpretive, theory
development, and discussion phase.
Researcher Bias
Researcher bias exists in any type of research; however researcher behavior can
limit the amount of bias that is present. Neuman (2003) identifies six categories of
interviewer bias that can be applied to focus groups and focus group moderators. The six
categories include: 1) errors by the respondent, 2) unintentional errors by the interviewer,
3) intentional errors by the interviewer, 4) bias by interviewer’s expectations of
respondents, 5) lack of interviewer probing, and 6) influence on responses due to
interviewer behavior.
In order to limit these biases, the focus group moderator became familiar with
conducting focus groups and became aware of the potential biases and methods for bias
reduction. The first category of bias as outlined in Neuman (2003), errors by the
respondent, includes errors made because of the presence of others such as lying,
misunderstanding, or embarrassment. This bias was avoided through the moderator
creating an open atmosphere where participants felt comfortable sharing their thoughts,
feelings, and experiences and where the moderator was clear in stating the focus group
questions and in explaining how the focus group worked. The second category of bias,
unintentional errors by the interviewer, includes the interviewer reading questions out of
order, mis-recording respondent answers, and misreading questions. In order to reduce
this bias, the focus group moderator became familiar with conducting focus groups,
including becoming familiar with the focus group topical guide and the order of the
questions. In addition, the moderator employed a note-taker and a tape recorder to aid in
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reducing any unintentional error by the moderator. The third bias, intentional errors by
the interviewer, includes changing answers on purpose or omitting questions on purpose.
In order to minimize this bias, the moderator stayed close to the focus group topical
guide.
The fourth bias, bias by interviewer’s expectations of respondents, includes the
moderator expectations about a respondent’s answer based on appearance or perceived
living situation (Neuman, 2003). To reduce this bias, the moderator worked to remain
neutral and refrain from making value judgments about the participants. The fifth bias,
lack of interviewer probing, was reduced through the moderators understanding how and
when to probe properly. In addition, the moderator developed potential probes to be
included in the topical guide, should they be needed. The six and final bias, influence on
responses due to interviewer behavior, includes changes in respondents answers based on
moderators tone, comments, appearance, or reactions. In order to reduce this bias, the
moderator remained neutral and open to all responses and avoided passing verbal or nonverbal judgment to the responses given by participants in the focus group discussions.
And last, in order to obtain a greater understanding of researcher bias in general, a
detailed journal of research perceptions, biases, and beliefs was kept throughout the
qualitative research process so that potential bias could be determined, understood, and
reduced.
Trustworthiness
Trustworthiness in qualitative research is much like validity and reliability in
quantitative research. According to Lincoln and Guba (1985), the basic question
addressed by trustworthiness is, “How can an inquirer persuade his or her audiences that
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the research findings of an inquiry are worth paying attention to?” (p. 290).
Trustworthiness establishes confidence in the research findings, applicability of findings
to other contexts, consistency in findings if research was conducted on similar subjects,
and neutrality of the researcher so that the findings are determined by participants, not by
researcher bias (Lincoln & Guba, 1985). Lincoln and Guba (1985) discuss four criteria
by which trustworthiness can be operationalized in research: 1) credibility, 2)
transferability, 3) dependability, and 4) confirmability. These four criteria were
employed in the proposed research and will be discussed in greater detail below.
The first criteria, credibility, determines if the data reflects reality. In qualitative
research, the researcher assumes multiple realities and then attempts to represent them
(Hoepfl, 1997). Credibility is met through the richness of the information collected and
can be measured in a number of ways including triangulation, allowing others to analyze
raw data, and member checks. Obtaining a second coder aided in establishing credibility
as well as performing member checks with focus group participants (Lincoln & Guba,
1085). After each focus group, the note taker presented a summary of the main ideas that
had been identified in each question and asked if participants had any changes or
additions they would like to make to the summary; when changes or additions were
made, this information was included. Debriefing between the note-taker and the
moderator occurred directly after each focus group discussion. These steps aided in
increasing the credibility of this study.
The second criteria, transferability, examines whether research findings are
applicable to similar situations or in other contexts (Lincoln & Guba, 1985). In order to
establish transferability, the proposed research study maintained detailed notes and
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journaling. In addition, the researcher will ensure that the code book, focus group topical
guide, and results of the study be made available to the public so that the study may be
transferred to varying contexts if warranted.
The third criteria, dependability, determines if the results stay consistent over time
and across varying researchers. Lincoln and Guba (1985) propose one method that they
term “inquiry audit” (p. 317) where consistency is met through employing additional
researchers that review the process and product of the research. Therefore, dependability
was met in this study by employing an additional researcher to aid in the process of the
research and in the data analysis. An additional researcher was present throughout the
focus group discussions, debriefing sessions, and provided feedback on the focus group
topical guide. An additional coder analyzed at least 10% of the data to ensure
consistency of the data and inter-rater reliability. The second coder was trained to
understand the codebook.
The fourth criteria, confirmability, refers to the neutrality of the researcher’s
interpretations in qualitative research. Lincoln and Guba (1985) suggest that to meet
confirmability, an audit trail must be generated that includes 1) raw data; 2) analysis
notes; 3) reconstruction and synthesis products; 4) process notes; 5) personal notes; and
6) preliminary developmental information (p. 319-320). In order to meet the
confirmability criteria, a tape recorder was employed to record the focus groups, field
notes were written, a note-taker was employed, debriefing sessions I after each focus
group, a code book was employed, and detailed notes (journal) of a personal nature were
maintained that included ideas, thoughts, biases, motivations, predications, and
expectations. These steps discussed above attributed credibility, transferability,
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dependability, and confirmability to the qualitative research employed in this study so
that the study maintained overall trustworthiness.
Quantitative Data Analysis Plan
Univariate & Bivariate Analyses
Quantitative data analyses were performed primarily using SPSS statistical
software (SPSS 16.0, SPSS Inc., Chicago), although SAS statistical software (SAS
Institute Inc, Cary, NC) was used in the factor analysis. First, frequency distributions
were performed on all categorical level variables to determine response distributions and
means and standard deviations were calculated for all continuous variables. These
procedures identified any outliers or non-meaningful responses that were recoded if
necessary. In addition, for continuous variables, response patterns emerged which
sometimes called for collapsing of data based on the distribution.
Next, bivariate analysis was performed to test associations between all sociodemographic variables (age, gender, ethnicity, marital status, religious and party
affiliation, type of pharmacy, pharmacy school and year attended, and length of time in
practice) and pharmacist dispensing practices. Because the criterion variable, dispensing
practices, is measured at both the nominal and ordinal level and the socio-demographic
variables are measured on the nominal, ordinal, and ratio levels, three statistical tests
were performed to detect bivariate associations: Chi-Square tests, Kruskal-Wallis Tests,
and Spearman Correlations.
A Chi-Square test of independence is the appropriate statistic to use when both
variables are assessed at the nominal level to determine if there is a relationship between
the two variables. The Kruskal-Wallis test is appropriate in bivariate analysis with an
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ordinal-level criterion variable and a nominal level predictor variable. Spearman
correlations are recommended when there is an ordinal-level predictor variable and an
ordinal-level criterion variable. This test yields the correlations between two variables
and will determine the strength of the relationship between two variables (Hatcher &
Stepanski 1994).
Bivariate associations were also be explored between (a) knowledge and
dispensing practices, (b) attitudes and dispensing practices, (c) subjective norms and
dispensing practices, (d) perceived behavioral control and dispensing practices, and (e)
intention to dispense and dispensing practices. Chi-Square tests and Kruskal-Wallis tests
were used to assess the relationships between knowledge and dispensing practices,
attitudes and dispensing practices, subjective norms and dispensing practices. KruskalWallis tests were used to assess the relationships between perceived behavioral control
and dispensing practices and intention to dispense and dispensing practices (Hatcher &
Stepanski 1994).
Multivariate Analyses
Logistic regression models were constructed to discover whether emergency
contraception knowledge, attitudes, subjective norms, perceived behavioral control, and
intention to dispense taken together or separate, are predictive of pharmacists’ dispensing
practices. The dependent variable, dispensing practices, was measured by two survey
questions and was grouped to create dichotomous yes/no variable.
Logistic regression is the appropriate statistical test to use when the dependent
variable is dichotomous and when there is a single dependent variable with multiple
predictor or independent variables. In addition, logistic regression should be employed
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when the criterion variable is nominal or ordinal and when the predictor variables are at
the nominal, interval, or ratio level (Hatcher & Stepanski 1994).
There are five independent variables, knowledge, attitudes, social norms,
perceived behavioral control, and intention to dispense. Knowledge consists of 10
questions and is measured at the nominal level. A knowledge score ranging from 1-10
was created for each study participant based on how many questions they get correct.
Therefore, knowledge was put into the regression model as a continuous variable.
Attitude consisted of 8 separate questions and was measured at the nominal and ordinal
levels. The 7 ordinal level likert scale questions were treated as continuous variables
when put into the model. For the other question, it will be collapsed into categories to
create a nominal level variable. Subjective norms consisted of 6 questions and were
measured at the ordinal and nominal levels. The 4 likert scale questions were treated as
continuous variables when put into the model and the two nominal level questions were
collapsed into categories and run at the nominal level. Perceived behavioral control
consisted of 4 questions and was measured at the ordinal level. Because the 4 questions
are likert scale questions, they were treated as continuous variables when put into the
model. Intention to dispense Plan B consisted of 8 likert scale questions measured at the
ordinal level and were entered into the model as a continuous variable.
In constructing logistical regression models, specific steps should be taken.
Approximately six models will be created to detect (1) if knowledge is predictive of
dispensing practices, (2) if attitudes are predictive of dispensing practices, (3) if
subjective norms are predictive of dispensing practices, (4) if perceived behavioral
control is predictive of dispensing practices, (5) if intention to dispense is predictive of
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dispensing practices, and (6) if all variables taken together are predictive of dispensing
practices. Also, the socio-demographic variables were entered into each model to act as
control variables. With each model, appropriate diagnostics were run to test for
collinearity.
The Wald F statistic is the measure in logistic regression that tests the null
hypothesis: that none of the predictor variables are related to the log odds of the criterion
variable. In addition, the Wald F will measure the models’ goodness of fit. In logistic
regression, pseudo R-Square is used to measure the strength of association between the
variables. The significance between knowledge, attitudes, subjective norms, and
perceived behavioral control in predicting dispensing practices was measured by odds
ratios and 95% confidence intervals. A p-value of less than .05 was employed as a
measure at which to reject the null hypothesis.
Linking Datasets
Three different yet intimately related datasets were produced upon completion of
this research. Data was procured from 1) the curriculum review survey, 2) focus group
discussions with pharmacy students, and 3) the state-wide pharmacist survey. Taken
together, findings demonstrated what is intended to be taught to pharmacy students, what
is actually being learned by pharmacy students, and how practicing pharmacists’
perceptions of emergency contraception are associated with their dispensing practices.
In essence, this research examines both the education and practice of pharmacists
by following the natural progression of pharmacists from education to subsequent
practice. It examines the emergency contraception curricula and course content intended
to teach future pharmacists, surveys pharmacy students to understand how this course
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content translates into learned knowledge and projected dispensing behavior, and then
lastly it surveys the practicing pharmacists to understand their emergency contraception
knowledge, attitudes, and actual dispensing practices. In total, this research study
employs a mixed methods design to offer a completed picture of pharmacists and
emergency contraception from education to practice.
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Chapter Four: Results
Introduction
Chapter four has been partitioned into three sections based on each research
question. Thus, Section 1 discusses the pharmacy school curriculum review and answers
research question 1, Section 2 describes the pharmacy student focus group discussions
and answers research question 2, and Section 3 describes the statewide pharmacist survey
and answers research question 3.
Research Questions
Question 1: What do the 91 accredited schools of pharmacy in the U.S. teach about
emergency contraception?
Question 1a: What objectives, course assignments, course readings, and lectures
concerning emergency contraception are provided in the required courses at the
91 accredited schools of pharmacy in the U.S.?
Question 1b: What objectives, course assignments, course readings, and lectures
concerning emergency contraception are provided in the elective courses at the 91
accredited schools of pharmacy in the U.S.?
Question 2: How is emergency contraception course content taught at accredited schools
of pharmacy, as perceived by fourth year pharmacy students at the four accredited
schools of pharmacy in Florida?

106

Question 2a: What did pharmacy students learn about emergency contraception in
their pharmacy school classes?
Question 2b: How was emergency contraception taught in their pharmacy school
classes?
Question 2c: What are the projected emergency contraception dispensing
practices of pharmacy students?
Question 3: What is the relationship among emergency contraception knowledge,
attitudes, subjective norms, perceived behavioral control, intention to dispense, and
dispensing practices of Florida pharmacists registered with the Board of Pharmacy?
Question 3a: Is emergency contraception knowledge predictive of dispensing
practices of Florida pharmacists?
Question 3b: Are attitudes about emergency contraception predictive of
emergency contraception dispensing practices of Florida pharmacists?
Question 3c: Are subjective norms about emergency contraception (whether
important people such as colleagues, supervisors, corporate headquarters, and
peers think they should dispense emergency contraception) predictive of
emergency contraception dispensing practices of Florida pharmacists?
Question 3d: Is perceived behavioral control, the perceived ease or difficulty of
dispensing emergency contraception, predictive of dispensing practices of Florida
pharmacists?
Question 3e: Is intention to dispense emergency contraception predictive of
dispensing practices of Florida pharmacists?
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Question 3f: Are emergency contraception knowledge, attitudes, subjective
norms, perceived behavioral control, and intention to dispense taken together,
predictive of emergency contraception dispensing practices of Florida
pharmacists?
Section I: Pharmacy School Curricula Review
The first research question was addressed through a web-based survey of Deans
of accredited schools of pharmacy in the U.S. As of April 2007, there were 91 accredited
schools of pharmacy in the U.S. In this case, the target population, the sampling frame,
and the sample are the same because the survey acts as a census. The Deans of all 91
schools were sent an electronic survey via Ultimate Survey querying them about
emergency contraception course content in their Pharm. D. programs at their respective
institutions. Please see Appendix U for a list of the pharmacy schools that received the
survey. Because not all schools had Academic Deans, a decision was made to request
information from the Deans of all schools. Of the 91 Deans, 47 responded, yielding a
52% response rate. The Dillman Tailored Design Method was employed in data
collection which included the following four letters: (a) a pre-notice, (b) an abbreviated
informed consent form, (c) a cover letter and questionnaire, and (d) a thank you/reminder
letter. A fifth letter was generated and added to the study design during the data
collection process to act as a second reminder letter to help yield a higher response rate.
This letter was submitted and approved by the IRB prior to use. Please see Appendix V
to view this second follow-up letter.
The Dean’s survey included only three questions with follow-up questions
depending on the answer provided. The first two questions asked Deans if they offer
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required courses and/or elective courses that provide content on emergency
contraception. Content was described as including lectures, course readings, course
objectives etc. If they answered that they did include content on emergency
contraception, they were asked to include the title of the course and include the syllabi for
review. The third and final question asked Deans if they think that pharmacy school
curricula in the U.S. should include content material on emergency contraception and to
explain their answer. Content was defined as including pharmacology, legal and ethical
issues, and the continual controversy that surrounds emergency contraception.
Of the 47 Deans that responded, 87.2% (n=41) reported that they do offer
required courses that provide content on emergency contraception, 8.5% (n=4) reported
that they do not, and 4.3% (n=2) said that they were not sure (Table 9). In terms of
elective courses, 17% (n=8) reported that they do offer elective courses that provide
content on emergency contraception, 72.3% (n=34) reported that they do not offer these
courses and 10.6% (n=5) said that they were not sure. All respondents (n=47, 100%)
reported that they believe that schools of pharmacy in the U.S. should include content
material on emergency contraception (Table 9).
Table 9. Quantitative Results from Dean’s Survey (n=47).
Variable
Does school offer required courses that provide content on EC?
Yes
No
Not Sure
Does school offer elective courses that provide content on EC?
Yes
No
Not Sure
Should pharmacy school curricula include content on EC?
Yes
No
EC = emergency contraception
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Frequency

Percent

41
4
2

87.2%
8.5%
4.3%

8
34
5

17.0%
72.3%
10.6%

47
0

100.0%
0.0%

Of the 87.2% (n=41) of Deans that said their schools offer required courses that
provide content on emergency contraception, 34% (n=14) did not list the titles of the
courses or attach the syllabi for review when asked. Sixty-five percent (n=27) either
listed course titles or provided syllabi for review. Of the 17% (n=8) of schools that
reported that they do offer elective courses that provide content on emergency
contraception, 50% (n=4) did not list the titles of the courses or attach the syllabi for
review. The lists of courses, both required and elective, that were said to provide content
on emergency contraception have been classified into a typology based on the course
titles. This typology is found in Table 10 below and a full list of courses titles is
provided in Appendix W.
Table 10. A Typology of Required and Elective Courses that Contain Content on Emergency
Contraception per the Responses from the Dean’s Survey.
Classification of Required Courses
Pharmacotherapy & Therapeutics
Pharmacy Ethics
Pharmacology
Issues in Contemporary Pharmacy Practice
Over-the-Counter Medications
Women’s Health
Self-care
Professional Skills Development
Early Practice Experience I
Classification of Elective Courses
Women’s Health
Contraceptive Management
Self-care

Number of courses that fall into category
17
6
4
3
2
2
2
1
1
Number of courses that fall into category
2
1
1

The majority of courses that provide content on emergency contraception are
taught in pharmacotherapy and therapeutics courses. Specifically, many schools noted
that within these pharmacotherapy and therapeutics courses, this content was taught in
the women’s health section. Although it varies from school to school, most students have
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taken the pharmacotherapy and therapeutics courses listed by their second year of study.
After pharmacotherapy and therapeutics, schools listed that material on emergency
contraception was covered in pharmacy ethics, pharmacology, issues in contemporary
pharmacy practice, over-the-counter medications, women’s health, self-care, professional
skills development, and early practice experiment. One school in particular requires a
course called early practice experience and in this course students obtain certification
from the state in emergency contraception. Specifically, students learn about prescriptive
authority and are trained to counsel patients.
Among the four schools that listed elective courses that provide content on
emergency contraception, content was taught in a women’s health course (n=2), a
contraceptive management class (n=1), and a self-care class (n=1).
Question 1 asked, what do the 91 accredited schools of pharmacy in the U.S.
teach about emergency contraception? In addition, sub-questions inquired about what
objectives, objectives, course assignments, course readings, and lectures concerning
emergency contraception are provided in the required and elective courses at the 91
accredited schools of pharmacy in the U.S.? In order to more fully answer research
question 1, Deans were asked to submit the syllabi in which they reported to provide
course content on emergency contraception. However, only 10 syllabi were received
from seven schools or from 14% of the sample who reported that they provide course
content on emergency contraception in either required or elective classes. Additionally,
the syllabi that were received did not provide detailed information on objectives,
objectives, course assignments, course readings, and lectures concerning emergency
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contraception. In fact, only four out of the ten syllabi explicitly mentioned emergency
contraception.
In order to objectively analyze the syllabi that were retrieved for emergency
contraception course content, a method for categorization was developed. First, after
reviewing course syllabi, the defined categories for course content provided on the Deans
survey, and with the aid of established pedagogy, course content was defined as:
•
•
•
•
•

course description
objectives
lectures
readings
assignments
Next, each syllabus was examined based on course content area. Ratings ranged

from one to four and each area of course content received an individual rating. The
specific definition of each numeric rating is listed below and Table 11 displays these
ratings of course content in a comparative format.
Rating 1 = No overt mention of emergency contraception in content
Rating 2 = The topic listed in the content could lend itself to emergency contraception,
but does not specify
Rating 3 = The content mentions contraception, but not emergency contraception
Rating 4 = The content specifically mentions emergency contraception
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Table 11. Review of Retrieved Syllabi that Reported to Contain Content Material on Emergency
Contraception from the Dean’s Survey.
Course Title*
Description
Objectives Lectures Readings Assignments
4
n/a**
4
4
1
Contraceptive
Management
Elective
2
2
2
2
2
Professional Skills
Development II
Required
1
2
3
1
1
Pharmocotherapy II
Required
1
1
1
1
1
Integrated Science &
Therapeutics
Required
3
1
4
3
1
Women’s Health
Some offer required,
some elective
1
3
3
1
1
Endocrinology/
Gastroenterology
Required
1
1
1
1
1
Pharmacy Practice IV
Required
2
2
2
n/a
2
Pharmacy Ethics
Required
1
4
4
4
1
Therapeutics I
Required
4
4
4
4
4
Reproductive Course
Required
*Courses are listed in no particular order
**n/a is listed if the syllabi did not mention the specific content

Among all retrieved syllabi which reported to include content on emergency
contraception, only four of the ten syllabi overtly mentioned emergency contraception in
any of the content areas. Two out of ten syllabi cited contraception in a content area, but
not emergency contraception, three out of ten mentioned a topic area that could lend itself
to emergency contraception such as ethics or women’s health, and two out of the ten
syllabi retrieved made no overt mention of emergency contraception or contraception, or
even contained a topic that could lend itself to a discussion about emergency
contraception. In general, there was no particular patterning or clustering of where the
content was located or described, however courses that contained emergency
113

contraception in one content area were more likely to contain it in another content area
and vice versa.
In addition, although it was not requested that the schools include a description of
where the emergency contraception course content is taught when attaching syllabi, one
school did include additional information about how this content is taught in class. This
Dean responded that within their course, emergency contraception is used “as an example
of one of the many ethical dilemmas that pharmacists confront and help them construct a
thought process on how to deal with the issues, while respecting the patients’ right and
their own values”. This depiction provides insight into how this content may be
addressed in this particular class where students learn to balance patient rights and their
own values. It would be interesting to follow up on this and perhaps observe a pharmacy
class to view how this material is actually taught.
The third and final question of the Dean’s survey asked if they believe that
pharmacy school curricula in the U.S. should include content on emergency
contraception. All respondents said yes. They were then asked to explain their answer in
an open-ended format. Of all 47 respondents, 27.7% (n=13) did not answer as to why
they thought this content should be included in pharmacy school curricula, however
72.3% (n=34) did.
Through qualitative coding and analysis, five main themes emerged from the
open-ended response data. Overall, pharmacy school Deans answered that school
curricula should include material on emergency contraception due to 1) pharmacy
practice and training, 2) the role of pharmacists in terms of counseling and education, 3)
the controversies that exist about the medication 4) the nature of the medication: it is a
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drug therapy and, 5) the idea that this curricula will increase pharmacists’ knowledge for
best patient care. These five themes are listed in order based on the number of times they
were mentioned and will be discussed below.
Pharmacy Practice/Training
The largest grouping of respondents (mentioned 18 times) answered that
pharmacy school curricula should include content material on emergency contraception
because of issues surrounding pharmacy practice and training. Specifically, the Deans
expressed that pharmacists will encounter this medication in their practice and therefore
pharmacists should have this training so that they can perform well in their professional
practice. Examples of this sentiment are presented below:
•

Pharmacists need to be trained with respect to all prescribed drugs that they may
encounter in practice.

•

It is a part of practice and each pharmacist should know how to assess the
situation and safely use these products.

•

It is a component of pharmacy practice with medical, social, and ethical aspects.

•

It is in within the scope of practice for pharmacists especially ones that work in
community settings so the pharmacology, dispensing issues and ethics should be
discussed.

•

California pharmacists may dispense emergency contraception under a state
protocol. Training is essential.

Role of Pharmacists: Counseling/education
Another major category of response (mentioned 13 times) that emerged from the
data was the need for training of pharmacists on emergency contraception due to the
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perceived counseling and educational role of pharmacists. Specifically, participants
responded that pharmacists need to be knowledgeable on emergency contraception in
order to provide accurate information to patients and to be able to discuss, counsel, and
advise patients on the medication. Some responses are presented here:
•

This subject arises in all Community Pharmacy settings and pharmacists need to
be able to intelligently discuss this with patients when questions are asked.

•

It is legal and pharmacies are a front line delivery method of EC. Many
misperceptions abound about these products and pharmacists should know the
facts if their patients ask them questions.

•

Pharmacists serve patient health needs in terms of products and accurate
information. This area may be very important for many patients and families.

•

Pharmacists need to be able to give appropriate advice.

•

…Education in this area of pharmaceutical care will enable the pharmacist to be
an advisor to the physician and a counselor to the patient.

•

Because pharmacists will encounter this medication in the pharmacies, it is
important for them to understand how emergency contraception works. This will
enable them to have an informed conversation with a patient considering
emergency contraception. Even if they do not plan to work in a retail setting, they
will inevitably be asked questions regarding emergency contraception at some
point in their career.

Controversy
Many respondents alluded to the controversy and dilemma that surrounds
emergency contraception (mentioned 11 times). Many respondents noted that pharmacy
school curricula should include content on emergency contraception despite how
controversial the medication may be:
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•

…It is our job as educators to expose pharmacy students to as much pharmacy
knowledge as possible, no matter how controversial.

•

Curricula should include all drug therapeutic uses, including mitigation of
physiologic conditions, where pharmacists play role, no matter how controversial
their role and the drug’s use might be. Student pharmacists deserve to have
information regarding therapeutic indications, legal implications, and discussion
of various “opinions” provided in their course work.

•

From a pharmacist’s and pharmacology perspective, it is important for students
to be aware of the mechanism of action, important counseling points and the
ethical arguments surrounding EC.
Some respondents believed that content should be taught so that pharmacists

understand that emergency contraception is not the same as a medical termination or
similarly so that they understand that emergency contraception’s mechanism of action is
comparable to that of hormonal contraception:
•

…Students should be informed about the product, and most especially, should be
informed that it is not the same as mifepristone (RU 486).

•

Pharmacists now are in the position to not only dispense prescriptions for EC, but
to also provide it without a prescription to those 18 years and older. Knowledge
regarding mechanism of action (especially in regards to the mechanism being the
SAME as all hormonal contraception), appropriate use and counseling is
essential to the role of a pharmacist…
Another pharmacist believed that content should be taught so that pharmacists can

have knowledge about the medication should they want to refuse dispensing:
•

…Even if a pharmacist engages the right to refuse dispensing (which I do approve
of based on moral or ethical conflicts ) – pharmacists must have appropriate
knowledge on why he/she has chosen to refuse and what his/her obligation is to
the patient at that point in time.
Additionally, these two respondents talk about the balance that some pharmacists

try to keep between professional responsibilities and personal beliefs.
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•

This is a medication applicable to a sizable portion of the population. It is a very
emotional issue as well. Pharmacists MUST know the information necessary for
them to be a reasonable counselor on use and MUST be aware of their
professional responsibilities to provide care for patients while balancing that with
their own personal beliefs. If you are a pharmacist, or a pharmacy student you
do NOT have any choice. You must know about EC.

•

…Factual information is helpful for the patient regardless of religious beliefs and
should be available. Informing people of the correct facts does not mean you are
pushing them one way or the other on the issue.

Drug Therapy
It was mentioned 8 times that emergency contraception content should be taught
in pharmacy schools because it is a drug therapy and many Deanss said flatly that it is the
duty of pharmacy school curricula to teach about all drug therapies. Some respondent
comments are below:
•

It’s a drug therapy!

•

Emergency contraception is an OTC product. Schools teach about OTC
products…

•

Curricula should include all drug therapeutic uses…

•

It is pharmacological therapy – that’s our job

•

It involves drug therapy

•

Pharmacy schools should educate students on all legal uses of pharmacologic
therapy

Knowledge for Best Patient Care
Lastly, it was mentioned 7 times in the open-ended responses that curricula
should include content on emergency contraception so that each pharmacist has the
knowledge of the medication for best patient care.
•

Same reasons as any therapeutic topic, so pharmacists can provide the best
patient care to all patients no matter what the medication is…
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•

Because pharmacists will encounter this medication in the pharmacies, it is
important for them to understand how emergency contraception works. This will
enable them to have an informed conversation with a patient considering
emergency contraception. Even if they do not plan to work in a retail setting, they
will inevitably be asked questions regarding emergency contraception at some
point in their career.

•

…(pharmacists) must be aware of their professional responsibilities to provide
care for patients while balancing that with their own personal beliefs…

•

…Since emergency contraception is a reality and growing in use, it is critically
important that the pharmacist is the drug expert in this area of patient care no
different from diabetes or other conditions…
On the whole there were sentiments that pharmacists must know correct

information about emergency contraception regardless of personal or religious beliefs and
regardless of the controversial nature of this topic for best patient care, professional
practice, and counseling/education of patients. In addition, given the 52% response rate,
it is important to note that we did not hear from 48% of the sample. Therefore, this
nonresponsiveness is a limitation in that we have no information from the Deans of these
schools and no way to capture these responses.
Section II: Pharmacy Student Focus Groups
The second research question was addressed through focus groups conducted at
all four accredited Schools of Pharmacy in Florida: Florida Agricultural and Mechanical
University (FAMU), Nova Southeastern University (NOVA), Palm Beach Atlantic
University (PBA), and University of Florida (UF). All four schools were contacted
regarding participation in the focus groups and letters of support were procured.
A topical guide was developed prior to the focus group discussions by the
researcher and a panel of experts, which consisted of pharmacy faculty, recent pharmacy
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school graduates, practicing pharmacists, and a focus group expert (n=8). A preliminary
list of topic areas was generated that began with non-threatening issues leading into more
specific questions. Through the topical guide development and feedback from the panel,
it became clear that there were many close-ended questions that needed to be addressed
by the focus group participants. Because focus group discussions lend themselves to
open-ended questions, a paper and pencil survey was developed that contained these
close-ended questions. This paper and pencil survey was administered to students prior
to starting the focus group. See Appendix X for the topical guide and the paper and
pencil pre-survey that was administered to students. Prior to the actual focus groups, the
researcher piloted the focus group session with colleagues.
Paper and Pencil Pre-Survey Results
In total, 21 third and fourth year Pharm. D. students participated in the focus
group discussions (8 from UF, 4 from FAMU, 5 from PBA, 4 from NOVA). The paper
and pencil survey consists of 10 questions, five of which are close-ended and five of
which are open-ended. All survey data were entered into a Microsoft® Office 2003
spreadsheet (Microsoft Corporation, Redmond, Washington). Data from the five closeended questions can be viewed below in Table 12.
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Table 12. Paper and Pencil Focus Group Survey Data: Close-Ended Questions (N=21)
Variable
N
Did you take any classes in your Pharm D program which taught you
about EC?
Yes
19
No
2
Have your pharmacy school classes discussed the new OTC status of EC?
16
Yes
4
No
1
Missing
Have your pharmacy school classes discussed the dispensing issues (e.g.
pharmacists refusals to dispense) surrounding EC?
Yes
14
No
6
Missing
1
Will you dispense EC upon becoming a pharmacist?
16
Yes
1
No
3
Not sure
1
Missing
Are pharmacists well enough informed to confidently dispense EC?
Yes
9
No
7
Not sure
4
Missing
1

Percent
90.5%
9.5%
76.2%
19.0%
4.8%
66.7%
28.5%
4.8%
76.1%
4.8%
14.3%
4.8%
42.9%
33.3%
19.0%
4.8%

Although 90.5% of students responded that they did learn about emergency
contraception in their pharm D classes, still nearly 20% answered either that they would
not or that they were not sure about their future dispensing of the medication. Similarly,
while the majority of students responded that they did learn about emergency
contraception in their classes, over half (52.3%) of participants were either not sure if
pharmacists were well enough informed to dispense emergency contraception or believed
that pharmacists were not well enough informed to confidently dispense the medication.
The first open-ended question asked which classes taught about emergency
contraception and asked to specify if the class was required or was offered as an elective.
Of the students who responded that their Pharm D program taught about emergency
contraception (n=19), nine students said that a required pharmacotherapy course covered
121

this material, six students mentioned that a required therapeutics course covered this
material, four said that a required ethics course covered it, and three students each
answered that a required medical chemistry course or a required pharmacy care course, or
an elective women’s health course covered this material. Lastly, two students each said
that a required law course or a required patient care management course or a dynamics
course covered emergency contraception. All in all, most students responded that they
were taught about emergency contraception in a required pharmacotherapy course which
substantiated findings from the curriculum review survey.
When asked what type of instructional method was used, the majority of students
reported class lectures as the most reported instructional method, followed by discussion
and class readings. One student said that they had a debate format in a class. The bulk of
the students said that they learned the most from a lecture format and one student noted
that they learned the most from personal research as the professors did not teach them
much. Most students stated that there was more information that they wished they had
learned including OTC laws, the effects of prolonged use, details on side effects,
counseling points, contraindictions, time limits, explanation of how it is not an abortion,
the effect of Plan B on an already pregnant female, laws and regulations, adverse effects,
interaction with women taking birth control at the same time, industry standards/policies,
risks associated with repeat use, and ethics.
Focus Group Discussion Analysis
Focus group research questions asked about three major topical areas: 1)
knowledge about emergency contraception from their pharmacy schools classes, 2)
teaching instruction on emergency contraception within those classes, and 3) projecting
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dispensing practices of emergency contraception upon becoming a pharmacist.
Therefore, the following analyses were partitioned by topical area. Although responses
fell into these three categories, new and unexpected themes emerged from the data.
Knowledge. Students were asked both about their specific knowledge of
emergency contraception from pharmacy schools classes and were queried about their
general knowledge. There was a major disconnect between what students reported on the
quantitative paper and pencil survey and what was shared in the focus group discussions.
As opposed to what students reported on the paper and pencil survey, the majority of
pharmacy students reported that they did not learn about emergency contraception from
their pharmacy school classes when queried in the focus group discussions. When
pharmacy students were asked where they have gotten information about emergency
contraception that they trust, some said they received this information from class;
however the majority answered from outside sources such as work, print media, internet,
news, and friends.
“I would definitely say that the majority of what we know is from either from working in
retail or other outside sources. Not necessarily from our curriculum.”
Of the students that did receive some training in required classes, the majority
commented that it was brief:
“…I just remember one slide like one bullet point you know during our birth control or
female hormone lecture…And they haven’t discussed it a lot yet. So…”
The most frequently cited answer to where they received information about
emergency contraception was work with student’s answering “in the actual workplace”
and “from working”. When at work, they either read the package insert, asked a
pharmacist, read continuing education (CE) credit materials, or a client approached them
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with questions about the drug and they had to look up information. Examples of these
sentiments are below:
“Like she said continuing education is usually sponsored by drug companies, um they
send educational materials to you know where you work, retailer. Also if you’re just
working in a pharmacy with your… um with a pharmacist and you dispense it, you don’t
know what it is, you ask them”.
“Customers coming up too. Say oh what about the morning pill and I’m like huh; It’s
prescription and he’s like not anymore.”
“Package insert…
(another member) Yeah to educate ourselves.
(another member) “You know myself. I was like interested in it. So you know reading the
thing that comes with it you know.”
“…just working experience and having different people coming up and ask us questions
about it and you have to go look up”
Other outside sources included friends, a Pharmacy Times article, the internet,
and one student mentioned hearing about the firing of pharmacists who did not dispense
it in the news:
“I kinda just looked it up briefly on the internet; about how it works…”
“I personally did some internet research just for a law class that we had. Which was
kind of um… you know not a required thing but you know if you don’t know what Plan B
is all about then you as a student you need to take it upon yourself to find the
information. So that kinda, outside the classroom.”
“um… another way that I had heard about it was… actually it’s been in the news, I think
several times. Where pharmacists were actually um…you know fired from their
positions. So that has been kind of a….”
“Yeah, uh my friend…And my friend she knows I’m in pharmacy school so, I looked it up
for her. So you know I like to… I like to look things up for her and answer any questions,
you know. I’m her on call pharmacist.
When asked specifically about the knowledge gained about emergency
contraception in their pharmacy school classes, pharmacy students described four major
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areas of knowledge: 1) knowledge about timing and composition, 2) knowledge about
mechanism of action, 3) no knowledge, and 4) perceived knowledge of others (see Table
7).
The topical area of timing and composition represents whether students
understood the correct timing around administration of emergency contraception and if
they understood its composition. Plan B is hormonal contraception, containing high
doses of progestin (levonorgestrel). It is 75%-89% effective in preventing pregnancies
when taken within 72 hours (3 days) to 120 hours (5 days) after sexual intercourse
(American Medical Women’s Association (AMWA), 1996; Kaiser Family Foundation,
2000). Although students seemed to have varying degrees of understanding of the actual
timeframe, the majority of students understood that there was a time component to
acquiring the medication after unprotected intercourse. As shown in Table 7, some
students had more accurate knowledge around timing and composition than others.
Knowledge of mechanism of action refers to comprehension of how emergency
contraception works in the body. Although the exact mechanism of action is unknown, it
is thought that the medication works through the following three mechanisms, 1) through
a delay or inhibition of ovulation, 2) through inhibition of fertilization, and 3) through
preventing implantation (American Pharmaceutical Association special report, 2000).
Although students in one of the focus groups seemed to understand the three mechanisms
of action of emergency contraception, specific knowledge was not held by the majority of
students. In addition, there was some confusion as to the definition of when life begins.
This argument was most thoroughly represented by a discussion in one of the focus
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groups where some students believed that life begins at implantation and others believed
that life begins at fertilization. See the excerpt below:
Member 2: But… in order to abort it well first you have to look at the definition of
pregnancy. To actually be pregnant, as a medical definition, there has to be implantation.
Is that an agreed statement?
Member 1: I disagree.
Member 1: I (unclear)… I’ve read a couple of articles that state that um…the original
term pregnancy was actually um… the egg and a sperm… you know conception… at that
point…
Member 2: As defined by…?
Member 1: and one article said that that definition is changing. So I don’t know.
Member 4: I don’t think it you know…Webster or whoever medical can tell me where I
think contraception begins. So as defined by… per person I would think is un… is
sufficient enough for you know… in my opinion.
Member 2: Well, what I was looking at when I did my research… I was looking at the
American Medical Association, and where they define medically where pregnancy starts.
Cause there’s many times that you have a fertilized egg that doesn’t get implanted
naturally…so that’s where they have a hard time drawing pregnancy and starting at
implantation… at fertilization versus implantation.
Member 5: For them as an organizational body…
Member 5: But you could take the analogy of a plant seed… does that seed have the
capability of growing into a plant?
Member 2: Yes.
Member 5: And…but in order for it to happen it must… fall in soil and be watered and
somewhat…
Member 2: Correct.
Member 5: So a lot of things have to happen for the plant to grow, but nevertheless the
possibility was there when it was just a seed. For some people the seed of life is once the
sperm enters the egg. It’s all an ethical dilemma.
Member 5: Each person has to make their own belief.
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Member 5: You can defer judgment to you know bodies such the AMA or other larger
institutions but… it’s just a judgment call
Member 2: The question we come back to though is whether or not Plan B, is any
different than any other birth control method…
Member 2: and chemically it’s not
Member 2: So the real question is then, if we have a problem with Plan B, we should
really have a problem with every birth control method out there that’s an oral
contraceptive. Because it’s literally the same thing. So that’s the problem that…
Member 5: That is a logical statement.
Member 2: the argument runs into… is that if you’re going to reject this method, you
have to reject something that’s the same thing. And that’s where our problem lies. As a
profession because we’re not being consistent.
Member 1: I agree.
Member 3: Well being that it has three different mechanisms… again you’d have to go
back to where you believe conception starts… so if it’s going to work by thickening the
endometrium, and just preventing the egg from meeting the sperm… I personally don’t
see why not. But if it’s going to…which I don’t think it’s what you guys (alluded to)… it…
it aborting… so once the… the sperm is fertilizing the egg…is it gonna… that’s where I
believe conception starts. Is that where, it’s going to work? And if that’s the case, then
you’re getting into abortion and being pro-life verus pro-choice. But I think you guys
said that that’s not how it works.”
The topical area of no knowledge encompasses the idea that some students did not
learn about emergency contraception in their pharmacy school classes and therefore
gained no knowledge from this venue. Some students briefly noted that they were being
quiet because they did not have knowledge about emergency contraception (Table 13). It
is important to acknowledge that what is absent from discussion is sometimes just as
important as what is present. In addition, a few students expressed interest in wanting
more information on emergency contraception, specifically around the ethics of
dispensing.
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The theme perceived knowledge of others refers to how the participants described
emergency contraception knowledge of other pharmacists and the general community.
Although students were not questioned about what level of knowledge other pharmacists
and the community had around emergency contraception, these perceptions were
expressed in the discussions and are worth mentioning. Most students remarked that
pharmacists do not have knowledge on how it works and perceived that the wider
community thinks that it causes an abortion.
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Table 13. Major Themes of What Students Learned in their Pharmacy School Classes and
Representative Quotes
Theme
Representative Quote
Timing & composition
Accurate “...this is not an abortion pill. This can only be used within the first
5 days. It can be dispensed two tablets together but all of the
research has done one pill and then twelve hours later. It can be,
you know, used in this situation. It’s, you know, effectiveness is only
85%”
“Like you know I remember learning it’s a high dose of the regular
birth control so it’s that’s one thing that always stink in my head”
Confusion “You take one, like you take one immediately and you take the other
one within 72 hours.”
“Twenty-two… within twenty-two hours and then twelve hours later
and then that was pretty much it, right?”
Mechanism of action
“...So we’re not really sure but there’s three or four different
ways…we believe it works.”
“One of them is in…you know like (another member) was saying,
it’s um… a far as just like thickening the endometrial, you know,
mucosa so that the um… egg is less uh… less apt to travel um…
that’s one of ways that it works; just in the same way as birth
control… works.”
“Member 1: I remember one line it said this is not an abortifacient.
Member 2: I have a question on that.We’re referring to third
mechanism of action which states that it could or could not effect
implantation Member 2: but isn’t that also the same mechanism of
action of Ortho Tri-Cyclen? If you look at the mechanism of
action…Member 1: It is. Member 2: in Plan B and in Ortho TriCyclen for example, they’re identical.”
No knowledge
“Member 2: We haven’t had this (have we?). Member 3: Yeah,
that’s why I’m kinda quiet…”
“I kinda just looked it up briefly on the internet; about how it
works..other than that like other than it being brought up in ethics
class..about how some pharmacists would dispense it, some
others..some err…others don’t. So that’s why I’m like…I’m kinda
learning here too”
Perceived knowledge
of others
“The only thing that people have ever heard about emergency
contraception is that it aborts a baby.”
“One thing that I, I think is important um for mostly for pharmacists
cause a lot of the pharmacists that I’ve come across during
internships and stuff like that. They don’t, it doesn’t seem like they
really get how it works….”
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Teaching Instruction. To measure issues around emergency contraception
teaching instruction, students were asked about particular methods of teaching instruction
on the paper and pencil survey and were asked if they were aware of any position,
negative, or even neutral attitudes that they perceived as held about emergency
contraception by the instructor. Apart from the survey questions that captured this
question discussed earlier, two themes emerged from this questioning, 1) professor
attitude and 2) need to educate. In terms of the professor attitude when teaching
emergency contraception, the majority of students answered that the professor was
neutral in their attitude about emergency contraception.
“ Yeah, I’d pretty much say they were neutral. I mean I didn’t really see any positive or
negative thoughts about it when they were teaching us about it. I mean we touched first of
all how it works (unclear) how the medication works and then we discuss it in open
group. You know the teacher was neutral he didn’t, he told us not (unclear) you have to
follow the law um that are under that we practice under.”
“I think they were very cautious because they don’t want to put their biases into it.
They’re just supposed to teach us what’s out there at this point. And even though we try
to bring up… well what about the ethical issues and stuff they kinda floated over it and
didn’t really want to go to far into it.”
Although it was more of a minority view, a few students felt that the professor
attitude was more negative than positive or neutral:
“If anything I felt they erred on the side of against it. Only because of it’s potential for
abuse and the side effects and things like that…”
Another theme that was mentioned when discussing emergency contraception
teaching instruction was the need to educate around emergency contraception. The
reason this is included here as this theme was mentioned repeatedly in the discussions
around dispensing practices and therefore it is practical to mention here as well. This
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theme of duty to educate and counsel was a common theme among all focus group
sessions and will be discussed more thoroughly in the next section.
“…Basically them (professors) telling us that we need to educate the patient before we
give it to them so they are aware of what it’s actually doing. That it’s not supposed to be
a form of regular you know contraception.”
Projected Dispensing Practices. Questions around dispensing practices of
pharmacists by far yielded the most discussion and many non-expected themes emerged
from these discussions. Not only were pharmacy students asked a close-ended question
on the paper and pencil survey about whether they would dispense emergency
contraception in the future, but many questions throughout the focus group discussions
focused on their future dispensing practices. On the paper and pencil survey, almost 20%
of the sample responded that they were either not sure or that they definitely would not
dispense emergency contraception upon becoming a pharmacist. The focus group
discussions uncovered many hesitations in terms of dispensing, where the majority of
students said that they would probably dispense, but that they felt hesitancy in doing so.
“Yeah, don’t get me wrong I will dispense it but I will feel weird in a way, in the back of
my mind.”
Hesitancy in dispensing was mainly due to biases held by the study participants.
Hesitancy in dispensing was due to many issues including: hesitancy due to mechanism
of action, repeat use, age requirement, due to the situation of a particular woman, due to
side effects, and due to believing it is wrong (Table 8). An overall theme of judgment
emerged from this data.
Hesitancy in dispensing or not wanting to dispense due to mechanism of action
refers to the idea that pharmacists may not want to dispense emergency contraception
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because of not knowing through which mechanism of action that it actually works. One
student remarked that if she/he were required to dispense this medication that it may in
fact change her/his career path (see Table 8). These comments points towards the belief
that emergency contraception is a form of abortion.
The most cited reason for being hesitant to dispense emergency contraception
came from issues with repeat use. Participants thought that repeat use was wrong and
was grounds for refusal. They employed what they called “professional judgment” to
decide whether or not to refuse dispensing of the medication. Participants maintained
strong judgment against dispensing to women or men who came in repeatedly for the
medication.
Following this same idea, many participants were hesitant to dispense due to the
teenage use. Students seemed to have a problem with teens using this medication and
were concerned that someone else would come in and buy the contraception for teens
under 18 years of age. Repeat use by teenagers was also frowned upon.
Dispensing also varied based on the situation of the woman. For example,
students were more likely to have favorable attitudes about dispensing to women who are
raped than to teenagers. In the discussion about the situation of the woman, the same bias
towards women who use it repeatedly came up.
Students were hesitant to dispense emergency contraception OTC due to the
perceived side effects of the medication (Table 14). Many participants felt that the
medication should not have gone OTC due to the perceived side effects and that it should
be controlled by physicians. Interestingly, students did not mention what particular side
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effects the medication caused but were sure that they were going to come out with studies
demonstrating these side effects very soon.
In addition, a few students did not want to dispense the medication because they
believed it was wrong and compared dispensing it to being a willing accomplice in a
crime: “You do not want to be considered a willing accomplice to something that you
feel is wrong.”
In contrast to these ideas and responses of not wanting to dispense, many students
reported having no problem with dispensing emergency contraception. Many had no
problem dispensing emergency contraception due to the mechanism of action, meaning if
it works the same as oral contraception and they are willing to dispense that, then they are
willing to dispense emergency contraception. In addition, many students that felt that it
was not their job as pharmacists to judge or refuse to dispense any medication based on
moral or any other judgment. Two students noted that dispensing emergency
contraception is part of a pharmacists’ job:
“I think for any um… any drug, it’s really… If you have religious reasons for not
dispensing drugs then why are you a pharmacist?... Like you know that’s part of the job,
right? You do have to give people drugs.”
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Table 14. Major Themes of Projected Dispensing Practices and Representative Quotes
Theme
Representative Quote
Hesitancy in
dispensing/not wanting to
dispense
Due to mechanism of action
“That’s the problem, we just don’t know… it seems like… we
just don’t know how it’s going to work, so…”
Moderator: So would you say that you feel more hesitant
towards dispensing because not knowing the true mechanism
of action?
Member 3: “I do.”
Member 1: “I definitely do. I feel like I could even change my
career path…because of some places require that, then I feel
like I couldn’t pursue that career path…”
Due to repeat use
“I’m a little undecided because um… right now there is no
limitation as to you know if person A can come pick it up
today and next week come pick it up again or… so I think my
limitations are you know like I may consider dispensing it you
know if I you know… you know pending when I was in that
situation you know and I think… I think I’m okay with it
because ultimately I think it’s my goal to be um… to counsel
the person and maybe you know… get… give them another
perspective. But if it was a situation where I you know was
always being confronted with you know maybe the same
person or you know I’m in an area where I have to do as
often, I don’t know…”
“Yeah, I think that’s a little bit despicable, coming every
weekend and being like yeah I want my Plan B now.”
“if I see the same person coming in… I mean I would say
no…as a medical professional you know that is not healthy
and I would say absolutely not you need to go see a doctor”
Due to teen use
“...I will feel uncomfortable in a way. Because you know I see
a teenager who’s just doing whatever and having sexual
intercourse and not really caring about themselves and this
going to be their method, even though you tell them not to.
You know I’m married and maybe I’m not taking birth control
and something happens… you know it’s a…it’s a different
situation I guess. But I wouldn’t want it to be used as the
teenagers, oh it’s okay now don’t protect yourself because you
have a birth control pill over the counter. You know so it’s
kind of conflicting but by law I would still probably do but just
feel a little bit guilty if I see a younger person. Like an 18 year
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old come in.”

“another thing is that would make me hesitant to dispense is
the fact that you only have to be 18…”
Due to the situation of
women
“I think, I mean, as a human you would feel different you
know if you see an 18 year old girl coming in getting one in
comparison to a female who got raped... I mean there’s gonna
be a big difference on how you feel about that because I mean
if a person was raped then I would definitely you know
understand compared to an 18 year old girl who is immature
and doesn’t really know all of the consequences…and who
will probably do it again… you know there’s a difference. I
mean that’s just my personal opinion…there’s a big difference
there.”
Due to side effects
“Well I don’t think it should have been over the counter, due
to the fact that it’s a high dose and with high doses you get the
most side effect you know. Those are the medications that
highly need supervision.”
“This way they’re not even going to the doctor to get birth
control pills for Pete’s sake…”
“I just think that you know there has to be studies that shows
over long periods of time how this drug has affect anybody.
You know I’m pretty sure… let’s say 5 years down the line
from now there’s gonna be a big study saying you know…
some kind of something developed…”
“It’s gonna go… go back to prescription…”
No problem with
dispensing
Due to mechanism of action
“I don’t have a problem with it. I take a look at it. I have no
problem dispensing oral contraception…I see it as the same
drug… I see it as the same mechanism of action. If I’m willing
to fill birth control, I’m willing to fill Plan B.”
Because it’s not our job to
judge
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“It’s not our job to judge. It’s not what we’re here for. I
would never apply that to my job.”
“...I definitely don’t agree with any pharmacist who refuses to
dispense any medication…not just the emergency
contraception…but anything based on your own personal
beliefs. If you don’t have a medical reason why this person
shouldn’t take it, then it’s really not your place...”
“My personal belief is that we are…when you inject your own
personal belief into a situation such as this which is not of the
interest of the patient… we are overstepping our rights pretty
much as a pharmacist...we’re supposed to be there to provide
medication and information and protect the patient. And by us
refusing a product that they’ve already made their mind up
that they want and previously their doctor has also agreed
with that… and provided a prescription for that fact. For us to
step in an say no we won’t fill this is… we’re abandoning our
patient in a way. That’s how I feel about.
“..if they meet all the requirements and I feel that they are
safe as a health…from a health perspective, I have no
problem dispensing it and I don’t really think of it about if
they are too young or a it’s a male picking up or anything like
that. Like I… I just don’t personally feel any sort of moral you
know thing at all.”

There were other major, yet unexpected themes that emerged from the data.
These included: 1) duty to counsel, 2) stigma, and 3) the argument between professional
judgment and mandatory dispensing. In addition to these themes, participants shared
stories of refusal that are included below.
The first major yet unexpected theme that emerged from the discussions around
dispensing practices was duty to counsel. Most, if not all participants felt that it was their
duty to counsel and educate consumers about emergency contraception. This was an
interesting finding in that Plan B is not a pharmacy counseled product (Food and Drug
Administration, 2006). Although the FDA mandates that a healthcare professional must
be available to answer questions that a consumer may have about Plan B OTC,

136

counseling for Plan B OTC is not required. The only thing that is required for OTC
purchase of Plan B is proof of age 18 or older (Food and Drug Administration, 2006).
“They absolutely have to get the counseling from the pharmacist, because the technician,
a cash register person, whatever… someone who’s standing helping out in the pharmacy,
does not understand why it’s important to educate the person about this drug...”
“I think a little more counseling is needed. At that point you just can’t ask for an ID…ok
you’re over 18… there you go. You need to ask a little bit more you know questions;
when did you have intercourse and make sure that it was in the correct time. And that
way you’re educating them.”
Many study participants explained that they felt that it was their duty to educate
and counsel consumers on this product due to the OTC status of the drug:
“…Now if it would have stayed a prescription then you know I know they may deny
counseling with me however they went to a physician, they were examined, they obviously
were spoken to about the medication and if they don’t want to hear my counseling that’s
fine… I’m a little more at ease with that. Than in the sense that now it’s over the counter
and they just come and buy it and go…”
“And me personally, I think it all comes down to like I personally don’t think that that
drug should have been placed over the counter just because of the counseling issue.”
Other reasons provided for the need to counsel clients on emergency
contraception was due to a belief that consumers are ignorant about their health and that
repeat users and teens are irresponsible. Examples of the need to counsel due to the
ignorance of consumers:
“…Take the pill they think it’s taken care of, they could be… three weeks later out at a
Dolphins game, tailgating, be drinking most of the morning and half of the afternoon and
they’ve damage… they’ve potentially caused damage to their fetus because they didn’t
understand that they needed to follow back up with their doctors…”
“I agree with you. Cause some people may not even know what their cycle is and then
just probably just wasting their money too and buying something that’s not going to
work. You know? Some people don’t even think about when they’re really ovulating or
what they should look for. So I agree with you on counseling…”

137

Examples of the belief that education is needed because repeat use and teens are
irresponsible are included below:
“I think that… the other major thing that concerns me with the Plan B, especially going
back to the ignorance in a… in women’s health that a lot of people like to self medicate
in this country and they might not seek out getting the Plan A, the regular oral
contraceptives, and just utilize the Plan B frequently and there’s not a lot of data on how
effective it is if it’s used more frequently; if it becomes less effective and I think that’s
what the evidence that they’ve been telling us is. That when it’s used more
frequently it’s not as effective and I… I think when they have that over the counter the
pharmacist needs to at least tell the… the patient that they need to seek out a good oral
contraceptive from that point on.”
“… in some instances I believe that you know it’s a reason for young people to have
unprotected sex. They feel you know, well I can’t get pregnant; you know I can (either)
take birth control; I can take emergency contraception… but their not aware of the other
things… the outcomes of it…you know STDs, (unclear) for example…I mean I can tell
you from experience. I see it everyday at the pharmacy… right here… (unclear) right
now we have to have birth control in stock… I mean this we have to have all of (the) at
the beginning of the year… birth control… I mean it’s like hot item. Believe it or not
those same patients within three months after that has to get prescription for STD. So my
thing is yes, you’re not gonna get pregnant but then again you… you are not protecting
yourself (about) the other risks. So yeah I mean I think about it but I… well it’s just an
excuse for them to go ahead and have unprotected sex… but at the same time you know
it’s not my place to say well you can’t… I cannot dispense it to you.”
“… I think that… I had a lady come in with her boyfriend, young girl she might have
been maybe just 18. I asked her if she needed any counseling. You know (unclear) wanted
to know the side effects on it. And she said no, she just kinda wanted to buy it and run
out. I guess cause of being embarrassed or whatever; so that’s kinda worrisome because
you know if they over use that, that could cause problems for them health-wise. So I
think that’s a big issue. I think somehow, it needs to be… counseling has to be a
mandatory thing. I think that that… cause they could refuse counseling but I feel that with
that medication, I don’t think that you should be allowed to refuse.”
Many sentiments such as these below carried a hint of paternalism in the form of
counseling despite Plan B not being a counseled product.
“… well they chose to get it, I’m not the one who gave them access to it but I can at least
tell how to use it right so that they don’t harm themselves. Cause by me not giving it to
them I’m abiding to my ethical beliefs but them taking it can harm them more than benefit
them if I don’t give them counseling.”
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“… I think I’m okay with it because ultimately I think it’s my goal to be um… to counsel
the person and maybe you know… get… give them another perspective.”
“I think you need to sit and hear ok this is not a drug that you can use every time...”
“… I guess concerned when a male comes in to buy it because we can’t refuse, if he’s
18, if he shows his ID you know that’s what our discussion was (in lab)… we can’t really
refuse him but how do we know he’s not gonna you know… you know worse case
scenario… go out and rape somebody and force a 15 year old to take it…”
One way to perhaps explain this overwhelming need to counsel and educate
consumers can be found in participant ideas about pharmacy as a profession. One of the
first questions asked in the warm up of the focus group discussions is why students want
to be a pharmacist and almost all students responded that they chose to become
pharmacists so that they can help and counsel people.
“… I enjoy helping people and… my (ideal) pharmacist is someone who would get out
and help the customers.”
“I want to become a pharmacist… once again it’s a helping profession it gives you the
ability to help people in the way that the pharmacist role is going… rather than just
standing back behind the counter and filling things out… helping the patients and
counseling them and helping them…”
“…the counseling piece has always been very important to me and I’ve always kind of
felt obligated to do some counseling and interaction and this gives me an opportunity to
do that with more security… this would be something that would give me the opportunity
to counsel um… and also give me the opportunity to educate…”
The area of stigma took on two forms, one where participants noted the stigma
that consumers feel when coming in and asking for Plan B and two, the overall stigma
that participants seemed to have about users of Plan B and around OTC drugs in
particular. These quotes embody the noted stigma that consumers may feel when
requesting the medication:
“Nobody’s happy… nobody’s smiling going… I want my Plan B.”
139

“They’re usually very quiet about it. They come in and they’re kinda like do you sell the
Plan B? You kinda see them lurking in the aisle before they come up to make sure
nobody’s there or if it’s a male pharmacist, they wait till a female at the register.”
Upon coming into the focus group, some participants had a preconceived notion
of what kind of person uses Plan B and therefore already had a stigma towards the person
using the medication. When answering the question, what is the first thing that comes to
mind when you hear the term emergency contraception, all focus groups said that the first
thing that comes to mind is a young girl or teenager trying to fix their mistake or risky
sexual behavior. It is possible that this stigma or notion of a Plan B user may negatively
impact access to this medication. Focus group participants mentioned that other stigmas
were present for other OTC products such as Sudafed, syringes, and nicotine patches. It
is strange that there did not seem to be the same stigma around prescription oral
contraceptives even though prescription oral contraceptives and Plan B are
compositionally the same.
When discussing dispensing practices, data from the focus group discussions
demonstrated a tension between what is called professional judgment and mandatory
dispensing. Professional judgment is the idea that pharmacists should be able to decide
whether or not to dispense medication based on their personal beliefs/religion/values and
mandatory dispensing is the thought that if you are a pharmacists, you should be required
to dispense all approved and legal drugs that your pharmacy carries. There was much
discussion around both sides of this argument in all of the focus groups, however only
one excerpt is shown here:
“… if it’s religious… if they have a religious belief… I know that they is not supposed to
you know take their religion to the workplace but… however as long as they able to refer
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the patient you know to where they can get it … I feel like it’s you know it’s their
professional judgment and they… they don’t want to dispense it…”
Member 4: “I don’t…”
Member 1: “so I don’t think we can force them and say hey you have to do this. They are
profess… they are professionals and I think their right has to be protected also.”
Member 4: “… but a lot of times people use that as an excuse because if you… if it was
truly that they didn’t want to dispense it because of their religious beliefs…what about all
the other medications that… you know what I mean, that fall under that category also…
like nobody refuses to dispense Viagra… nobody refuses to dispense Cialis… nobody
refuses to dispense regular birth control… so… then why would your religious beliefs
only tell you that you can’t dispense Plan B? Like that doesn’t make any sense.”
Member 1: “But the thing is you know…it’s harder like for the older pharmacists… it’s
harder for them to accept changes. So you know they still have that old mindset.”
Member 4: “They should retire.”
Member 3: “I mean I wouldn’t personally refuse anyone, um however I do feel that
everyone has their right to believe whatever you believe; but it’s all in how you handle
the situation. Ok, if um… if I didn’t want to dispense it and I said to the patient we just
don’t have it in stock, let me refer you to blah blah blah. Fine. Ok, I can deal with that
but… some people are just downright rude and saying I don’t dispense this drug… you
know and just kinda like…right away catch the attitude…and I don’t think that’s
appropriate at all. Now if they do you know something like we don’t have it in stock why
don’t I refer you to this store. That’s okay. I wouldn’t have an issue with that.”
Member 3: “If that’s your personal religious belief, fine I think you handled it as best as
you could in that case. But if you’re gonna you know get rude about it… then no…”
Member 4: “I think that the issue… that I have with it is like she said… when you’re…
when they’re rude… or when they say you know… you shouldn’t take this because I…
I’m not giving this to you because I don’t believe in it or you shouldn’t be having
unprotected sex or you’re too young to be taking… you know what I’m saying when they
say… cause I’ve heard pharmacists say…”
Member 4: “Like they won’t just say I can’t dispense this you know whatever. They’ll…
they tell the patient… why they think they shouldn’t be taking it and that they shouldn’t be
taking it and they shouldn’t be doing this and that’s… I mean that’s not our place to do
that.”
Member 1: “But I… on the other side… this is probably gonna be on the side of the
pharmacy side. I feel like if we just… if we as… as a professional if we allow you know…
141

if we allow them to take all of our rights away… you know what kind of professional we
are? We just gonna be doing whatever we are told to do. You know our profession is not
gonna be protected; we not gone have right to do what we feel is
right.”
Member 4: “But it’s not about… it’s not about your religious beliefs though.Your right is
to say… as a pharmacist I have a right to say… you… I’m not gonna dispense this to you
because it’s going to cause you to bleed to death… I’m not gonna dispense this to you
because I can see that you are addicted to narcotics… I’m not going to dispense it to you
because you’re already taking something that has the same ingredients in it. Not I have a
right to tell you that I’m not gonna give it to you because I don’t believe you should be
taking it. That’s not…you know what I mean. So I feel like our professional rights are
protected because we do have the authority to say we’re not going to dispense anything
to you that is going to endanger your health or your safety.”
Member 5: And as far as the patient made up their mind or a doctor wrote in on a
prescription pad, you’re (unclear) saying that a pharmacist is a mere um…vendor um…
just there to exchange products and not exchange service. And if the patient made up
their mind it doesn’t mean that we should necessarily have to follow whatever they
decide. I’ve seen multiple prescriptions that I would not have dispensed on any day of my
life… just because it was written on a prescription pad doesn’t mean it was correct. Oh
and just because a patient makes up their mind doesn’t mean it’s correct…”
Lastly, many stories of refusals and pharmacists and pharmacies limiting access to
emergency contraception were expressed during the focus groups and will be shared here.
Participants noted that they work with pharmacists who refuse to dispense Plan B.
“And regardless of what everyone would like to say about pharmacists don’t pass
judgment, there’s a lot of students who pass judgment now; which means they are
going to be pharmacists who pass judgment. And I’ve worked with pharmacists who
refuse to dispense...”
“Yeah, I… I personally work in a pharmacy where we had two pharmacists, when it was
prescription only, refuse to fill it and… two pharmacists who would. So it was a very
interesting cause I was involved in the juggling back and forth between…that particular
situation.”
“… (another) pharmacist that we have, he hides them… when we get in an order.”
All: He hides it? Member 3: Where the heck does he hide it?
Member 2: I have no idea. I went to the room the other day and then the pharmacist look
for it and I thought he had it…I’m like (are those things right there). Cause we made a…
we made a bet… a hundred dollars that we can…that we can find (whether) he hides
them at. I know he’s not taking it out of the pharmacy…that’s against the law.
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He puts them somewhere… he… he makes sure he works on Tuesday night when the
order gets in…to make sure he takes them out of those box and puts them somewhere we
don’t know”
“…(a professor) warned us about there’s this one student on rotation who got a
prescription um for Plan B, um it was CVS in Gainesville and the pharmacist doesn’t
want to fill it but she um, the student gave it to their patient anyway and got into so much
trouble. But the pharmacist kind of just blamed it on the student. Well it’s the student’s
fault because you’re really not supposed to but um I guess the point is like um don’t do
anything your like your preceptor wouldn’t do. Just make sure like if your preceptor
says no I don’t want to fill it then you don’t give it to the patient…”
“It depends on the pharmacist, some pharmacists are totally cool with it but there were
pharmacists who would just refuse to give it to their patients.”
“(a professor) just warned us like if your preceptor doesn’t feel comfortable, then don’t
do it.”
“…I was working with a pharmacist and he mentioned that he had um you know I’m not
against any religion, that he had a Jewish pharmacist who would just not dispense it at
all no matter what because he felt that sperm shouldn’t be wasted. So um… it was… he
just wouldn’t do it at all…”
“I’ve had some pharmacists that won’t sell it to men… also in that same Jewish place...
It has to be a female over 18.”
Summary
In sum, there was a disconnect between what pharmacy students reported on the
paper and pencil survey and what was uncovered in the focus group discussions. On the
paper and pencil survey students reported learning about emergency contraception in
their pharmacy school classes, however when queried in the focus groups discussions
pharmacy students revealed that this learning did not come from their pharmacy school
classes but rather from outside sources.
Question 2 asked about how emergency contraception course content was taught
at accredited schools of pharmacy. According to the focus group discussions what is
taught in pharmacy school classes about emergency contraception is brief and over half
143

of the sample felt that pharmacists are not well enough informed to confidently dispense
emergency contraception. The majority of participants felt that their professors
maintained a neutral attitude in teaching about the medication. In addition, participant
level of knowledge about emergency contraception was not specific. Many students
entered the focus group with a preconceived notion about people who use emergency
contraception and were hesitant in dispensing the medication. Many participants held
biases or judgments towards emergency contraception users. This stigma may be
explained through a belief that pharmacists have a duty to educate and counsel clients. It
is likely that these beliefs were learned from school. Refusing to dispense emergency
contraception is real as noted in many of their stories and the arguments for refusing to
dispense and for mandatory dispensing were present throughout the focus groups without
resolution.
Section III: State-Wide Pharmacist Survey
The third research question was addressed through a state-wide survey of
pharmacists. Although 552 surveys were mailed out to pharmacists around the state of
Florida, only 146 were returned (138 paper-based and 8 online) yielding a 26% response
rate. After speaking with committee members, a second mailing was sent. The second
mailing only had one contact point and did not follow Dillman’s method due to budget
constraints. Because 185 more surveys were needed at this point, another 712 surveys
were sent out to a random sample of pharmacists and great care was taken to ensure that
pharmacists were not double sampled. Of the 712 surveys mailed out in the second
mailing, 130 were returned yielding a 18% response rate. However, 30 surveys were
either returned by mail or they left messages about how they were retired, sick, or not
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currently living in Florida. In total, 1,264 surveys were mailed out, 272 were returned
and ~30 were incorrect. Therefore, the final sample size was 272 (which is 82% of the
original sample hoped for) with a 22% response rate overall. Because the study was not
funded and because the research and mailing costs were out of pocket expenses for the
researcher, surveying more pharmacists could not continue and therefore they desired
sample of 331 was not reachable. The following analysis will report on the 272 surveys
that were returned.
Quantitative Data Analysis: Univariate & Bivariate Analysis
Quantitative data analyses were performed using SPSS statistical software (SPSS
16.0, SPSS Inc., Chicago). Frequency distributions were performed on all categorical
level variables to determine response distributions and means and standard deviations
were calculated for all continuous variables. These procedures identified any outliers or
non-meaningful responses and response patterns which could call for collapsing of data
based on the distribution. All collected and entered data as well as frequency distribution
output data are available on CD.
Univariate Analysis. The sample included 272 pharmacists, female (52.6%) and
male (47.4%) (Table 15). Age ranged from 25 to 87 and can be equally distributed into
thirds with 30.9% under 36 years of age, 34.6% between the ages of 36-50, and 32.7%
between the ages of 51-87. The ethnic composition of the sample was primarily White
(70.6%), followed by Hispanic (10.7%), Asian (7.4%), Black (6.2%), and Other (3.3%).
A little over 67% of pharmacists were married with the remainder single (27.6%) or
living with their partner (3.7%). Almost 38% of the sample were Republican, followed
by Democrats (25%), Independents (17.3%), and none or undecided (15.8%). In terms of
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religion, 67.3% reported some form of Christianity, 8.8% claimed no religion, 7%
reported being Jewish, 6.2% reported being Hindu or Buddhist, 1.5% Islamic, and 9.2%
did not answer the question. When queried about religiosity, 47.4% of the pharmacists
claimed to be either religious or religious and spiritual, while 25.4% reported to be
spiritual only, and 25.4% selected undecided, none of the above, or prefer not to respond.
Table 15. Sociodemographics Characteristics of Study Sample (N=272)
Variable
Total population N (%)
Gender
Female
143 (52.6)*
Male
129 (47.4)
Age, years
< 36
84 (30.9)
36-50
94 (34.6)
51-87
89 (32.7)
Ethnicity
White
192 (70.6)
Black
17 (6.2)
Hispanic
29 (10.7)
Asian
20 (7.4)
Other
9 (3.3)
Marital status
183 (67.3)
Married
10 (3.7)
Living with partner
28 (10.3)
Divorced or separated
4 (1.5)
Widowed
43 (15.8)
Never been married
Political Affiliation
103 (37.9)
Republican
68 (25.0)
Democratic
47 (17.3)
Independent
43 (15.8)
None/undecided
6 (2.2)
Other
Religion
183 (67.3)
Christian
17 (6.2)
Hindu or Buddhist
19 (7.0)
Jewish
4
(1.5)
Islamic
24 (8.8)
None
25 (9.2)
Missing
Religiosity
Religious
43 (15.8)
Spiritual
69 (25.4)
Religious and Spiritual
86 (31.6)
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Undecided
None of the above
Prefer not to respond

13 (4.8)
35 (12.9)
21 (7.7)

*Some percentages do not add to 100 because of rounding or missing data

The remainder of the demographic questions queried about pharmacists’ current
positions and their pharmacy education and training (Table 16). Just over 32% had been
practicing pharmacy for 8 years or less, 33.5% had been practicing between 9 and 22
years, and 33.8% had been practicing pharmacy between 23 and 55 years. Over half of
the sample (51.8%) was employed at a community-chain pharmacy, almost 20% worked
at a hospital pharmacy, 15.4% reported working at another type of pharmacy such as
home infusion, or mail order, and another 12.9% of pharmacists reported working at a
community-independent pharmacy. Just over 58% of the sample said that they were staff
pharmacists, 27.6% reported to be pharmacy managers, and 14.3% reported to have a
different job title such as clinical pharmacist, pharmacy owner, or medical liaison.
Almost 81% of the sample claimed to be employed full-time, 17.3% worked part-time,
and a smaller 1.8% were retired. In terms of pharmacy school attendance, the top five
schools attended, which represented 47.8% of the sample, were University of Florida
(24.6%), Nova Southeastern University (11.8%), Florida Agricultural & Mechanical
University (4.4%), Mercer University (3.7%), Massachusetts College of Pharmacy
(3.3%). Almost a third of the sample (32.4%) graduated between 1949-1982, 28.7%
graduated between 1983-1998, and 34.6% graduated between 1999-2007.
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Table 16. Demographics on Pharmacy Practice and Training (N=272)
Variable
Total population N (%)
Years in Practice
<9
88 (32.4)*
9-22
91 (33.5)
23+
92 (33.8)
Type of Pharmacy where Employed
141 (51.8)
Community—Chain
35 (12.9)
Community—Independent
54 (19.9)
Hospital
42 (15.4)
Other (e. g. Home Infusion, Mail Order)
Job Title
Staff Pharmacist
158 (58.1)
Pharmacy Manager
75 (27.6)
Other (e. g. Clinical Pharmacist)
39 (14.3)
Current Employment Status
220 (80.9)
Full-time
47 (17.3)
Part-time
5 (1.8)
Retired
Pharmacy School Attended**
University of Florida
67 (24.6)
Nova Southeastern University
32 (11.8)
Florida Agricultural & Mechanical University
12 (4.4)
Mercer University
10 (3.7)
Massachusetts College of Pharmacy
9 (3.3)
Year Graduated
88 (32.4)
1949-1982
78 (28.7)
1983-1998
94 (34.6)
1999-2007
*Some percentages do not add to 100 because of rounding or missing data
**Only certain data presented for this variable

Univariate analysis was performed for each independent variable (knowledge,
attitudes, subjective norms, and perceived behavioral control). Knowledge was measured
by 10 questions. Higher levels of knowledge were found for comprehension of number
of pills in Plan B package, timing of administration, percentage of effectiveness, how to
sell OTC to men who request it, Plan B and it’s relationship to abortion, and the
relationship between timing and Plan B effectiveness. Lower levels of knowledge were
found for understanding Plan B’s true mechanism of action, comprehension of who can
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sell Plan B to consumers, how to sell OTC to women in advance of need, and the
relationship between Plan B and birth defects (Table 17).
Table 17. Categorical Classifications for Knowledge
Knowledge Items*
Number of pills in Plan B package
Correct
Incorrect
Timing of administration
Correct
Incorrect
Mechanism of action
Correct
Incorrect
Percentage of effectiveness
Correct
Incorrect
Who can sell Plan B to consumers
Correct
Incorrect
How to sell OTC to women (in advance of need)
Correct
Incorrect
How to sell OTC to men
Correct
Incorrect
Plan B can cause birth defects (True/False)
Correct
Incorrect
Plan B can act as an abortifacient (True/False)
Correct
Incorrect
The sooner a woman takes Plan B, the more
effective it will be (True/False)
Correct
Incorrect

Total population N (%)
185 (68.0)
87 (32.0)
188 (69.1)
84 (30.9)
120 (44.1)
152 (55.9)
186 (68.4)
86 (31.6)
121 (44.5)
151 (55.5)
61 (22.4)
211 (77.6)
183 (67.3)
89 (32.7)
120 (44.1)
152 (55.9)
146 (53.7)
126 (46.3)
248 (91.2)
24 (8.8)

*Missing cases are treated as incorrect

A composite score was developed from the 10 questions that measured
knowledge such that each participant was given a knowledge score, 0 out of 10. The
mean, standard deviation, range as well as the distribution of the knowledge composite
variable is provided in Table 18. On a scale of 0-10, the mean knowledge score for
participants was 5.36, meaning that the sample had average knowledge across the board.
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The knowledge composite score had a normal distribution with a slight left skew
meaning that there was a slight skew towards higher level of knowledge about Plan B in
the sample. It was assumed that a pharmacist did not know the answer to a question if
they left the question blank. Therefore, an unanswered knowledge question was treated
as don’t know. Pharmacists received a 1 if they answered the question correctly and a 0
if they answered the question incorrectly or did not answer the question. There were 47
pharmacists who left 1 or more knowledge questions blank. Of these 47 pharmacists, 27
only left 1 item blank, 6 left 2 items blank, 3 left 3 items blank, 5 left 4 items blank, 5 left
7 items blank, and 1 left all items blank.
Table 18. Univariate Statistics for Knowledge Composite Variable, N=272
N (%)
Mean (SD)
Range
5.36 (2.46)
0-10
Knowledge Composite Variable
9 (3.3%)
0
16 (5.9%)
1
19 (7.0%)
2
16 (5.9%)
3
31 (11.4%)
4
40 (14.7%)
5
38 (14.0%)
6
49 (18.0%)
7
30 (11.0%)
8
19 (7.0%)
9
5 (1.8%)
10

Skewness
-.381

Table 19 represents the univariate analysis for the items that measured attitudes
about Plan B. In general, attitudes about Plan B use and users tended to vary. While
over half of the sample (52.9%) disagreed with the statement that easy availability of
Plan B would discourage the use of regular contraception, 45.5% either agreed or were
not sure. A similar finding was found with the statement easy availability of Plan B
promotes promiscuity. While 53.7% of the sample disagreed with the statement, the
other 44.5% either agreed or were not sure. Over 64% of the sample reported that they
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did not feel uncomfortable dispensing Plan B because of their religious/ethnical beliefs,
however 33.8% reported that they either did feel uncomfortable due to their
religious/ethical beliefs or they didn’t know. A large percentage of the sample felt that
repeated use of Plan B is wrong (61%). In terms of comfort with dispensing Plan B to
different groups of people, a large proportion of the sample (66.9%) felt comfortable
dispensing to adult women, less felt comfortable dispensing to men (41.5%), and even
less felt comfortable dispensing to adolescents (38.6%). This finding is consistent with
the dependent variable, dispensing practices which will be discussed below. In addition,
the majority of pharmacists (79%) felt that Plan B should be offered to women who are
raped in all hospital emergency rooms, regardless of hospital affiliation.
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Table 19. Categorical Classifications for Attitude
Attitude Items*
Easy availability of Plan B will discourage regular contraceptive use
Agree
Disagree
Neither Agree nor Disagree
Easy availability of Plan B promotes promiscuity
Agree
Disagree
Neither Agree nor Disagree
I feel uncomfortable dispensing Plan B because of my religious/ethnical
beliefs
Agree
Disagree
Neither Agree nor Disagree
Repeated use of Plan B is wrong
Agree
Disagree
Neither Agree nor Disagree
I feel comfortable dispensing Plan B to adult women
Agree
Disagree
Neither Agree nor Disagree
I feel comfortable dispensing Plan B to adolescents (teens <18 yrs old)
Agree
Disagree
Neither Agree nor Disagree
I feel comfortable dispensing Plan B to men
Agree
Disagree
Neither Agree nor Disagree
Should Plan B be offered to women who are raped in all hospital
emergency rooms, regardless of hospital affiliation?
Yes
No/Not sure

Total population N
(%)
85 (31.2)**
144 (52.9)
39 (14.3)
74 (27.2)
146 (53.7)
47 (17.3)
59 (21.7)
176 (64.7)
33 (12.1)
166 (61.0)
66 (24.3)
34 (12.5)
182 (66.9)
63 (23.2)
23 (8.5)
105 (38.6)
133 (48.9)
30 (11.0)
113 (41.5)
117 (43.0)
38 (14.0)
215 (79.0)
53 (19.5)

*The first seven questions were measured on a 5-point Likert scale from completely agree to completely
disagree and were collapsed for easier comprehension
**Some percentages do not add to 100 because of rounding or missing data

A composite score was developed from the 7 questions that measured attitudes.
Since the attitude questions were measured on a 5-point Likert scale, each respondent
received a score from 1-5 for each individual question and the composite score included a
total score for all attitude questions. The attitude composite score ranged 7 to 21 where a
152

higher score equates to more positive attitudes about Plan B. The mean, standard
deviation, and range is provided in Table 20 for this new continuous variable attitudes
about Plan B. On a scale of 7-21, the mean attitude score for participants was 14.87,
meaning that the sample had average attitudes across the board. The attitude composite
score had a normal distribution with a slight left skew meaning that there was a slight
skew towards more positive attitudes about Plan B in the sample.
Table 20. Univariate Statistics for Attitude Composite Variable
Study Sample (N=272)
Mean (SD)
Attitude Composite Variable
14.87 (3.98)

Range
7-21

Skewness
-.327

Figure 5 represents the univariate analysis of some of the items measuring
subjective norms. Overall, the majority of the sample perceived that their
partners/business colleagues, professional organizations that they are most active in, their
supervisor, and their close friends and family think that they should dispense Plan B. In
addition, 11.4% of the sample reported that there is someone at their pharmacy who
refuses to dispense Plan B, 41.2% reported that there is no one at their pharmacy who
refuses to dispense, 26.7% were not sure, and 18.4% of the sample reported that their
pharmacy does not carry Plan B (data not listed in chart). When asked if there is a policy
in place at their pharmacy if someone refuses to dispense Plan B, 29.4% said yes, 24.3%
said no, 23.5% were not sure, and 19.1% of the sample reported that their pharmacy does
not carry Plan B (data not listed in chart).
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Figure 5. Categorical Classifications for Subjective Norms (whether
each group listed thinks they should dispense)
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A composite score was developed from the 4 questions that measured subjective
norms such that each participant was given an composite score ranging from 4 to 16. The
mean, standard deviation, and range is provided in Table 21 for this new continuous
variable subjective norms about Plan B. On a scale of 4-16, the mean subjective norms
score for participants was 12.99. The subjective norms composite score had a normal
distribution with a left skew meaning that there was a skew towards pharmacists thinking
that influential people think that they should dispense Plan B.
Table 21. Univariate Statistics for Subjective Norms Composite Variable
Study Sample (N=272)
Mean (SD)
Range
Subjective Norms Composite Variable
12.99 (2.71)
4-16

Skewness
-1.115

Figure 6 represents the univariate analysis of the items measuring the construct
perceived behavioral control. A large proportion of pharmacists reported that it was easy
for them to counsel (69.5%) and educate (72.4%) clients about Plan B, while 14.3% and
10.7% felt that it was difficult to counsel and educate respectively. In addition, 67.6% of
pharmacists reported that it is easy to dispense Plan B and 25.4% reported that it is easy
to refuse to dispense the medication.
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Figure 6. Categorical Classifications for Perceived Behavioral
Control (How easy is it for you to...)
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A composite score was developed from the 4 questions that measured perceived
behavioral control such that each participant was given an composite score ranging from
4 to 16. The mean, standard deviation, and range is provided in Table 22 for this new
continuous variable perceived behavioral control. On a scale of 4-16, the mean perceived
behavioral control score for participants was 12.73. The perceived behavioral control
composite score had a normal distribution with a left skew meaning that there was a skew
towards pharmacists responding that they have a higher comfort level in dispensing Plan
B.
Table 22. Univariate Statistics for Perceived Behavioral Control Composite Variable
Study Sample (N=272)
Mean (SD)
Range
Skewness
Perceived Behavioral Control Composite
12.73 (2.74)
4-16
-.912
Variable

Dispensing practices can be divided into two separate measures, 1) self reported
dispensing practices of pharmacists (dependent variable) and 2) intention to dispense
Plan B. Table 23 and 24 summarize the univariate analysis for the self-reported
dispensing practices including both the frequency distribution for the categorical level
items and the means, standard deviations, and ranges for the continuous level questions.
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A similar proportion of pharmacists have ever been asked to fill a prescription of
Plan B (55.1%) or sell Plan B OTC (56.6%). Although these proportions of pharmacists
have been asked to dispense Plan B, strangely, less have actually filled a prescription
(47.1%) or sold Plan B OTC (51.8%). Almost 60% of the sample have ever dispensed
emergency contraception either by prescription or OTC. In addition, 70.6% of the
sample would have the opportunity to come in contact with Plan B at their workplace.
Table 23. Categorical Classifications for Dispensing Practices
Dispensing Practices Items
Ever been asked to fill a prescription of Plan B
Yes
No
Ever personally filled a prescription of Plan B
Yes
No
Ever been asked to sell Plan B over-the-counter
Yes
No
Ever personally sold Plan B over-the-counter
Yes
No
Ever dispensed by prescription OR over-the-counter
Yes
No
Would you ever have the opportunity at your workplace to come
into contact (see, dispense, fill a prescription) with Plan B?
Yes
No

Total population N (%)
150 (55.1)*
122 (44.9)
128 (47.1)
144 (52.9)
154 (56.6)
115 (42.3)
141 (51.8)
128 (46.3)
162 (59.6)
105 (38.6)
192 (70.6)
74 (27.2)

*Some percentages do not add to 100 because of rounding or missing data

Table 24 summarizes the means, standard deviations, and ranges for self-reported
dispensing practices by prescription and OTC over the past 12 months. When asked how
many Plan B prescriptions pharmacists have personally filled in the past 12 months,
answers ranged from 0 to 100 with a mean of 2.33 and a standard deviation of 9.29.
When asked how many times pharmacists have sold Plan B OTC in the past 12 months,
answers ranged from 1 to 200 with a mean of 5.64 and a standard deviation of 16.91.
156

Table 24. Means, Standard Deviations, and Ranges for Dependent Variable Dispensing
Practices
Characteristic
Mean
SD
Range
Skewness
Number of Plan B prescriptions
2.33
9.29
0-100
9.169
filled in past 12 months
Number of times sold Plan B over5.64
16.91
0-200
7.466
the-counter in past 12 months

Table 25 shows the number of times pharmacists have dispensed emergency
contraception in the last 12 months. Over the last year, pharmacists have dispensed
emergency contraception OTC more than they have by prescription which may mean that
the OTC measure has increased use and access to this medication. Of the pharmacists
that reported that they have ever filled a prescription of Plan B, 60.7% have not filled any
prescriptions in the past 12 months, 29.8% have filled 1-5 prescriptions, 7.7% have filled
6-10 prescriptions, 1.1% reported filling between 11-50 prescriptions, and 0.7% filled
between 51-100 prescriptions. No pharmacist reported filling more than 100
prescriptions of Plan B over the past 12 months. Of the pharmacists that reported that
they have ever sold Plan B OTC, 48.5% have not sold emergency contraception OTC
over the past 12 months, 29.4% sold 1-5 packages of Plan B, 9.9% sold 6-10 packages,
10.7% reported selling 11-50 packages, 1.1% sold between 51-100 packages, and over
0.4% of pharmacists sold between 101-200 prescriptions over the past year. No
pharmacist reported dispensing more than 200 prescriptions of Plan B over the past 12
months.
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Table 25. Number of Times Pharmacists have Dispensed EC in the Last 12 Months
By Prescription N (%)
Over-the-counter N (%)
0
165 (60.7)
132 (48.5)
1-5
81 (29.8)
80 (29.4)
6-10
21 (7.7)
27 (9.9)
11-50
3 (1.1)
29 (10.7)
51-100
2 (0.7)
3 (1.1)
101-200
0 (0.0)
1 (0.4)

Table 26 summarizes the univariate analysis for intention to dispense. Intention
to dispense measures the likelihood or intention of dispensing Plan B to varying groups
of people and was partitioned into categories based on dispensing by prescription or
OTC. Intention or likelihood of dispensing Plan B does vary by the consumer requesting
the medication or by the situation of use. For example, when viewing intentions of OTC
dispensing of Plan B, a greater percentage of pharmacists reported being likely to
dispense to women who have experienced incest or rape (71%), followed by women who
have experienced a problem with their birth control method (67.3%), followed by women
who request the method after having unprotected sexual intercourse (66.2%) and last to a
person other than the ultimate consumer of the product such as parents or a boyfriend
(46.7%). Interestingly, it was almost split half and half in terms of pharmacists
likelihood of dispensing OTC to a person other than the ultimate consumer of the product
such as parents or a boyfriend.
When viewing intention to dispense by prescription to varying groups of people,
pharmacists were most likely to dispense to women who have experienced incest or rape
(72.4%), followed by women who request the method after having unprotected sexual
intercourse (71%), followed by women who have experienced a problem with their birth
control method (68.4%), and lastly to sexually active teens under age 18 (61.8%).
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Interestingly, a greater proportion of pharmacists were likely to dispense to all groups by
prescription than OTC.
It is important to note that some of the items that measure intention to dispense
are not real-life examples as pharmacists may never know if a woman is raped or not or if
a woman has had unprotected intercourse or if her birth control method failed. However,
a pharmacist would know if the person requesting Plan B is a teenager or if it is a person
is a male. In addition, it is assumed that the consumer has had some sort of unprotected
intercourse if they are requesting the medication in the first place. That being said, the
variable intention to dispense measures hypothetical bias of intention should pharmacists
be privy to this information about the consumer.
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Table 26. Categorical Classifications for Intention to Dispense
Intention to Dispense Items
Likelihood of dispensing OTC to women who have experienced incest or
rape
Likely
Unlikely
N/A
Likelihood of dispensing OTC to women who have experienced a
problem with their birth control method
Likely
Unlikely
N/A
Likelihood of dispensing OTC to women who request the method after
having unprotected sexual intercourse
Likely
Unlikely
N/A
Likelihood of dispensing OTC to a person other than the ultimate
consumer of the product such as parents or a boyfriend
Likely
Unlikely
N/A
Likelihood of dispensing by prescription to women who have
experienced incest or rape
Likely
Unlikely
N/A
Likelihood of dispensing by prescription to women who have
experienced a problem with their birth control method
Likely
Unlikely
N/A
Likelihood of dispensing by prescription to women who request the
method after having unprotected sexual intercourse
Likely
Unlikely
N/A
Likelihood of dispensing by prescription to sexually active teens under
age 18
Likely
Unlikely
N/A

Total population N
(%)
193 (71.0)*
47 (17.3)
30 (11.0)
183 (67.3)
60 (22.1)
27 (9.9)
180 (66.2)
65 (23.9)
24 (8.8)
127 (46.7)
116 (42.6)
28 (10.3)
197 (72.4)
43 (15.8)
31 (11.4)
186 (68.4)
55 (20.2)
30 (11.0)
193 (71.0)
51 (18.8)
27 (9.9)
168 (61.8)
72 (26.5)
30 (11.0)

*Some percentages do not add to 100 because of rounding or missing data

A composite score was developed from the 8 questions that measured intention to
dispense Plan B such that each participant was given an intention score ranging from 4 to
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16. The mean, standard deviation, and range is provided in Table 27 for this new
continuous variable intention to dispense Plan B. On a scale of 4-16, the mean attitude
score for participants was 12.70. The intention composite score had a normal distribution
with a left skew meaning that there was a skew towards a greater intention or likelihood
to dispense Plan B.
Table 27. Univariate Statistics for Intention to Dispense Plan B Composite Variable
Study Sample (N=272)
Mean (SD)
Range
Intention Composite Variable
12.70 (4.12)
4-16

Skewness
-1.199

Bivariate Analysis. Chi-square tests were used to estimate the associations
between sociodemographic variables, demographic practice and training variables and the
dichotomous dependent variable dispensing practices. Results for socio-demographic
variables and dispensing are summarized in Tables 28-30 and results for practice and
training variables and dispensing are summarized in Table 31. Overall, gender, ethnicity,
political affiliation, religion, and religiosity were not found to be significantly associated
with dispensing of emergency contraception. The only socio-demographic variables
associated with emergency contraception dispensing was pharmacist age, where younger
pharmacists (under 36 years of age) were more likely to have ever dispensed emergency
contraception as compared to older pharmacists and marital status, where individuals who
have never been married and individuals who are living with their partner were more
likely to have ever dispensed emergency contraception.
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Table 28. Chi Square Results of Ever Dispensed EC by Sociodemographic Variables
Ever Dispensed EC
Chi –
Characteristic
% Yes
Square(df)
Pattern of Finding (p value)
Gender
Female
56.7%
1.94(1)
Not Significant (p=0.164)
Male
65.1%
Age, years
< 36
Pharmacists under 36 years of
74.7%
9.12(2)*
age are more likely to have
36-50
53.8%
ever
dispensed EC (p=0.010)
51-87
56.8%
Ethnicity
White
59.1%
0.99(4)
Not Significant (p=0.911)
Black
70.6%
Hispanic
62.1%
Asian
63.2%
Other
66.7%
Marital status
Married
Individuals who have never
59.4%
7.85(3)*
been
married are more likely
Living with partner
70.0%
to have ever dispensed EC
Divorced/Separated/Widowed
45.2%
(p=0.049)
Never been married
76.2%
Political Affiliation
Republican
58.0%
3.92(3)
Not Significant (p=0.270)
Democratic
56.1%
Independent
61.7%
None/undecided/other
72.9%
Religion
Christian
57.0%
6.44(5)
Not Significant (p=0.265)
Hindu
60.0%
Buddhist
100.0%
Jewish
68.4%
Islamic
50.0%
None
66.7%
Religiosity
Religious
50.0%
6.24(3)
Not Significant (p=0.100)
Spiritual
71.0%
Religious and Spiritual
55.4%
Undecided/ None of the
63.2%
above/ Prefer not to respond
*Indicates statistical significance at p<.05.
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Although future analysis will focus only on combined dispensing, Tables 34 and
35 provide a breakdown of socio-demographic variables by prescription and OTC. No
socio-demographic variables were found to be associated with dispensing emergency
contraception by prescription. For OTC dispensing, pharmacist age was significantly
associated with dispensing emergency contraception where younger pharmacists (under
36 years old) were more likely to have dispensed emergency contraception OTC as
compared to older pharmacists. This finding demonstrates that the association with
dispensing and age is only significant for dispensing OTC. Marital status was no longer
significant for either dispensing by prescription or OTC.
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Table 29. Chi Square Results of Dispensing EC by Prescription by Sociodemographic Variables
Ever Dispensed EC by
Prescription
Characteristic
% Yes
Chi –Square(df) Pattern of Finding (p value)
Gender
Female
44.8%
0.64(1)
Not Significant (p=0.423)
Male
49.6%
Age, years
< 36
Not Significant (p=0.069)
58.3%
5.33(2)
36-50
42.6%
51-87
43.8%
Ethnicity
White
Not Significant (p=0.595)
46.9%
2.78(4)
Black
52.9%
Hispanic
37.9%
Asian
60.0%
Other
55.6%
Marital status
Married
Not Significant (p=0.276)
45.4%
3.86(3)
Living with partner
50.0%
Divorced/Separated/Widowed
40.6%
Never been married
60.5%
Political Affiliation
Republican
40.8%
5.41(3)
Not Significant (p=0.144)
Democratic
45.6%
Independent
51.1%
None/undecided/other
60.4%
Religion
Christian
46.4%
2.61(5)
Not Significant (p=0.759)
Hindu
60.0%
Buddhist
71.4%
Jewish
47.4%
Islamic
50.0%
None
50.0%
Religiosity
Religious
39.5%
9.98(5)
Not Significant (p=0.076)
Spiritual
60.9%
Religious and Spiritual
40.7%
Undecided
46.2%
None of the above
54.3%
Prefer not to respond
33.3%
*Indicates statistical significance at p<.05.
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Table 30. Chi Square Results of Dispensing EC OTC by Sociodemographic Variables
Ever Dispensed EC OTC
Characteristic
% Yes
Chi –Square(df) Pattern of Finding (p value)
Gender
Female
49.6%
1.2(1)
Not Significant (p=0.273)
Male
56.3%
Age, years
< 36
68.7%
12.26(2)*
Pharmacists under 36 years
of age were more likely to
36-50
42.9%
have ever dispensed EC
51-87
50.0%
OTC (p=0.002)
Ethnicity
White
Not Significant (p=0.715)
51.1%
2.11(4)
Black
64.7%
Hispanic
55.2%
Asian
57.9%
Other
66.7%
Marital status
Married
Not Significant (p=0.169)
52.8%
5.03(3)
Living with partner
70.0%
Divorced/Separated/Widowed
38.7%
Never been married
61.9%
Political Affiliation
Republican
47.0%
6.56(3)
Not Significant (p=0.087)
Democratic
50.0%
Independent
55.3%
None/undecided/other
68.8%
Religion
Christian
49.7%
5.08(5)
Not Significant (p=0.406)
Hindu
50.0%
Buddhist
83.3%
Jewish
68.4%
Islamic
50.0%
None
58.3%
Religiosity
Religious
42.9%
2.94(5)
Not Significant (p=0.710)
Spiritual
58.0%
Religious and Spiritual
51.8%
Undecided
53.8%
None of the above
58.8%
Prefer not to respond
52.4%
*Indicates statistical significance at p<.05.
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Results for practice and training variables by dispensing are summarized in Table
31. The number of years a pharmacist is in practice, the type of pharmacy where
employed, job title, and current employment status all were significantly associated with
dispensing emergency contraception. No relationship was found between dispensing and
pharmacy school attended or year of graduation. Specifically, pharmacists with fewer
years of practice, who were employed at a community-chain pharmacy, and part-time
staff pharmacists were more likely to have ever dispensed emergency contraception.
These findings stayed consistent when these variables were analyzed separately by
prescription and OTC.
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Table 31. Chi Square Results of Dispensing EC by Practice and Training Variables
Ever Dispensed EC
Characteristic
% Yes
Chi –
Pattern of Finding (p
Square(df)
value)
Years in Practice
<9
72.4%
9.01(2)*
Pharmacists with less
years
of practice were
9-22
59.1%
more likely to have
23+
50.5%
ever dispensed EC
(p=0.011)
Type of Pharmacy where Employed
Community—Chain
87.1%
94.93(3)*
Pharmacists
employed at a
Community—Independent
54.3%
community-chain
Hospital
26.4%
pharmacy are more
Other (e. g. Home Infusion, Mail Order)
20.0%
likely to have ever
dispensed EC
(p<0.0001)
Job Title
Staff Pharmacist
61.7%
16.14(2)*
Staff pharmacists are
more likely to have
Pharmacy Manager
31.5%
ever dispensed EC
Other (e. g. Clinical Pharmacist)
6.8%
(p<0.0001)
Current Employment Status
Full-time
87.7%
15.74(2)*
Full-time pharmacists
are more likely to
Part-time
12.3%
have ever dispensed
Retired
0.0%
EC (p<0.0001)
Pharmacy School Attended**
University of Florida
51.1%
78.09(82)
Not Significant
(p=0.602)
Nova Southeastern University
62.5%
Florida Agricultural & Mechanical
83.3%
University
Mercer University
60.0%
Massachusetts College of Pharmacy
66.7%
Year Graduated
1949-1982
54.0%
3.58(2)
Not Significant
(p=0.167)
1983-1998
60.0%
1999-2007
67.7%
*Indicates statistical significance at p<.05.
**Only certain data presented for this variable
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Bivariate associations were also explored between (a) knowledge and dispensing
practices, (b) attitudes and dispensing practices, (c) subjective norms and dispensing
practices, and (d) perceived behavioral control and dispensing practices. Results are
summarized in Tables 37-40.
Bivariate analysis was computed for knowledge as an ordinal level variable on a
scale of 0-10 with 0 representing low knowledge and 10 representing high knowledge
and with knowledge as a categorical variable with low knowledge representing scores
from 0-3, average knowledge for those that answered between 4-7 knowledge questions
correctly, and 8-10 were said to have high knowledge. Kruskal-Wallis analysis of
variance was computed for the ordinal level analysis and chi-square analyses were
computed for the categorical level knowledge variable. Both categorizations of
knowledge yielded significant results where knowledge about emergency contraception
was found to be significantly related to having ever dispensed it. Similarly significant
results were found when dispensing practices were separated by prescription and OTC
(Table 32).
Table 32. Bivariate Results of Dispensing EC and Knowledge
Ever Dispensed EC
% Yes
Chi –
Square(df)
Knowledge (ordinal level scale 0-10)
n/a
69.48(10)*
Knowledge (categorical level)
Low Knowledge
Average Knowledge
High Knowledge
*Indicates statistical significance at p<.05.

25.4%
64.3%
88.9%

49.58(2)*

Pattern of Finding (p
value)
Significant
(p<0.0001)
Significant
(p<0.0001)

To test the associations between attitudes about emergency contraception and
dispensing practices, Kruskal-Wallis analysis of variance tests were computed for the
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ordinal level subjective norm questions and Pearson chi-squares were computed for the
one categorical level question (see Table 33). The Kruskal-Wallis test can be used in
bivariate analysis with an ordinal-level predictor variable and a nominal level criterion
variable. Table 33 reveals that attitudes about emergency contraception are significantly
related to whether a pharmacist has ever dispensed emergency contraception, irrespective
of whether it was dispensed by prescription or OTC. Because there was one question on
the pharmacist survey measuring attitudes on a nominal level, a chi-square test of
association was performed between this question and having ever dispended emergency
contraception. The question asked if Plan B should be offered to women who are raped
in all hospital emergency rooms, regardless of hospital affiliation. Pharmacists’ thoughts
about whether Plan B should be offered to women in hospital emergency rooms was
found to be significantly related to having ever dispensed emergency contraception where
pharmacists that answered that Plan B should be offered to women who are raped in all
hospital emergency rooms were more likely to have ever dispensed emergency
contraception than pharmacists who did not think that it should be offered.
Table 33. Bivariate Results of Dispensing EC and Attitudes
Ever Dispensed EC
% Yes
Chi –
Square(df)
Attitude Composite Variable
n/a
37.56(14)*
Should Plan B be Offered to Women who
are Raped in Hospital Emergency Rooms?
Yes
No
*Indicates statistical significance at p<.05.

64.3%
45.3%

6.39(1)*

Pattern of Finding
(p value)
Significant
(p=0.001)
Significant
(p=0.011)

To test the associations between subjective norms and dispensing practices,
Kruskal-Wallis analysis of variance tests were computed for the ordinal level subjective
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norm questions and Pearson chi-squares were computed for categorical level questions
(Table 34). Subjective norms or perceived social pressures around dispensing of
emergency contraception are significantly related to having ever dispensed it. In
addition, whether there is an employee at their pharmacy who refuses to dispense
emergency contraception and whether there is a policy in place at a pharmacists’
workplace if a refusal should occur are both significantly related to having ever dispensed
emergency contraception. Specifically, pharmacists were more likely to dispense the
medication if there were no employees at their pharmacy who refuses to dispense
emergency contraception. In addition, more pharmacists were likely to have ever
dispensed emergency contraception if there was a policy in place should a pharmacist
refuse to dispense the medication.
Table 34. Bivariate Results of Dispensing EC and Subjective Norms
Ever Dispensed EC
% Yes
Chi –
Square(df)
Subjective Norms Composite Variable
n/a
40.23(10)*
Employee at Pharmacy who Refuses to
Dispense EC
Yes
No
Policy at Workplace if Refusal Occurs
Yes
No
*Indicates statistical significance at p<.05.

Pattern of Finding (p
value)
Significant
(p<0.0001)

60.0%
77.1%

3.96(3)*

Significant (p=0.046)

88.8%
67.7%

11.85(3)*

Significant (p=0.001)

To test associations between dispensing emergency contraception and perceived
behavioral control (how difficult or easy it is to dispense emergency contraception),
Kruskal-Wallis analysis of variance was computed (Table 35). Perceived behavioral
control was significantly related to ever dispensing emergency contraception. However,
when dispensing was separated out, perceived behavioral control was not found to be
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related to dispensing by prescription but stayed significant for dispensing OTC. It makes
some intuitive sense that dispensing OTC would be related to perceived behavioral
control as a pharmacist is more likely to have control dispensing OTC when there is no
prescription or patient doctor relationship in the way of dispensing the medication.
Table 35. Bivariate Results of Dispensing EC and Perceived Behavioral Control (PBC)
Chi –
Pattern of Finding (p
Square(df)
value)
Perceived Behavioral Control (PBC)
23.54(11)*
Significant (p=0.015)
PBC By Prescription Only
18.34(11)
Not Significant
(p=0.074)
PBC OTC Only
20.76(11)*
Significant (p=0.036)
*Indicates statistical significance at p<.05.

To test associations between intention or likelihood to dispense and dispensing
Plan B, Kruskal-Wallis analysis of variance was computed (Table 36). Intention to
dispense Plan B was found to be significantly related to ever dispensing Plan B by
prescription or OTC. Findings stayed significant when individual analysis was
performed for dispensing just by prescription or only OTC.
Table 36. Bivariate Results of Intention to Dispense and Dispensing EC
Chi –
Square(df)
Ever Dispensed EC by Prescription or OTC
50.49(12)*
*Indicates statistical significance at p<.05.

Pattern of Finding (p
value)
Significant (p<0.001)

Multivariate Analysis. Question 3: What is the relationship among emergency
contraception knowledge, attitudes, subjective norms, perceived behavioral control,
intention to dispense, and dispensing practices of Florida pharmacists registered with the
Board of Pharmacy?
Question 3a: Is emergency contraception knowledge predictive of dispensing
practices of Florida pharmacists?
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Question 3b: Are attitudes about emergency contraception predictive of
emergency contraception dispensing practices of Florida pharmacists?
Question 3c: Are subjective norms about emergency contraception (whether
important people such as colleagues, supervisors, corporate headquarters, and
peers think they should dispense emergency contraception) predictive of
emergency contraception dispensing practices of Florida pharmacists?
Question 3d: Is perceived behavioral control, the perceived ease or difficulty of
dispensing emergency contraception, predictive of dispensing practices of Florida
pharmacists?
Question 3e: Is intention to dispense emergency contraception predictive of
dispensing practices of Florida pharmacists?
Question 3f: Are emergency contraception knowledge, attitudes, subjective
norms, perceived behavioral control, and intention to dispense taken together,
predictive of emergency contraception dispensing practices of Florida
pharmacists?
Six logistic regression models were computed to directly answer the above
research questions to detect (1) if knowledge is predictive of dispensing practices, (2) if
attitudes are predictive of dispensing practices, (3) if subjective norms are predictive of
dispensing practices, (4) if perceived behavioral control is predictive of dispensing
practices, (5) if intention to dispense is predictive of dispensing practices, and (6) if all
variables taken together are predictive of dispensing practices. The socio-demographic
variables identified in Tables 33 and 36 to be statistically significant (p<0.05) (age,
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marital status, years in practice, type of pharmacy where employed, job title, and current
employment status) acted as control variables in each of the regression models.
Knowledge and Dispensing Practices: It was hypothesized that pharmacists with
high levels of knowledge about emergency contraception would be more likely to
dispense it (Table 37). To test this hypothesis, the dependent variable was regressed
against the continuous variable knowledge (scale 0-10) while controlling for sociodemographic variables. Knowledge was found to be a significant predictor of having
ever dispensed emergency contraception. Specifically, for every one point increase in
knowledge score, the odds of a pharmacist dispensing emergency contraception were
increased by a factor of 1.7 (p< 0.001).
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Table 37. Logistic Regression Analysis for Knowledge and Dispensing Practices while
Controlling for Socio-demographic Variables
95.0% C.I.for OR
B
Knowledge

.538

S.E. Wald df

Sig.

.102 27.760 1 p<0.001

Age, years
< 36 (ref group)

OR

Lower

Upper

1.713

1.402

2.093

1.148 2 p<0.563

36-50

.095

.675

.020 1 p<0.888

1.100

.293

4.131

51-87

.827

.951

.756 1 p<0.385

2.287

.354

14.756

.350 1 p<0.554

1.881

.232

15.281

Marital status
Married (ref group)
Living with partner

7.404 3 p<0.060
.632 1.069

Divorced/Separated/Widowed

-.479

.618

.600 1 p<0.438

.620

.185

2.079

Never been married

1.689

.682 6.139 1 p<0.013

5.414

1.423

20.593

Years in Practice
<9 (ref group)

.834 2 p<0.659

9-22

.319

.647

.243 1 p<0.622

1.376

.387

4.890

23+

-.248

.897

.076 1 p<0.782

.780

.135

4.526

Type of Pharmacy Employed*
Community—Chain (ref
group)
Community—Independent

45.011 3 p<0.001

-1.743

.548 10.130 1 p<0.001

.175

.060

.512

Hospital

-3.121

.542 33.129 1 p<0.001

.044

.015

.128

Other (e. g. Home Infusion)

-3.597

.662 29.555 1 p<0.001

.027

.007

.100

.497 4.836 1 p<0.028

.335

.127

.888

.645

.866

.244

3.067

.174

.059

.509

.000

.000

.

Job Title
Staff Pharmacist (ref group)

4.972 2 p<0.083

Pharmacy Manager

-1.092

Other (e. g. Clinical
Pharmacist)

-.144

Current Employment Status*
Full-time (ref group)
Part-time

.050 1 p<0.823
10.172 2 p<0.006

-1.750

.549 10.172 1 p<0.001

Retired

-20.807 16947 .000 1 p<0.999
*Indicates statistical significance at p<.05 for the whole group variable
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The model was rerun limiting potential confounders to those with a p-value of
0.05 and there was a slight decrease in the OR for each level of increased knowledge
(Table 38). Pharmacists who have never been married were more likely to dispense
emergency contraception as compared to married individuals. Pharmacists working at a
community independent, hospital, or other pharmacy were not as likely to dispense
emergency contraception as compared to pharmacists who work at a community chain
pharmacy. Pharmacy managers were not as likely to dispense emergency contraception
as compared to staff pharmacists and part-time pharmacists were not as likely to dispense
as compared to pharmacists who were employed full-time.
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Table 38. Logistic Regression Analysis for Knowledge and Dispensing Practices while
Controlling for Marital Status, Type of Pharmacy where Employed, Job Title, and Current
Employment Status
95.0% C.I.for OR
B
Knowledge
Marital status

.519

S.E.

Wald df

Sig.

.096 29.302 1 p<0.001

OR

Lower

Upper

1.680

1.392

2.027

6.795 3 p<0.079

Married (ref group)
Living with partner

.532

1.069

.248 1 p<0.619

1.702

.210

13.822

Divorced/Separated/Widowed -.375
Never been married
1.445

.572

.430 1 p<0.512

.687

.224

2.108

.613 5.556 1 p<0.018

4.242

1.276

14.107

Type of Pharmacy where
Employed*
Community—Chain (ref
group)
Community—Independent

44.690 3 p<0.001

-1.62

.530 9.370 1 p<0.002

.197

.070

.558

Hospital

-3.03

.522 33.817 1 p<0.001

.048

.017

.134

Other (e. g. Home Infusion,
Mail Order)

-3.24

.608 28.443 1 p<0.001

.039

.012

.129

.195

.073

.521

.000

.000

.

.369

.147

.928

.777

.232

2.600

Job Title*
Staff Pharmacist (ref group)
Pharmacy Manager
Other (e. g. Clinical
Pharmacist)
Current Employment Status

10.630 2 p<0.005
-1.63

.502 10.630 1 p<0.001

-20.6 17037.97

.000 1 p<0.999
4.508 2 p<0.105

Full-time (ref group)
Part-time

-.997

.470 4.487 1 p<0.034

Retired

-.252
.616 .167 1 p<0.683
*Indicates statistical significance at p<.05 for the whole group variable

Attitudes and Dispensing Practices: It was hypothesized that pharmacists with
positive attitudes about emergency contraception would be more likely to dispense it. To
test this hypothesis, the dependent variable was regressed against the continuous variable
attitudes (scale 7-21) and one categorical level question around attitudes while
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controlling for the socio-demographic control variables (Table 39). Pharmacist attitudes
about emergency contraception were found to be a significant predictor of having ever
dispensed emergency contraception. Specifically, for every one point increase in attitude
score, the odds of dispensing increased by 1.2 (p<0.001). The categorical question that
measured attitudes that queried about if Plan B should be offered to women who are
raped in hospital emergency rooms was not statistically significant.
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Table 39. Logistic Regression Analysis for Attitudes and Dispensing Practices while Controlling
for Socio-demographic Variables
95.0% C.I.for OR
B
Attitudes

.209

S.E.

Wald df

Sig.

OR

.056 14.025 1 p<0.001 1.233

Age, years
< 36 (ref group)

Lower

Upper

1.105

1.376

.497 2 p<0.780

36-50

-.294

.621

.224 1 p<0.636

.745

.221

2.516

51-87

.085

.916

.009 1 p<0.926 1.089

.181

6.553

Marital status
Married (ref group)

5.353 3 p<0.148

Living with partner

-.657

.944

.485 1 p<0.486

.518

.081

3.297

Divorced/Separated/Widowed

-.256

.608

.177 1 p<0.674

.774

.235

2.551

Never been married

1.295

.619 4.370 1 p<0.037 3.651

1.084

12.291

Years in Practice
<9 (ref group)

.339 2 p<0.844

9-22

.180

.620

.084 1 p<0.772 1.197

.355

4.038

23+

-.192

.887

.047 1 p<0.829

.825

.145

4.700

Type of Pharmacy where
Employed*
Community—Chain (ref
group)
Community—Independent

57.842 3 p<0.001

-1.539

.531 8.399 1 p<0.004

.215

.076

.608

Hospital

-3.627

.545 44.253 1 p<0.0001

.027

.009

.077

Other (e. g. Home Infusion)

-4.280

.678 39.821 1 p<0.001

.014

.004

.052

.486 5.077 1 p<0.024

.334

.129

.867

.573

.712

.231

2.189

.171

.058

.504

.000

.000

.

Job Title
Staff Pharmacist (ref group)

5.080 2 p<0.079

Pharmacy Manager*

-1.096

Other (e. g. Clinical
Pharmacist)

-.340

Current Employment Status*
Full-time (ref group)

.352 1 p<0.553
10.261 2 p<0.006

Part-time

-1.767

Retired

-21.03 15894.85

.552 10.261 1 p<0.001
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.000 1 p<0.999

Should Plan B be Offered to
Women who are Raped in
Hospital Emergency Rooms?

.278

.539

.265 1 p<0.607 1.320

.459

3.800

*Indicates statistical significance at p<.05 for the whole group variable

The model was rerun limiting potential confounders to those with a p-value of
0.05 and there was no change in the OR for attitudes (Table 40). Much like the
knowledge variables, pharmacists who have never been married were more likely to
dispense emergency contraception as compared to married individuals. Pharmacists
working at a community independent, hospital, or other pharmacy were not as likely to
dispense emergency contraception as compared to pharmacists who work at a community
chain pharmacy. Pharmacy managers were not as likely to dispense emergency
contraception as compared to staff pharmacists and part-time pharmacists were not as
likely to dispense as compared to pharmacists who were employed full-time.
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Table 40. Logistic Regression Analysis for Attitudes and Dispensing Practices while Controlling
for Marital Status, Type of Pharmacy where Employed, Job Title, and Current Employment
Status
95.0% C.I.for OR
B
Attitudes
Marital status

.208

S.E.

Wald df

Sig.

.051 17.003 1 p<0.001

OR

Lower

Upper

1.232

1.116

1.360

5.981 3 p<0.113

Married (ref group)
Living with partner

-.596

.932

.409 1 p<0.523

.551

.089

3.423

Divorced/Separated/Widowed -.299
Never been married
1.234

.567

.277 1 p<0.599

.742

.244

2.254

.564 4.783 1 p<0.029

3.435

1.137

10.381

Type of Pharmacy where
Employed*
Community—Chain (ref
group)
Community—Independent

59.698 3 p<0.001

-1.43

.511 7.844 1 p<0.005

.239

.088

.651

Hospital

-3.49

.514 46.279 1 p<0.001

.030

.011

.083

Other (e. g. Home Infusion,
Mail Order)

-3.92

.620 40.050 1 p<0.001

.020

.006

.067

Job Title
Staff Pharmacist (ref group)
Pharmacy Manager
Other (e. g. Clinical
Pharmacist)
Current Employment Status*

3.666 2 p<0.160
-.861

.452 3.621 1 p<0.057

.423

.174

1.026

-.369

.555

.691

.233

2.053

.172

.065

.456

.000

.000

.

.442 1 p<0.506
12.514 2 p<0.002

Full-time (ref group)
Part-time
Retired

-1.75

.497 12.514 1 p<0.001

-21.0 16126.07 .000 1 p<0.999
*Indicates statistical significance at p<.05 for the whole group variable

Subjective Norms and Dispensing Practices: It was hypothesized that pharmacists
who have influential people in their life who think they should dispense emergency
contraception would be more likely to dispense it. To test this hypothesis, the dependent
variable was regressed against the continuous variable subjective norms (scale 4-16) and
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two categorical level questions around subjective norms while controlling for the sociodemographic control variables (Table 41). The variable subjective norms was found to
be a significant predictor of having ever dispensed emergency contraception.
Specifically, for every one point increase in subjective norms or important people
thinking they should dispense emergency contraception, the odds of dispensing
emergency contraception increased by 1.3 (p<0.018). Neither of the two categorical
questions measuring subjective norms was significant.
Table 41. Logistic Regression Analysis for Subjective Norms and Dispensing Practices while
Controlling for Socio-demographic Variables
95.0% C.I.for OR
B
Subjective Norms Total Score

.321

S.E.

Wald df

Sig.

.136 5.580 1 p<0.018

Age, years
< 36 (ref group)

OR

Lower

Upper

1.379

1.056

1.801

.936 2 p<0.626

36-50

-.472

.789

.358 1 p<0.549

.624

.133

2.926

51-87

.251

1.084

.053 1 p<0.817

1.285

.153

10.762

.352 1 p<0.553

2.174

.167

28.280

1.121 2.387 1 p<0.122

5.655

.628

50.923

.938 3.342 1 p<0.068

5.555

.884

34.924

Marital status
Married (ref group)

4.870 3 p<0.182

Living with partner

.776
Divorced/Separated/Widowed 1.733
Never been married
1.715

1.309

Years in Practice
<9 (ref group)

.751 2 p<0.687

9-22

.442

.762

.337 1 p<0.561

1.556

.350

6.923

23+

-.233

1.042

.050 1 p<0.823

.792

.103

6.104

.369

.091

1.491

Type of Pharmacy where
Employed*
Community—Chain (ref
group)
Community—Independent

10.449 3 p<0.015

-.997

.712 1.957 1 p<0.162
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Hospital

-1.90

.758 6.329 1 p<0.012

.148

.034

.656

Other (e. g. Home Infusion,
Mail Order)

-2.81

1.061 7.020 1 p<0.008

.060

.008

.481

Job Title
Staff Pharmacist (ref group)

2.721 2 p<0.257

Pharmacy Manager

-1.04

.648 2.575 1 p<0.109

.354

.099

1.259

Other (e. g. Clinical
Pharmacist)

-.705

.853

.494

.093

2.628

.209

.066

.662

.000

.000

.

.805

.169

3.839

.404

.122

1.334

Current Employment Status*
Full-time (ref group)

.684 1 p<0.408
7.089 2 p<0.029

Part-time

-1.56

Retired

-21.0 28301.60

.588 7.089 1 p<0.008
.000 1 p<0.999

Is there anyone in your
pharmacy who refuses to
-.217
.797 .074 1 p<0.785
dispense EC?
Is there a policy in place at your
pharmacy if someone refuses to -.907
.609 2.213 1 p<0.137
dispense EC?
*Indicates statistical significance at p<.05 for the whole group variable

The model was rerun limiting potential confounders to those with a p-value of
0.05 and there was a very slight decrease in the OR for subjective norms (Table 42). In
addition, pharmacists working at a community independent, hospital, or other pharmacy
were not as likely to dispense emergency contraception as compared to pharmacists who
work at a community chain pharmacy. Part-time pharmacists were not as likely to
dispense as compared to pharmacists who were employed full-time.
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Table 42. Logistic Regression Analysis for Subjective Norms and Dispensing Practices while
Controlling for Type of Pharmacy where Employed and Current Employment Status
95.0% C.I.for OR
B
Subjective Norms Total Score
Type of Pharmacy where
Employed*
Community—Chain (ref
group)
Community—Independent
Hospital
Other (e. g. Home Infusion,
Mail Order)
Current Employment Status*

.287

S.E.

Wald df

Sig.

.081 12.658 1 p<0.001

OR

Lower

Upper

1.332

1.137

1.560

39.024 3 p<0.001

-1.11

.559 3.971 1 p<0.046

.329

.110

.982

-2.66

.502 28.076 1 p<0.001

.070

.026

.187

-2.96

.603 24.120 1 p<0.001

.052

.016

.168

.218

.083

.577

.000

.000

.

9.438 2 p<0.009

Full-time (ref group)
Part-time

-1.52

.495 9.438 1 p<0.002

Retired

-20.3 28378.23 .000 1 p<0.999
*Indicates statistical significance at p<.05 for the whole group variable

Perceived Behavioral Control and Dispensing Practices: It was hypothesized that
pharmacists that find that it is easy to dispense emergency contraception will be more
likely to dispense it. To test this hypothesis, the dependent variable was regressed against
the continuous variable that measured perceived behavioral while controlling for the
socio-demographic control variables (Table 43). The variable perceived behavioral
control was found to be a significant predictor of having ever dispensed emergency
contraception. Specifically, for every one point increase in perceived behavioral control
or perceived ease in dispensing Plan B, the odds of dispensing it increased by 1.1
(p<0.022).
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Table 43. Logistic Regression Analysis for Perceived Behavioral Control (PBC) and Dispensing
Practices while Controlling for Socio-demographic Variables
95.0% C.I.for OR
B
PBC Total Score

.160

S.E.

Wald df

Sig.

.070 5.212 1 p<0.022

Age, years
< 36 (ref group)

OR

Lower

Upper

1.173

1.023

1.346

.098 2 p<0.952

36-50

-.207

.685

.091 1 p<0.763

.813

.212

3.114

51-87

-.122

.907

.018 1 p<0.893

.885

.150

5.233

Marital status
Married (ref group)
Living with partner

3.343 3 p<0.342
1.128

1.275

.782 1 p<0.376

3.089

.254

37.626

Divorced/Separated/Widowed .062
Never been married
1.066

.639

.010 1 p<0.922

1.064

.304

3.723

.636 2.812 1 p<0.094

2.903

.835

10.091

Years in Practice
<9 (ref group)

.344 2 p<0.842

9-22

.382

.661

.334 1 p<0.563

1.466

.401

5.354

23+

.382

.875

.190 1 p<0.663

1.464

.263

8.140

Type of Pharmacy Employed*
Community—Chain (ref
group)
Community—Independent

37.170 3 p<0.001

-1.78

.547 10.677 1 p<0.001

.167

.057

.489

Hospital

-2.87

.551 27.137 1 p<0.001

.057

.019

.167

Other (e. g. Home Infusion,
Mail Order)

-3.12

.649 23.223 1 p<0.001

.044

.012

.156

Job Title
Staff Pharmacist (ref group)

5.548 2 p<0.062

Pharmacy Manager

-1.10

.490 5.105 1 p<0.024

.331

.127

.864

Other (e. g. Clinical
Pharmacist)

-.805

.585 1.892 1 p<0.169

.447

.142

1.408

.167

.055

.511

.000

.000

.

Current Employment Status*
Full-time (ref group)
Part-time

9.850 2 p<0.007
-1.78

.570 9.850 1 p<0.002

Retired

-21.3 23058.79 .000 1 p<0.999
*Indicates statistical significance at p<.05 for the whole group variable
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Type of pharmacy where employed, job title, and current employment status were
the only socio-demographic variables that were significant and therefore a logistic
regression with only these variables were computed to find if there were any significant
associations present (Table 44). Pharmacists working at a community independent,
hospital, or other pharmacy were not as likely to dispense emergency contraception as
compared to pharmacists who work at a community chain pharmacy. Pharmacy
managers were not as likely to dispense emergency contraception as compared to staff
pharmacists and part-time pharmacists were not as likely to dispense as compared to
pharmacists who were employed full-time.
Table 44. Logistic Regression Analysis for Perceived Behavioral Control (PBC) and Dispensing
Practices while Controlling for Type of Pharmacy where Employed, Job Title, and Current
Employment Status
95.0% C.I.for OR
B
PBC Total Score
Type of Pharmacy where
Employed*
Community—Chain (ref group)

S.E. Wald df

Sig.

.161 .066 6.017 1 p<0.014

OR

Lower

Upper

1.175

1.033

1.337

37.918 3 p<0.001

Community—Independent

-1.70 .519 10.751 1 p<0.001

.182

.066

.504

Hospital

-2.79 .524 28.428 1 p<0.001

.061

.022

.171

Other (e. g. Home Infusion)

-2.81 .581 23.510 1 p<0.001

.060

.019

.187

Job Title*
Staff Pharmacist (ref group)

6.653 2 p<0.036

Pharmacy Manager

-1.12 .466 5.774 1 p<0.016

.326

.131

.814

Other

-.982 .561 3.061 1 p<0.080

.374

.125

1.125

.154

.054

.442

.000

.000

.

Current Employment Status*

12.125 2 p<0.002

Full-time (ref group)
Part-time

-1.87 .537 12.125 1 p<0.001

Retired

-21.2 2268 .000 1 p<0.999
*Indicates statistical significance at p<.05 for the whole group variable
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Intention to Dispense and Dispensing Practices: It was hypothesized that
pharmacists that have a greater intention to dispense emergency contraception will in fact
be more likely to dispense it. To test this hypothesis, the dependent variable was
regressed against each of the eight questions that measured intention to dispense (Table
45). For every one increment increase in intention to dispense or likelihood to dispense
Plan B, the odds of dispensing increased by 1.2 (p<0.001).
Table 45. Logistic Regression Analysis for Intention to Dispense Plan B and Dispensing
Practices while Controlling for Socio-demographic Variables
95.0% C.I.for OR
B
Intention to Dispense Plan B

.249

S.E.

Wald df

Sig.

.053 22.333 1 p<0.001

Age, years
< 36 (ref group)

OR

Lower

Upper

1.283

1.157

1.423

.472 2 p<0.790

36-50

-.248

.705

.124 1 p<0.725

.780

.196

3.108

51-87

.181

.978

.034 1 p<0.853

1.199

.176

8.146

.058 1 p<0.809

.780

.104

5.845

.634 1.244 1 p<0.265

.493

.142

1.708

.651 2.539 1 p<0.111

2.820

.788

10.095

Marital status
Married (ref group)
Living with partner

4.379 3 p<0.223
-.248

Divorced/Separated/Widowed -.708
Never been married
1.037

1.028

Years in Practice
<9 (ref group)

.111 2 p<0.946

9-22

.117

.717

.027 1 p<0.870

1.124

.276

4.584

23+

-.105

.941

.012 1 p<0.911

.900

.143

5.690

Type of Pharmacy where
Employed*
Community—Chain (ref
group)
Community—Independent
Hospital

43.056 3 p<0.001

-1.09

.575 3.604 1 p<0.058

.335

.109

1.036

-3.28

.576 32.470 1 p<0.001

.037

.012

.116
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Other (e. g. Home Infusion,
Mail Order)

-3.53

.676 27.250 1 p<0.001

Job Title
Staff Pharmacist (ref group)

.029

.008

.110

1.459 2 p<0.482

Pharmacy Manager

-.440

.508

.750 1 p<0.386

.644

.238

1.743

Other (e. g. Clinical
Pharmacist)

-.654

.626 1.092 1 p<0.296

.520

.153

1.772

.205

.066

.633

.000

.000

.

Current Employment Status*
Full-time (ref group)
Part-time

7.586 2 p<0.023
-1.58

.575 7.586 1 p<0.006

Retired

-20.6 18155.73 .000 1 p<0.999
*Indicates statistical significance at p<.05 for the whole group variable

In the analysis between intention to dispense Plan B and ever dispensing, type of
pharmacy where employed and current employment status were the only two sociodemographic variables that were significant and therefore a logistic regression with only
these variables was computed to find if there were any significant associations present
(Table 46). For intention to dispense Plan B, pharmacists working at a community
independent, hospital, or other pharmacy were not as likely to dispense emergency
contraception as compared to pharmacists who work at a community chain pharmacy. In
addition, part-time pharmacists were not as likely to dispense as compared to pharmacists
who were employed full-time.
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Table 46. Logistic Regression Analysis for Intention to Dispense Plan B and Dispensing
Practices while Controlling for Type of Pharmacy where Employed and Current Employment
Status
95.0% C.I.for OR
B
Intention to Dispense Plan B
.251
Type of Pharmacy where
Employed*
Community—Chain (ref group)

S.E.

Wald df

Sig.

.049 26.417 1 p<0.001

OR

Lower

Upper

1.285

1.168

1.414

53.300 3 p<0.001

Community—Independent

-1.11

.533 4.347 1 p<0.037

.329

.116

.936

Hospital

-3.17

.512 38.493 1 p<0.001

.042

.015

.114

Other (e. g. Home Infusion)

-3.50

.590 35.254 1 p<0.001

.030

.009

.096

.257

.097

.677

.000

.000

.

Current Employment Status*

7.563 2 p<0.023

Full-time (ref group)
Part-time

-1.36

.494 7.563 1 p<0.006

Retired

-21.3 17382 .000 1 p<0.999
*Indicates statistical significance at p<.05 for the whole group variable

Final Model
All variables in model together and dispensing practices: Even after controlling
for all predictor and potentially confounding variables, knowledge, intention or likelihood
to dispense Plan B, marital status, type of pharmacy where employed, and employment
status still maintained a statistically significant relationship with ever dispensing Plan B
(Table 47). Specifically, for every one increment increase in knowledge score, the odds
of dispensing increased by 1.7. Likewise, for every one unit increase in intention to
dispense or likelihood to dispense Plan B, the odds of dispensing increased by 1.1. For
marital status, pharmacists who have never been married were more likely to have ever
dispensed Plan B as compared to marriage pharmacists. Pharmacists working at a
hospital or other type of pharmacy were less likely to have ever dispensed Plan B as
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compared to pharmacists working at a community chain pharmacy and pharmacists
working full-time were more likely to have ever dispensed Plan B as compared to
pharmacists working part-time. No statistical significance was found for attitudes,
subjective norms, perceived behavioral control, intention to dispense by prescription, age,
years in practice, or job title when all the variables were in the model together.
Multicollinearity or the linear relationships between explanatory variables was
determined through a tolerance computation (Table 47). Since all tolerances for the
predictor variables were high, there is no problem with multicollinearity in this study.
This finding means that the relationship between the predictor variables and the
dependent variable, ever-dispensed, are direct and therefore, strong linear dependencies
are not seen among the independent variables.
In order to better understand and offer a complete picture for the last research
question and model, (Question 3f: Are emergency contraception knowledge, attitudes,
subjective norms, perceived behavioral control, and intention to dispense taken together,
predictive of emergency contraception dispensing practices of Florida pharmacists?), it
was necessary to take a few components into consideration, 1) the logistic regression
analysis with all variables in the model (Table 47), 2) a goodness of fit test, and 3) a
likelihood ratio test. Together, these elements can aid in understanding the relative fit of
the final model. The Hosmer and Lemeshow goodness of fit test demonstrated a nonsignificant relationship between the predictor variables (Chi-square 5.91, p=0.658),
which suggests that the variables are fitting the model. In addition, the likelihood ratio
test was significant (Chi-square 129.70, p<0.001, also signifying that the variables are
fitting the model. These three components suggest that overall the variables are fitting
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the model and that all predictor variables taken together are associated with dispensing
practices of Florida pharmacists.
Table 47. Logistic Regression Analysis for All Variables in Model

Main Research Variables
Knowledge
Attitudes
Subjective Norms

Wald
13.89
0
0.911
0.155
4.4

Sig.
p<0.001
p<0.993
p<0.340
p<0.694
p<0.036

0.983
0.954
0.637
5.181

p<0.612
p<0.329
p<0.425
p<0.159

Living with partner
Divorced/Separated/Widow
Never been married
Years in Practice
<9 (ref group)

0.475
0.282
4.889
0.294

p<0.490 2.767
p<0.596 1.727
p<0.027 10.574
p<0.863

0.153
0.229
1.307

10-22
23+
Type of Pharmacy where
Employed*
Community—Chain (ref
group)
Community—Independent
Hospital
Other (e. g. Home Infusion)
Job Title
Staff Pharmacist (ref group)
Pharmacy Manager
Other (e. g. Clinical
Pharmacist)
Current Employment Status*

0.105
0.018

p<0.746
p<0.892

0.22
0.075

Perceived Behavioral Control
Intention to Dispense Plan B
Confounders
Age, years
< 36 (ref group)
36-50
51-87
Marital status
Married (ref group)

OR
1.745
0.999
1.16
1.039
1.192

95.0% C.I.for OR
Lower
Upper
1.302
2.338
0.837
1.193
0.855
1.574
0.858
1.259
1.012
1.404

Tolerance
.770
.592
.642
.780
.554
.323

2.543
2.958

0.391
0.206

16.55
42.393
.885

1.35
0.845

49.939
13.01
85.535
.318
8.27
9.581

12.803 p<0.005

.703

0.997
9.313
7.602
2.128

p<0.318
p<0.002
p<0.006
p<0.345

0.456
0.075
0.068

0.098
0.014
0.01

1.113

p<0.291

0.491

0.131

1.84

1.588

p<0.208

0.31

0.05

1.914

6.187

p<0.045

.791

Full-time (ref group)
Part-time
6.187 p<0.013 0.17
0.042
Retired
0
p<1.000
0
0
*Indicates statistical significance at p<.05 for the whole group variable
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2.129
0.395
0.46

.800
0.686
.

Table 48. Summary Table of Main Findings
OR for Single
Crude
Predictor
Main Variables
OR
Model*
Knowledge
1.57
1.68 (1.39,
(1.38,
2.02)
1.78)
Attitudes
1.12
1.23 (1.11,
(1.05,
1.36)
1.19)
Subjective Norms
1.42
1.33 (1.13,
(1.24,
1.56)
1.63)
Perceived Behavioral Control 1.19
1.17 (1.03,
(1.07,
1.33)
1.32)
Intention to Dispense
1.24
1.28 (1.16,
(1.15,
1.41)
1.33)
*Model is adjusted for confounders

OR with All Predictors in
Model*
1.74 (1.30, 2.33)
0.99 (0.83, 1.19)
1.16 (0.85, 1.57)
1.03 (0.85, 1.25)

1.19 (1.01, 1.40)

Summary of Results
Table 48 provides a summary of the main findings in this study. It includes the
crude ORs for each main predictor variable, the ORs for the single predictor model while
controlling for confounder variables, and the ORs for the final model with all predictors
in the model while controlling for confounder variables.
In the end, knowledge about emergency contraception was the most important
predictor of ever having dispensed emergency contraception. After knowledge, intention
to dispense was the second most important predictor of having ever dispensed the
medication. Although attitudes, subjective norms, and perceived behavioral control were
statistically significant in each of their own single predictor models, they failed to reach
statistical significance in the full model.

191

The following confounder variables were consistently significant in every single
predictor model and the full model: type of pharmacy where employed and current
employment status. For type of pharmacy, pharmacists working at a community
independent, hospital, or other pharmacy were not as likely to dispense emergency
contraception as compared to pharmacists who worked a at community chain pharmacy.
For employment status, part-time pharmacists were not as likely to dispense as compared
to pharmacists who were employed full-time.
Although marital status was not significant for all models, it was significant for
the single predictor models for knowledge and attitudes and was also significant in the
final model where never married individuals were much more likely to dispense as
compared to married individuals. The last confounding variable, job title, was not
significant in the full model but was significant for the single predictor models for
knowledge, attitudes, and perceived behavioral control where pharmacy managers were
not as likely to dispense emergency contraception as compared to staff pharmacists.
Additional Analyses
Table 49. Summary Table of Two Knowledge Items
Main Variables
Crude OR
Plan B can cause birth
1.76 (1.06, 2.91)
defects if taken by a
pregnant woman
Plan B can act as an
3.83 (2.28, 6.44)
abortifacient
*Model is adjusted for confounders

OR for Single
Predictor Model*
2.25 (1.10, 4.61)

OR with All
Predictors in
Model*
1.44 (0.66, 3.12)

5.17 (2.47, 10.8)

4.64 (2.15, 10.0)

Because discussion in the focus groups centered around two key issues: side
effects resulting from plan B and the potential for Plan B to induce and abortion,
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independent associations were computed for the two knowledge questions addressing
these issues: whether or not pharmacists thought that Plan B could cause birth defects if
taken by a pregnant woman and whether or not they thought Plan B acted as an
abortifacient. Table 49 includes the crude ORs for each item, the ORs for the single
predictor model while controlling for confounder variables, and the ORs for a model with
both items in the model while controlling for confounder variables.
Understanding that Plan B does not cause an abortion was the most important
predictor of ever having dispensed it. Although both items were statistically significant
in each of their own single predictor models, thinking Plan B causes birth defects failed
to reach statistical significance in the full model. Since the OR is so high for pharmacists
who thought that Plan B can cause an abortion, this item may be causing much of the
association between knowledge and dispensing practices which has implications for
future research and intervention efforts.
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Chapter Five: Discussion and Conclusions
Section I: Synthesis of Research Findings
Chapter five has been partitioned into three distinct sections. Section I provides a
synthesis of research findings for each of the three major research questions and methods,
key findings and conclusions for the study as a whole, and study limitations and
strengths. Section II discusses the holistic perspective that this study captures and
Section III provides broader conclusions and implications for public health as well as
future direction for research, policy, and practice.
Research Question 1: Pharmacy School Curriculum Review
Question 1: What do the 91 accredited schools of pharmacy in the U.S. teach about
emergency contraception?
Question 1a: What objectives, course assignments, course readings, and lectures
concerning emergency contraception are provided in the required courses at the
91 accredited schools of pharmacy in the U.S.?
Question 1b: What objectives, course assignments, course readings, and lectures
concerning emergency contraception are provided in the elective courses at the 91
accredited schools of pharmacy in the U.S.?
The findings from the pharmacy school curriculum review were as expected in
that the majority of accredited schools of pharmacy in the U.S. reported that they do offer
required courses that provide content on emergency contraception. A much smaller
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percentage reported offering elective courses that provide this content. All (100%)
respondents reported that pharmacy schools in the U.S. should include content material
on emergency contraception, however not all respondents reported doing so in their own
schools.
Participants in the curricula review reported that the majority of courses that
provide content on emergency contraception are taught in pharmacotherapy and
therapeutics courses. This finding was substantiated by data collected from the focus
group discussions. Understanding which courses teach emergency contraception content
to pharmacy students is important in terms of future educational and intervention efforts.
Although the curriculum review survey asked respondents to attach syllabi that
included content on emergency contraception, many did not. Only 10 syllabi (or 14% of
the sample) were retrieved across seven schools who reported that they provide course
content on emergency contraception in their classes. Even among the limited retrieved
syllabi, only four of the ten syllabi overtly mentioned emergency contraception in any of
the content areas.
In sum, important findings from the pharmacy school curriculum review included
the following: 1) that accredited schools of pharmacy in the U.S. report teaching about
emergency contraception in their pharmacy school classes, 2) that this content is taught
primarily in required pharmacotherapy and therapeutics courses, and 3) not enough
participants included syllabi in the review and the information that was detected from the
limited course syllabi was not helpful.
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Research Question 2: Pharmacy Student Focus Groups
Question 2: How is emergency contraception course content taught at accredited schools
of pharmacy, as perceived by fourth year pharmacy students at the four accredited
schools of pharmacy in Florida?
Question 2a: What did pharmacy students learn about emergency contraception in
their pharmacy school classes?
Question 2b: How was emergency contraception taught in their pharmacy school
classes?
Question 2c: What are the projected emergency contraception dispensing
practices of pharmacy students?
The pharmacy student focus groups uncovered rich information on the knowledge
pharmacy students reported learning about emergency contraception from their pharmacy
school classes, the teaching instruction from these classes, and the projected future
dispensing practices of pharmacy students.
Each focus group included an initial paper and pencil survey and a focus group
discussion. The paper and pencil survey revealed that although 90.5% of students
responded that they did learn about emergency contraception in their pharm D classes,
still over half (52.3%) of participants were either not sure or believed that pharmacists
were not well enough informed to confidently dispense emergency contraception and
nearly 20% answered either that they would not or that they were not sure about their
future dispensing of the medication. In addition, most students reported that there was
more information they wished they had received about emergency contraception. These
findings alone demonstrate that what is taught in pharmacy school classes is perceived as
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insufficient in providing pharmacists with the tools to confidently dispense emergency
contraception.
The focus group discussions revealed an important discrepancy or disconnect
between what students reported on their paper and pencil survey and what they reported
in the focus group discussions. Although the majority of students reported that they did
learn about emergency contraception in their pharmacy school classes on the paper and
pencil survey, the focus group discussions revealed the exact opposite; that for the most
part, students did not learn about emergency contraception in their pharmacy school
classes. In the focus group discussions, students reported that they received information
on emergency contraception from outside sources such as work, print media, internet,
news, and friends. This discrepancy between what the students reported on the paper and
pencil survey and what was reported in the focus group discussions is noteworthy. This
finding may be related to social-desirability bias and will be discussed in detail later in
this section.
Another important finding from the focus group discussions is that specific
knowledge was not reported by the majority of the students. Knowledge from pharmacy
school classes was disparate and only students in one of the focus groups seemed to
understand the three mechanisms of action of emergency contraception.
In terms of teaching instruction in pharmacy school classes, most students
responded that the professor attitude was neutral. A neutral attitude seems like the
desirable answer yet most likely unachievable. Although professors are supposed to
maintain a neutral attitude in class, students may be aware of their professor’s views on a
given topic, especially a topic as controversial as emergency contraception.
197

Questions around dispensing practices of pharmacists by far yielded the most
discussion and many unexpected themes emerged from these discussions. In terms of
emergency contraception dispensing, participants held major biases and judgments
depending on the situation of the person purchasing the contraception. Participants were
hesitant to dispense due to many issues including: hesitancy due to 1) mechanism of
action, 2) repeat use, 3) age requirement, 4) the situation of a particular woman, 5) side
effects, and 6) believing it is wrong. These biases could have a direct impact on access to
this form of contraception.
The focus group discussions revealed two other important and surprising findings:
1) that refusals to dispense this medication are common and 2) that pharmacists feel a
duty to educate about this medication even though it is not a pharmacist-counseled
product. In the literature review, refusals to dispense seemed isolated; however within
only four focus groups, unsolicited stories of refusals were present in each discussion.
This finding is alarming and indicates that uncovering the true prevalence of refusals is
critical. In addition, students reported a strong desire to educate and counsel consumers
about emergency contraception even though there is no legal need to do so. Future
research could focus on whether or not consumers want counseling/education from
pharmacists if it is not warranted. Also, perhaps there could be an important role for
pharmacists in providing accurate information to consumers who request it.
In sum, the focus group discussions with pharmacy students were revealing: First,
much of what pharmacy students learn about emergency contraception does not come
from their pharmacy school classes but comes from outside sources. Second, what is
taught in pharmacy school classes about emergency contraception is brief and over half
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of the sample felt that pharmacists are not well enough informed to confidently dispense
emergency contraception. Third, student knowledge about emergency contraception was
not specific. Fourth, many students entered the focus group with a preconceived notion
about people who use emergency contraception and would hesitate to dispense the
medication. Fifth, many participants held biases or judgments towards emergency
contraception users which may limit access. Sixth, participants feel a need to counsel
consumers about a medication that is not a pharmacy-counseled product. And last,
refusing to dispense emergency contraception is real and has the potential to limit access
to women in need.
Research Question 3: State-Wide Pharmacist Survey
Question 3: What is the relationship among emergency contraception knowledge,
attitudes, subjective norms, perceived behavioral control, intention to dispense, and
dispensing practices of Florida pharmacists registered with the Board of Pharmacy?
Question 3a: Is emergency contraception knowledge predictive of dispensing
practices of Florida pharmacists?
Question 3b: Are attitudes about emergency contraception predictive of
emergency contraception dispensing practices of Florida pharmacists?
Question 3c: Are subjective norms about emergency contraception (whether
important people such as colleagues, supervisors, corporate headquarters, and
peers think they should dispense emergency contraception) predictive of
emergency contraception dispensing practices of Florida pharmacists?
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Question 3d: Is perceived behavioral control, the perceived ease or difficulty of
dispensing emergency contraception, predictive of dispensing practices of Florida
pharmacists?
Question 3e: Is intention to dispense emergency contraception predictive of
dispensing practices of Florida pharmacists?
Question 3f: Are emergency contraception knowledge, attitudes, subjective
norms, perceived behavioral control, and intention to dispense taken together,
predictive of emergency contraception dispensing practices of Florida
pharmacists?
Of all the independent variables, knowledge about Plan B had the strongest
relationship to dispensing Plan B. Specifically, for every one point increase in
knowledge score, the odds of a pharmacist dispensing Plan B were increased by a factor
of 1.69 (p<0.001). Pharmacists had low levels of knowledge about understanding Plan
B’s true mechanism of action, limited awareness of who can sell Plan B to consumers and
how to sell OTC to women in advance of need, and the relationship between Plan B and
birth defects. These areas of low knowledge are of concern and should be addressed.
Pharmacist attitudes about Plan B were found to be a significant predictor of
having ever dispensed it. Specifically, for every one point increase in more positive
attitudes about Plan B, the odds of dispensing increased by 1.23 (p<0.001). Although the
sample had a slight skew towards more favorable attitudes about the medication, many
pharmacists felt uncomfortable dispensing to different groups of people. For example, a
third of the sample felt uncomfortable dispensing to adult women, 58.5% felt
uncomfortable dispensing to men, and 61.4% felt uncomfortable dispensing to
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adolescents. The variation in comfort dispensing Plan B based on the person requesting
the medication found in the state-wide survey is similar to the hesitancy in dispensing the
medication based on person found in the focus group discussions.
The variables subjective norms and perceived behavioral control were found to be
significant predictors of having ever dispensed Plan B (1.33, p<0.001 and 1.17 p<0.014
respectively). Interestingly, pharmacists were less likely to dispense Plan B when there is
an employee at their pharmacy who refuses to dispense it. Additionally, pharmacists
were more likely to have ever dispensed Plan B if the pharmacy in which they work had a
policy in place regarding what to do if a refusal should occur. These two findings
together demonstrate that both policy and pharmacy culture are associated with
dispensing practices and potentially access to care. Understanding this has major
implications for the development of intervention strategies.
Intention or likelihood to dispense Plan B varied by the consumer requesting the
medication. For every one increment increase in intention to dispense or likelihood to
dispense Plan B, the odds of dispensing increased by 1.28 (p<0.001). In general, a
greater percentage of pharmacists reported being likely to dispense to women who have
experienced incest or rape, followed by women who have experienced a problem with
their birth control method, followed by women who request the method after having
unprotected sexual intercourse, followed by dispensing (by prescription) to sexually
active teens under age 18, and last to a person other than the ultimate consumer of the
product such as parents or a boyfriend. In fact, almost half of pharmacists reported that
they were unlikely to dispense to a person other than the ultimate consumer of the
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product such as parents or a boyfriend. This finding is problematic in that any person
over 18 can purchase Plan B OTC.
Overall, the state-wide pharmacist survey was conclusive in finding that
knowledge, attitudes, subjective norms, perceived behavioral control, and intention to
dispense are all predictive of dispensing Plan B among Florida pharmacists. Although
each single predictor model tells a story, when all variables were in the model together,
knowledge about emergency contraception was the most important predictor of ever
having dispensed it. After knowledge, intention to dispense was the second most
important predictor of having ever dispensed the medication. Although attitudes,
subjective norms, and perceived behavioral control were statistically significant in each
of their own single predictor models, they failed to reach statistical significance in the full
model.
Key Findings/Conclusions for Entire Study
When viewing the study in totality, there are five main findings that should be
highlighted. The first main finding from the study as a whole is that there is a disconnect
between what pharmacy schools say they are teaching and what pharmacy students report
learning in their pharmacy school classes. However, the true dynamic of this discrepancy
is not known. For instance, are pharmacy schools teaching the content and the students
are not retaining the information or are pharmacy schools not effectively teaching the
information to students?
The second major finding that was found in both the focus groups and the
pharmacist survey is that soon-to-be pharmacists and already practicing pharmacists
report to be more or less likely to dispense Plan B based on the situation of the person
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requesting the medication. This finding demonstrates that pharmacists are potentially
allowing personal values or judgments to guide their practice through making dispensing
decisions based on the consumer purchasing it. These reported biases and the hesitancies
in dispensing are troubling.
The third important finding that was also mentioned above is that pharmacist
knowledge, attitudes, subjective norms, perceived behavioral control, and intention to
dispense all are predictive of having ever dispensed Plan B. Specifically, high levels of
knowledge, positive attitudes, an increased perception of important people thinking they
should dispense, perceived ease of dispensing, as well as an increased likelihood to
dispense all increase the odds that a pharmacist has ever dispensed Plan B. However,
high levels of knowledge had the greatest odds of ever dispensing Plan B. It is of
concern that pharmacists had limited knowledge in some critical areas such as how to
dispense Plan B OTC and comprehension of its true mechanism of action.
Viewing these three findings simultaneously, that low knowledge and decreased
intention to dispense (due to the situation of the consumer) of pharmacists equates to less
dispensing, that pharmacy students perception is that they are not learning about the
medication in their pharmacy school classes, and that there are major biases and
hesitancy about dispensing to varying groups of people, provides evidence of a major
problem that has the potential to limit access of emergency contraception to the women
who need it.
A fourth key finding that should be discussed is social desirability response bias.
This type of bias is typically seen when surveys employ threatening or sensitive questions
which can lead respondents to change their responses to appear socially or politically
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correct or more agreeable (Van de Mortel, 2008). Social desirability response may be
occurring in all three components of this research. For example, in the focus group
discussions students responded that they did receive information on emergency
contraception in their pharmacy school classes on the initial paper and pencil survey but
then the focus group discussions revealed that didn’t learn about emergency
contraception from their coursework, but more from outside sources. It is possible that
the paper and pencil survey question, did you take any classes in your Pharm D program
which taught you about EC?, led students to the pick the socially desirable answer but
when they started discussing it as a group, it became clear that they either did not receive
this information or that if they did, it was brief and not comprehensive. Even though the
curricula review survey and state-wide pharmacist surveys were completely anonymous,
it is possible that the same bias was occurring in these surveys. For example, perhaps a
greater proportion of Deans responded that they include content on emergency
contraception due to the social desirability of the answer thereby inflating the response.
The last key finding concerns not the data but the study design, specifically, the
importance of the mixed methods study design. In this case, the mixed methods study
design strengthened this study in that it allowed for the most complete analysis of this
issue. The quantitative elements captured important statistics and the qualitative findings
enriched the data by giving voice to the numbers. The study would not have been as
powerful without the focus group qualitative data. That is, the finding that pharmacy
students are not truly acquiring information on emergency contraception in their
pharmacy school classes would not have come to light. This study demonstrates the need
for mixed methods study design in order to fully understand the complexity of any issue.
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Study Limitations
Results from the study should be interpreted with caution due to several
limitations, the first of which is response rate. The state-wide pharmacist survey had a
low response rate (22%) even after employing the Dillman Tailored Design Method and
reviewing response rates from other studies that surveyed pharmacists. No data are
available for non-responders and therefore no calculations can be performed to detect
non-responder bias. Perhaps incentives provided for completing the survey may have
increased the response rate, however the study was not funded and therefore incentives
were not possible.
Although there was no problem with the response rate for the pharmacy school
curricula review, the lack of syllabi received is a limitation. Only 10 syllabi (14%) were
received from seven schools who reported that they provide course content on emergency
contraception in their courses. This limited number of syllabi made it difficult to make
generalizations about specific emergency contraception course content taught in U.S.
pharmacy schools. In addition, the syllabi that were received did not have detailed
information on how the emergency contraception course content was presented in class.
This finding was unexpected and in order to fully understand how emergency
contraception course content is taught in pharmacy schools, class observations as well as
interviews with professors may be needed.
A second limitation in this study is generalizablilty. Specifically, the state-wide
pharmacist survey does not procure a national sample and therefore results cannot be
generalized to all pharmacists in the U.S. Likewise, the pharmacy student focus groups
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cannot be generalized to all pharmacy students in the U.S. In addition, findings from this
research study cannot be generalized to non-English speaking individuals.
A third limitation only related to the focus group discussions is that cause and
effect relationships or statistical relationships could not be calculated. However, this
limitation is true for qualitative research in general and was expected. A fourth limitation
is that this study was not able to directly link the curricula review to the schools where
the focus groups were conducted. Although this process would have not provided
anonymity to the schools, it would have been stronger in demonstrating relationships
between teaching and learning.
A fifth limitation is the difficulty in identifying temporal sequence given the
cross-sectional nature of this research. For example, although there is a significant
relationship between knowledge and emergency contraception dispensing, does
knowledge lead to increased dispensing or does increasing dispensing lead to increased
knowledge? The same is true for the other significant relationships.
A sixth limitation that was discussed previously is the potential for socialdesirability bias where participants may have adjusted their true answer to reflect what
they thought was the more social desirable answer given the potentially sensitive subject
matter.
A last limitation that parallels social-desirability bias is that data collected in this
study was self-reported which means that it may be prone to some inaccuracy due to
inaccurate recall or discomfort in disclosing personal information. For example, the
information received from the pharmacy students is based solely on self-reporting,
meaning that what pharmacy students report learning about in their classes may not be
206

reflective of actual classroom instruction. However, the focus groups provided an
accurate picture of what pharmacy students remember learning about emergency
contraception and how they remember being taught this information.
Study Strengths
This study had many strengths and the first of which is its mixed methods study
design. Employing mixed methods deeply enriched this study and the findings. The big
picture or complete perspective could not have been obtained without the focus group
discussions as the qualitative data is the link to understanding that there is a disconnect
between what pharmacy schools say they are teaching and what pharmacy students report
learning. Overall this study was well designed, informed by theory and literature and
produced significant results that can be used to inform research, policy, and practice.
A second strength of this study comes from the study design. For one, the
randomization of the state-wide pharmacist study was a strength. Random selection of
pharmacists allows for generalization to all Florida pharmacists which provides a piece to
the puzzle in terms of understand dispensing practices on a national and geographical
level. In addition, the curriculum review study acted as a census of all accredited schools
of pharmacy in the nation which is useful in that not many studies are able to survey the
whole population in their sample.
A third strength is the unique universal perspective this study provides. Each
piece of this research study alone is significant, but together it offers a holistic
perspective. This study provides a three-pronged holistic view of pharmacy teaching,
education, and practice. It is through this perspective that the whole picture can be
captured, providing opportunities for intervention on multiple levels. It should be noted
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that emergency contraception is just one of the many drugs that should be addressed in
pharmacy education and training interventions. It is understood that this is one of the
many competing demands on pharmacy school curricula and practice.
A final strength of this study its substantial contribution to the literature on
pharmacist education, practice, and policy as it is the first known study of its kind. No
other study has been so comprehensive in its comprehension of pharmacist education and
practice. Although Van Riper and Hellerstedt’s (2005) South Dakota study assessed
pharmacists’ attitudes, knowledge, and dispensing practices of emergency contraception,
they failed to determine whether pharmacist knowledge and attitudes about emergency
contraception predict dispensing practices. The proposed study not only tested these
relationships but found statistical significance which has major implications for policy,
education, and practice.
Section II: Discussion of Universal Perspective
This research offers a unique perspective of three different but related datasets.
Taken together, findings demonstrate that teaching may be associated with student
learning, which in turn may be associated with dispensing practices of pharmacists which
inevitably may be associated with access to care. Figure 7 provides a model which can
act as a metaphor to describe this process. The model depicts a game of pool. In this
model, each pool ball represents a key element that is associated with the other eventually
leading to ‘the pocket’ or in this case, leading to health access or lack of health access
depending on how each cue ball is handled. However this depiction is telling, in that if
all of these elements are not in place, the health access ball may never make the pocket,
thereby limiting health access to those who need it. Of course there are other balls that
208

could be added to this model (e. g. health insurance, poverty etc.); however this study and
this model demonstrates how these particular elements are associated with each other to
potentially impact health access. It is important to note that intervention strategies can be
applied to any of the pool balls in order to address health access, not just to the teaching
ball. Although a multi-pronged approach addressing the pharmacy school curricula,
student learning, and pharmacist practice is ideal, an intervention at any point would be
beneficial.
This research followed the natural progression of pharmacists from education to
subsequent practice. It examined the emergency contraception curricula and course
content intended to teach future pharmacists, surveyed pharmacy students to understand
how this course content translates into learned knowledge and projected dispensing
behavior, and then lastly it surveyed practicing pharmacists to understand their
emergency contraception knowledge, attitudes, and actual dispensing practices. In total,
this research study employs a mixed methods design to offer a complete picture of
pharmacists and emergency contraception from education to practice.
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Figure 7. Pharmacist and EC Access Model
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Section III: Broader Implications for Public Health and Future Direction
Broader Implications for Public Health
Although this study is concerned with one health access issue and one group of
health service providers, it has broader implications for public health as a whole as well
as other areas and health service professionals. That is, education and training may be
associated with clinical practice for any health profession, for nurses, doctors, social
workers and the list goes on. The importance of effective teaching, translating to
efficient learning and informed practice and policy is important. As demonstrated in this
study, the best intention of pharmacy school teaching does not lead to best practice.
Practicing professionals should be trained to meet the needs of the public.
Access to health care should not be mitigated by personal beliefs and lack of
knowledge. Personal perspective and beliefs should not drive clinical practice, science
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should drive clinical practice. Specifically concerning is the lack of awareness around
how to dispense Plan B OTC where 77.6% of pharmacists did not understand how to
dispense Plan B OTC to women and 55.5% did not know who at the pharmacy could sell
Plan B to consumers. Also concerning was the lack of knowledge about Plan B in
general where 55.9% did not understand the correct mechanism of action, 55.9%
incorrectly reported that Plan B can cause birth defects and just over 46% reported that
Plan B can cause an abortion.
Another broad implication of this research concerns the idea of bias and issues of
self-report data. There are varying levels of bias to be aware of when researching a
controversial topic such as this one. This study uncovered three potentially varying
levels of bias, 1) professor bias, 2) student bias, and 3) pharmacist bias. The professor
bias can present itself in a few ways. For one, the professor may report that they teach
certain content but they really do not cover it. Secondly, a professor may teach content
but insert their biases in the content such that the true content is not taught correctly.
Student bias may occur when a student may incorrectly report that she/he did not receive
the information in class. Alternately, a student may come to class with a pre-set view or
bias about the medication that is different from the teachers’ view. Pharmacist bias may
be such that a pharmacist may have a bias towards a medication that no amount of
training will change. In addition, a pharmacist may skim important material just enough
to answer the questions in his/her continuing education courses so that they never gain
new knowledge. These types of bias are not only present for this particular issue and this
particular health profession but may be present with other health fields and topics as well.
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Also, limited knowledge about other drugs may be associated with health across many
varying professions.
Future Direction. Results from this study have implications for future research,
policy, and practice. Figure 6 can be used as a model to guide this discussion around the
overall conceptual model and potential areas for intervention.
Research. There is a need to better understand what is being taught to pharmacy
students in terms of emergency contraception course content. The curriculum review
survey did not fully capture what is being taught to students due to the low number of
syllabi provided by pharmacy schools. However, even after reviewing the limited
number of syllabi that were collected, pertinent information on course content could not
be obtained. Therefore, more information could potentially be gathered through
interviewing professors to determine what content is presented in class and perhaps
observing some pharmacotherapy courses where the content is said to be taught to better
understand the dissemination of this content.
•

In addition, because the majority of respondents from the curriculum survey
reported that they are teaching about emergency contraception, schools should
review their course outline to ensure that what they think is being taught within
their courses is actually being taught. Schools could look to see if there is a
disparity between formal objectives and what is being taught in class.

•

It would also be helpful to track the number of actual refusals that are taking place
at our local pharmacies or develop a ‘turn-it-in’ hotline or webpage where
consumers can report refusals that occur. This way, the magnitude of this
problem could be captured.
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•

One main element missing in this study is the voice of the consumer. How do
consumers feel about pharmacists and Plan B dispensing? Do consumers want to
be counseled? Do consumers feel that pharmacists should assume their perceived
role of the counselor/educator? Does fear of pharmacist bias and stigma impact
consumer Plan B seeking behaviors? It would be interesting to either conduct a
consumer study or even link results from a consumer study with the results from
this study to make appropriate inferences. A study aimed at understanding the
role of pharmacists from both the practitioner and consumer perspective may
provide additional insights.

•

It would also be interesting to review the stories of refusal from the pharmacy
student focus groups and layer these stories with the pharmacist professional code
of ethics. This may demonstrate how policy is translated (or not translated) into
practice.

•

Another potential research avenue would be to compare knowledge, attitudes, and
dispensing practices of Plan B with another OTC medication that does not have
the same moral implications to see if there are any differences or similarities.
Policy. There are also implications for pharmacy policy. This study uncovered

some important information regarding the way that pharmacy culture and policy are
associated with practice. Pharmacists that worked at a pharmacy with an existing
policy regarding refusals of emergency contraception were more likely to have ever
dispensed the medication and a pharmacist who worked at a pharmacy where a
colleague refuses to dispense the medication was less likely to have ever dispensed
Plan B. Since policy is associated with practice, a next step would be to contact the
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American Pharmacists Association (AphA), the American Medical Association
(AMA), and the American College of Obstetricians and Gynecologists (ACOG) and
work together to ensure that all pharmacies create policies regarding dispensing Plan
B and that there is protocol in place should pharmacists refuse to dispense a
medication.
Practice. There are also implications for better teaching. For example, it would
be helpful to bring together pharmacy school faculty and students to create a teaching
module that will be most effective in teaching students about emergency
contraception. This module could then be tested and implemented in pharmacy
school classrooms. Employing students in the development of this module along with
faculty may ensure effective teaching by the professor and efficient learning and
retention of material by the student. If it worked and was evaluated, this type of
module development and curriculum enhancement could be used by a variety of
controversial topics in science.
•

In terms of reaching already practicing pharmacists, better continuing education
credit opportunities to learn about this material would be helpful, although there is
already an informative and well-written one available through Postgraduate
Healthcare Education, LLC which is accredited to provide continuing pharmacy
education by the Accreditation Council for Pharmacy Education. Ensuring that
pharmacists are picking this particular CEU or a comparable one would be
helpful. Also, developing a training that can be provided to already practicing
pharmacists would be useful. This training could focus on the deficiencies in
knowledge found in this study, increasing pharmacist comfort level in dispensing
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to varying groups of people, along with a discussion of unfair and unjust bias
placed on a consumer and how this bias might limit access to those in need.
Requiring that pharmacists go through this training is essential.
Dissemination. The findings from this study will be widely disseminated. In
terms of education, providing findings to the accredited schools of pharmacy in the
U.S. will increase awareness about the disparity between teaching and student
learning. Pharmacy schools may use the results to enhance already existing curricula
or develop new curricula for students. These findings will also be disseminated to
pertinent organizations such as national and state pharmacy associations and other
like minded organizations in the field such as the American Medical Association.
The findings can then be used to support and implement new policy that will increase
access to this medication. Lastly, this research and its effective use of the Theory of
Planned Behavior can be added to the knowledge on the use of this theoretical
framework.
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Figure 8. Emergency Contraception Health Access Model
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In sum, this study uncovered a disconnect between pharmacist education and
practice. It also uncovered important findings regarding pharmacist biases which are
associated with dispensing and inevitably health access. Research from this study
suggested that knowledge, attitudes, social norms, perceived ease with dispensing, and
dispensing intention are associated with dispensing and access to care. Figure 8
pictorially demonstrates that effective teaching may be associated with efficient learning,
which creates informed practice, which may be associated to health access. Preconceived
bias or beliefs should also be considered in the model. Additionally, there are potential
areas for intervention at each stage. This study was well designed, informed by theory
and literature and produced important results that can be used to inform future research,
policy, and practice.
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Appendix A.
Table 50: Oral contraceptives that can be used for emergency contraception in the
United Statesa
Brand

Company

Pills per Dose

b

Ethinyl
Estradiol per
Dose (µg)

Levonorgestrel
per Dose
(mg)c</B< TD>

Progestin-only pills: Take 1 doseb
Plan B

Barr/Duramed

2 white pills

0

0.75

Ovrette

Wyeth-Ayerst

40 yellow pills

0

0.75

Combined progestin and estrogen pills: take 2 doses, 12 hours apart
Alesse

Wyeth-Ayerst

5 pink pills

100

0.50

Aviane

Barr/Duramed

5 orange pills

100

0.50

Cryselle

Barr/Duramed

4 white pills

120

0.60

Enpresse

Barr/Duramed

4 orange pills

120

0.50

Lessina

Barr/Duramed

5 pink pills

100

0.50

Levlen

Berlex

4 light-orange
pills

120

0.60

Levlite

Berlex

5 pink pills

100

0.50

Levora

Watson

4 white pills

120

0.60

Lo/Ovral

Wyeth-Ayerst

4 white pills

120

0.60

LowOgestrel

Watson

4 white pills

120

0.60

Lutera

Watson

5 white pills

100

0.50

Ogestrel

Watson

2 white pills

100

0.50

Ovral

Wyeth-Ayerst

2 white pills

100

0.50

Nordette

Wyeth-Ayerst

4 light-orange
pills

120

0.60
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Portia

Barr/Duramed

4 pink pills

120

0.60

Seasonale

Barr/Duramed

4 pink pills

120

0.60

Seasonique

Barr/Duramed

4 light-bluegreen pills

120

0.60

Tri-Levlen

Berlex

4 yellow pills

120

0.50

Triphasil

Wyeth-Ayerst

4 yellow pills

120

0.50

Trivora

Watson

4 pink pills

120

0.50

*Source: Princeton University and The Association of Reproductive Health
Professionals: Not2late.com, The Emergency Contraception Website.
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Package Insert for Plan B and RU-486
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Appendix C.
Figure 9. History of Emergency Contraception

Advent of
BC pill.
Packs of
pills cut up
to be used
as EC

1960s

FDA
approves 6
brands of
OCs to be
used as EC

1996

Nat’l
campaign
created by
Princeton
Univ. &
RHTP

1997

Washington
State begins
CDTA
program with
pharmacists

Preven, the
1st dedicated
product for
EC was
created

1998

Petition
filed in
support
of OTC
EC

1999

Plan B, the
2nd dedicated
product for
EC was
created
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2001

FDA
panel
supports
OTC
access of
EC

2003

2nd
petition
filed in
support
of OTC
EC

FDA struck
down
recommend
ation from
its
committee

2004

Makers of Plan
B submit new
application for
OTC EC for
women 16 yrs.
& older

FDA
approves
EC OTC
for women
18 & over

2006
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Table 51. Emergency contraception studies in a comparative context: Client knowledge &
attitude studies
Author
Study Description
Major Findings
Abbott et
al (2004)

Survey (self-administered
paper-based) of 158
women at an inner-city ED
in the US

Aiken et
al (2005)

Survey (interview) of 133
women in 1996 and 139
women in 2002 from a
hospital-based clinic and
drug treatment center in the
US

Aziken et
al (2003)

Survey (self-administered
paper-based) of 880 female
students attending a
University in Nigeria
Survey (interview) of 250
married women (ages 1548) in a health center in Iran

Babaee
et al
(2003)
Chuang
& Freund
(2005)

Corbett et
al (2005)

Harper &
Ellertson
(1995)

Jackson
et al
(2000)

Larsson
et al
(2004)

Survey (self-administered
paper-based) of 188
women (ages 18-44) in a
Boston neighborhood in the
US
Survey (25-item selfadministered paper-based
questionnaire) of 97 college
students between 18-21
years old in the US
Survey (telephone) of 550
undergraduate and
graduate students in the US

Survey (self-administered
paper-based) of 371 postpartum women from an
inner-city public hospital in
the US
Survey (mail questionnaire)
of 800 women attending a
family planning clinic in
Sweden

77% of women had heard of EC, although only half
of those knew how to use it. Of those who had heard
of it, 26% were not aware of the correct timing, 24%
were not aware that it was available in the U.S., and
45% were not aware that a prescription was required
for use. 51% of women reported that they would
think about using EC if they needed it; however 17%
reported moral or religious objections to its use
Between 1996 and 2002, the percentage of clients
who had ever heard of EC grew from 44% in 1996 to
73% in 2002 and comprehension of timing for use
also increased from 20% in 1996 to 51% in 2002.
Over half of women thought that there may be a
future need to use EC and of these, 95% reported
that they would use it if needed
58% of students were familiar with EC but only 18%
knew the 72 hour protocol for use and 49% believed
that the pills needed to be taken within 24 hours of
unprotected intercourse
8% of women knew about EC and 77% of women
reported that they would be willing to use it in the
future
82% of women in a Boston community had heard of
EC but only about half of those women knew how it
worked

Almost half of participants thought that EC was the
same as RU-486 and of women who reported to be
less likely to choose EC, 100% said that they would
feel judged or embarrassed if they had to ask for it
52% of respondents did not know the difference
between EC and RU-486. Democrats and people
who reported to be not religious had more favorable
attitudes towards EC than Republicans or highly
religious individuals. As knowledge about EC went
up, so did the positive attitudes about EC.
36% of women had heard of EC and only 7%
understood the appropriate timing for use. Two-thirds
of these women reported a willingness to use EC in
the future
98% of women were aware of EC but 38%
were not aware its effectiveness when taken
on the first day and 59% were not aware its
effectiveness when taken on the third day.
90% agreed that access to EC is positive
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Mathew
&
Urquhart
(2005)
Nguyen
et al
(2003)

Survey (self-administered
paper-based) of 78 women
attending an abortion clinic
in the UK
Survey (self-administered
paper-based) of 365
women who requested EC
in Switzerland

78% of women were familiar with EC and 90% of
women said they would consider using EC in the
future

Ottesen
et al
(2002)

Nationally representative
population-based study
(n=4283) in Switzerland
surveying (computerized
questionnaire) 16- to 20year-olds

89% of sexually active girls and 75% of sexually
active boys had heard of EC

Romo et
al (2004)

Survey (self-administered
paper-based) of 297 Latina
women ages 18-43 from a
clinic in the US

Tripathi
et al
(2003)

Survey (self-administered
paper-based questionnaire)
of 500 patients seeking
abortion services and 110
college students in India

17% of Spanish-speaking women and 41% of
English-speaking Latina women had heard of EC
and 25% believed that EC would end an existing
pregnancy. Only half of the women who have heard
of EC said that they would be willing to use it in the
future and those who did not comprehend the action
of EC were even less likely to say that they would
use it in the future
none of the clients surveyed were familiar w/ EC

Knowledge of EC was satisfactory but 42% thought it
had to be taken within 24 hours of unprotected
intercourse and 13% thought that EC was 100%
effective in preventing pregnancy

EC, Emergency contraception; ED, Emergency department
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Table 52. Emergency contraception studies in a comparative context: Provider knowledge,
attitudes, & practice.
Author
Study Description
Major Findings
Beckman
et al
(2001)

Survey (self-administered
paper-based) of 102 providers
(physicians, registered nurse
practitioners, certified nurse
midwives, & physician
assistants) in the U.S.

Chuan et
al (2004)

Survey (mail survey) of 282
providers (OB-GYN, family
practitioners, & general
internists) in the U.S.

Delbanco
et al
(1998)

Survey (telephone) of 754
women's health professionals
(Ob-gyn, family physicians,
nurse practitioners, &
physician assistants)
Survey (interview) of 167
physicians with expertise in
adolescent health in the U.S.

Gold et al
(1997)

At baseline, one-third of the sample did not know
the correct timing for EC & only 7% of providers
reported prescribing EC once a month. At followup, knowledge about EC & prescribing frequency
of EC significantly increased. However, providers
still had limited knowledge side effects and modes
of action. Attitudes about EC showed little
change.
94% of Ob-gins, 76% of family practitioners, &
63% of general internists ever prescribed EC.
Being female was a positive predictor & being
Catholic was a negative predictor for prescribing
EC. 75% of the physicians reported infrequent
prescribing of EC (less than five times a year),
regardless of their specialty
Although the number of physicians that prescribed
EC once in the last year increased, very few
commonly prescribe EC, regardless of specialty.

Attitude variables are predictors of failure to
prescribe EC.

Golden et
al (2001)

Survey (mail survey) of 233
Pediatricians in the U.S.

72.9% of respondents could not identify the FDA
approved methods for EC and roughly 72% could
not identify the correct timing for the drug. 68% of
respondents felt uncomfortable prescribing EC,
17% did not prescribe due to perceived
teratogenic effects & 12% did not prescribe due to
moral or religious reasons. 22% agreed that EC
provision encourages adolescent risk taking
behavior & 52.4% said they would place
restrictions on how many times they would
dispense the drug to a patient.

Onwuhafu
a et al
(2005)

Survey (self-administered
paper-based) of 232
community health extension
workers in Nigeria
Survey (paper-based) of 96
faculty physicians from one
Southern & three Midwestern
Universities

EC was not known about

Survey (interviews & paperbased questionnaire) of 72
providers (general
practitioners, nurses, &
midwives) in Turkey

Almost 1 in 10 providers were unfamiliar with the
words ‘emergency contraception’

Sable et al
(2006)

Sevil et al
(2006)

42% intended to prescribe EC for teens but 6577% intended for other specified groups. High
intention to prescribe was significantly associated
with positive attitudes but knowledge was not.
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Sills et al
(2000)

Survey (mail survey) of 121
Pediatricians in the U.S.

Tripathi et
al (2003)

Survey (self-administered
paper-based) of 405 health
care workers in India

Uzuner et
al (2005)

Survey (interviews) of 180
family planning providers in
Turkey

Wallace et
al (2004)

Survey (self-administered
paper-based) of 78 providers
(family physicians and nurse
providers)

Webb et al
(1993)

National study of British health
authorities

All but 1 doctor had heard of EC but about half did
not know the timing of EC or that it was FDA
approved. Knowledge, not attitudes, are
significant predictors of EC prescribing.
84% of gynecologists & 41% of general
practitioners were vaguely familiar with EC though
of those who had knowledge, most were unsure of
how to prescribe it. 51% of gynecologists & 17%
of practitioners reported ever prescribing it
Only half of providers knew the correct timing and
dose interval of EC. 39.4% of respondents
believed that EC causes abortion, 31.1% thought
that it was harmful for the fetus, 78.9% incorrectly
thought that pill use may increase unprotected
intercourse & that use will lead to men giving up
on condom use (75%).
96% reported that they were knowledgeable on
the indications & 78% reported that they
understood the protocols for prescribing EC
although knowledge inaccuracies were found
between perceived and actual knowledge. 44%
inaccurately thought that EC was an abortifacient.
90% thought that EC was an appropriate topic of
discussion at women’s exams and felt that the
benefits of EC outweighed the risks. 59% of
providers said they would restrict how many times
they prescribed EC, 14% thought that EC use
would discourage regular contraceptive use, 16%
were uncomfortable prescribing EC for religious or
ethical reasons, & 7% said that they would not
prescribe it under any circumstances
The majority of physicians surveyed report that
they prescribe EC a few times per week. 74%
reported that they have prescribed EC in the past,
with an average of 3.2 times in the past year

EC, Emergency contraception; ED, Emergency department; FDA, Food and Drug Administration
OB-GYN, Obstetricians/gynecologists

242

Appendix F.
Table 53. Emergency contraception studies in a comparative context: Pharmacists' knowledge,
attitudes, and dispensing practices.
Author
Study Description
Major Findings
Aneblo
m et al
(2003)

Survey (mail-based) of
pharmacy staff
(n=237) & nursemidwives (n=163) in
Sweden

Bennett
et al
(2003)

Survey (employed
mystery callers) of 315
pharmacists in the
U.S.

Borrego
et al
(2006)

Survey (mail-based) of
523 pharmacists in the
U.S.

Conard
at al
(2003)

Survey (mail-based) of
948 pharmacists in the
U.S.

Draut
(1999)

Survey (telephone) of
100 pharmacists in the
U.S.

Van
Riper et
al
(2005)

Survey (mail-based) of
501 pharmacists in the
U.S.

Both study groups had positive attitudes towards EC and
towards the OTC administration of EC; however nurse
midwives demonstrated more favorable attitudes than the
pharmacist group. In addition, verbal information and
counseling to clients on issues of EC was more commonly
reported by the nurse-midwife group than by the pharmacist
group and both groups reported that they wanted more
collaboration between health care providers.
Knowledge about & access to EC was limited. 30% of
pharmacists did not provide the correct timing required for
EC administration: 23% thought it needed to be taken within
24 hours & 7% thought it needed to be taken within 48 hours.
Also, 13% of the pharmacists said that EC would cause an
abortion. 65% (n=201) of pharmacists reported that they
would not be able to fill a prescription of EC that day.
Pharmacists from New Mexico had positive attitudes and
beliefs about prescribing EC but their knowledge was
average. 40% of the sample had an interest in becoming
certified to prescribe EC in their state-approved prescribing
training program. Of those pharmacists would wanted to be
certified, they were more likely to be male, non-Hispanic,
non-Christian, to report liberal or moderate political views,
and to say that they had employer approval, time, and
privacy at their pharmacy to prescribe EC.
48% of the pharmacists surveyed did not dispense EC.
Pharmacists under 45 years of age were more likely to report
dispensing EC; however no differences were found for sex.
Of the 59% of pharmacists who have dispensed EC to
adolescents, 83% said that they felt uncomfortable doing so.
There were no differences in feelings of comfort based on
age or sex.
Only 3 out of 100 pharmacists surveyed provided correct
information about EC and 38 (38%) pharmacists did not
know it was available in the U.S.
Only 54% of pharmacists worked in pharmacies that carried
EC. Of those, 67% had dispensed EC in 2003 but 24%
reported that they were not comfortable providing counseling
about the medication. 37% were unaware that the
medication is similar in its mechanism to oral contraceptives,
74% either incorrectly agreed or were uncertain about
whether EC causes birth defects when administered to
pregnant women & 85% of respondents either incorrectly
agreed or were uncertain about whether repeated use of EC
poses health risks. Only 5% of the sample correctly
answered all five of the knowledge questions on the survey.

EC, Emergency contraception
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Appendix G.
Pre-notice to Academic Deans*
Date:
To: JaneDoe@mail.edu
From: Alice Richman arichman@hsc.usf.edu
Subject: Academic Dean Survey
Hello and greetings. As part of my dissertation research, I am interested in learning
about the teaching of emergency contraception in our pharmacy school classrooms. I am
committed to identifying which classes, if any, within pharmacy school curricula
provides instruction on emergency contraception. This information is being sought as we
currently have little information on what classes cover this information or the extent of
this instruction. In order to reach these aims, I am asking you to help me gather this
information.
Within the next couple of days you will be receiving a brief three question survey from
the University of South Florida from this same email address. We would greatly
appreciate if you could take a few moments to complete it. By doing so you will help
ensure that we have the best information possible. Please be assured that your answers
are confidential and only group data will be reported.
If you have questions, feel free to contact Alice Richman or Ellen Daley at the University
of South Florida at the contact information provided below.
Thank you in advance for your cooperation.
Sincerely,
Alice R. Richman
USF College of Public Health
Phone: (813) 732-1903
Email: arichman@hsc.usf.edu

Ellen Daley, Ph.D.
USF College of Public Health
Phone: (814) 974-8518
Email: edaley@hsc.usf.edu

*The template for this letter was taken from Dillman (2000).
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Academic Dean Informed Consent Form
Researchers at the University of South Florida (USF) study many topics. We want to
learn about the instruction of emergency contraception in our pharmacy school
classrooms.
Title of research study: The Role of Pharmacists and Emergency Contraception:
An Assessment of Pharmacy School Curricula in the U.S. and the Knowledge, Attitudes,
and Dispensing Practices of Florida Pharmacists.
Person in charge of study: Alice R. Richman
Study staff who can act on behalf of the person in charge: Dr. Ellen Daley
Where the study will be done: In Florida
The purpose of this study is to review pharmacy school curricula in the U.S. for course
content related to emergency contraception. All Academic Deans from the 91 accredited
school of pharmacy in the U.S. will be sent a three question web-based survey that will
ask questions about their program curricula. In addition, Academic Deans will be asked
to provide course syllabi where applicable.
During this study, you will be asked to complete a three question survey pertaining to the
curricula and course content concerning emergency contraception at your institution.
You may also be asked to provide electronic copies of course syllabi. The survey should
not take more than 10 minutes to complete. If you decide not to take part in this study,
that is okay.
It will not cost you anything to take part in the study. Although there will not be any
immediate benefit to you, your participation in this study will be helpful in understanding
pharmacy school curricula and course content related to emergency contraception and
will advance the state of knowledge in this area. Your participation is greatly
appreciated. There are no known risks to those who take part in this study.
We may publish what we find out from this study. If we do, we will not use your name
or anything else that would let people know who you are.
If you have any questions about this study, call Alice Richman at (813) 732-1903 or Ellen
Daley at (813) 974-8518. If you have questions about your rights as a person who is
taking part in a study, call USF Research Compliance at (813) 974-5638.
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Academic Dean Cover Letter & Survey—Curricula Review
Date:
To: JaneDoe@mail.edu
From: Alice Richman arichman@hsc.usf.edu
Subject: Academic Dean Survey
Below you will find the brief three question survey on how emergency
contraception is being taught at pharmacy schools in the U.S. which Alice
Richman notified you about via email a few days ago. We found that there is
limited information on the current instruction on emergency contraception at
pharmacy schools, and thus we are asking for your help via this brief survey.
Please take a few minutes to answer the following questions. Your answers will
be kept confidential and data will only be reported in aggregate form.

Definition of Emergency Contraception: Emergency contraception is a type of hormonal
contraception, containing high doses of estrogen and progestin or progestin only. This
medication is 75%-89% effective in preventing pregnancies when taken within 120 hours
after sexual intercourse.
1) Does your School of Pharmacy offer required courses that provide content on
emergency contraception? Content can include lectures, course readings, course
objectives etc..
No _____
Not sure _____
Yes _____
If you answered Yes, please list the titles of courses and attach syllabi or link to
syllabi:
__________________
__________________
__________________
2) Does your School of Pharmacy offer elective classes that provide content on
emergency contraception? Content can include lectures, course readings, course
objectives etc..
No _____
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Not sure _____
Yes _____
If you answered Yes, please list the titles of courses and attach syllabi or link to
syllabi:
__________________
__________________
__________________

3) In your opinion, do you believe that School of Pharmacy curricula in the U.S.
should include content material on emergency contraception (including
pharmacology, legal and ethical issues, and the continual controversy that
surrounds the medication)?
Yes

Please explain

No

Please explain

Important: If you answered yes to either question 1 or 2, would you kindly attach an
electronic copy of the course syllabi listed to this email and forward them to Alice
Richman at arichman@hsc.usf.edu. If you do not have an electronic copy of the
syllabi of your courses, please tell me from where I may procure the syllabi (e.g.,
from a specific web site, URL).
Thank you for your time and attention. All identifying information will be kept
confidential. If you have questions about the study or would like a copy of the
study’s findings, please contact Alice Richman at arichman@hsc.usf.edu or call (813)
732-1903.
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Thank you/Reminder Email to Academic Deans*
Date:
To: JaneDoe@mail.edu
From: Alice Richmanarichman@hsc.usf.edu
Subject: Academic Dean Survey
About a week ago we sent you a survey via email. We are asking Academic Deans of the
schools of pharmacy in the U.S. about the curricula that addresses instruction on
emergency contraception. As of today, we have not received a completed survey from
you. I realize that we all have busy schedules, however we have contacted you and
others now in hopes of obtaining the insights that only Academic Deans, like yourself,
can provide. As we mentioned before, answers are confidential and will be combined
with others before disseminating the results. In case the previous questionnaire has been
deleted from your email account, we have included it again and hope you will respond.
Should you have any questions or concerns, feel free to contact me (Alice Richman) or
Ellen Daley at the contact information provided below. Thank you for your cooperation.
Alice R. Richman
USF College of Public Health
Phone: (813) 732-1903
Email: arichman@hsc.usf.edu

Ellen Daley, Ph.D.
USF College of Public Health
Phone: (814) 974-8518
Email: edaley@hsc.usf.edu

(Link to Survey Inserted Here)
*The template for this letter was taken from Dillman (2000).
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Appendix K: Sample Recruitment Flyer

Are you a 3rd or 4th year Pharm D. student in
Pharmacy School?
Then we need YOU to be part of a focus group of 3rd &
4th year Pharm D. students @ the University of Florida.
Who is eligible?
9 3rd or 4th year Pharm D. students.
9 English speaking individuals.
What will I have to do?
9 Participate in a focus group discussion with 7 other students.
9 Discuss your perceptions of emergency contraception course instruction and
projected dispensing practices.
How much time will this take?
9 Participation will take approximately 1 hour.
Do I get anything for my time?
9 Students will receive a $10 gift certificate to Starbucks.
9 Help add to the scientific body of knowledge.
When will the group meet?
9 Wednesday, August 29th at 10am Room 115A.
How can I sign up?
E-mail Alice Richman at arichman@health.usf.edu or call at (813) 732-1903.
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Focus Group Informed Consent Form

Informed Consent for an Adult
Social and Behavioral Sciences
University of South Florida
Information for People Who Take Part in Research Studies
Researchers at the University of South Florida (USF) study many topics. We want to
learn more about pharmacy students’ perception of emergency contraception course
content taught at accredited schools of pharmacy. To do this, we need the help of people
who agree to take part in a research study.
Title of research study: The Relationship among Emergency Contraception
Knowledge, Attitudes, and Dispensing Practices of Florida Pharmacists and Pharmacy
School Curricula in the U.S.
Person in charge of study: Alice R. Richman
Study staff who can act on behalf of the person in charge: Dr. Ellen Daley
Where the study will be done: Focus groups will be held at all four accredited Schools
of Pharmacy in Florida: Florida Agricultural and Mechanical University, Nova
Southeastern University, Palm Beach Atlantic University, and University of Florida

Should you take part in this study?
This form tells you about this research study. You can decide if you want to take part in
it. You do not have to take part. Reading this form can help you decide.
Before you decide:
•

Read this form.

•

Talk about this study with the person in charge of the study or the person explaining the
study. You can have someone with you when you talk about the study.

•

Find out what the study is about.

You can ask questions:
•

You may have questions this form does not answer. If you do, ask the person in charge
of the study or study staff as you go along.

•

You don’t have to guess at things you don’t understand. Ask the people doing the study
to explain things in a way you can understand.

After you read this form, you can:
•

Take your time to think about it.

•

Have a friend or family member read it.

•

Talk it over with someone you trust.
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It’s up to you. If you choose to be in the study, then you can sign the form. If you do not
want to take part in this study, do not sign the form.

Why is this research being done?
The purpose of this study is to find out what and how emergency contraception course
content is taught at accredited schools of pharmacy as perceived by third or fourth year
pharmacy students. In reaching this aim, you are being asked to participate in an hour
long focus group where you will be asked questions about the pharmacy school
instruction and course content related to emergency contraception. The focus group
discussions will be tape recorded but no identifying information will be used or linked to
the study results.

Why are you being asked to take part?
We are asking you to take part in this study because you are a third or fourth year Pharm.
D. student enrolled at an accredited school of pharmacy. We want to find out more about
what type of emergency contraception instruction you were taught in your pharmacy
school classes.

How long will you be asked to stay in the study?
You will be asked to spend about 1.5 hours in this study. The focus group itself will run
about one hour. The other thirty minutes will be spent at the beginning of the focus
group acquainting each other and explaining the process of the focus group discussion.

How often will you need to come for study visits?
A study visit is one you have with the person in charge of the study or study staff. You
will need to come for one study visit in all and that is today for the focus group
discussion.
•

Questions will be asked pertaining to course instruction on emergency contraception in
your pharmacy school classes such as any lectures, course assignments, and discussions
that you may have had in class. Questions will inquire about what you learned, what and
how you were taught, and questions will also ask about your projected dispensing
practices and perceptions of emergency contraception.

What other choices do you have if you decide not to take part?
If you decide not to take part in this study, that is okay. There are no other choices, such
as becoming involved in another focus group, that are offered by this study.

How do you get started?
If you decide to take part in this study, you will need to sign this consent form. After
consenting, you will be able to participate in the focus group.
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What will happen during this study?
During the study, you will be asked questions pertaining to your course instruction at
your institution in a group setting.
Here is what you will need to do during this study

In order to take part in the study, all you have to do is participate in the group discussion
that will last about an hour.

Will you be paid for taking part in this study?
We will pay you for the time you volunteer in this study in the form of a $10 gift card to
Starbucks. You will be given the gift card prior to your participation in the focus group.

What will it cost you to take part in this study?
It will not cost you anything to take part in the study.

What are the potential benefits if you take part in this study?
Although there will not be any immediate benefit to you, your participation in this study
will be helpful in understanding pharmacy school curricula and course content related to
emergency contraception and will advance the state of knowledge in this area. Your
participation is greatly appreciated.

What are the risks if you take part in this study?
There are no known risks to those who take part in this study.

What will we do to keep your study records private?
Federal law requires us to keep your study records private. All identifying information
will be kept confidential and will not be disseminated with the research findings. Your
name or school affiliation will not be used or linked to the study results. However,
certain people may need to see your study records. By law, anyone who looks at your
records must keep them confidential. The only people who will be allowed to see these
records are:
•

The study staff.

•

People who make sure that we are doing the study in the right way. They also make sure
that we protect your rights and safety:
o

The USF Institutional Review Board (IRB)

o

The United States Department of Health and Human Services (DHHS)

We may publish what we find out from this study. If we do, we will not use your name
or anything else that would let people know who you are.
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What happens if you decide not to take part in this study?
You should only take part in this study if you want to take part.
If you decide not to take part:
•

You won’t be in trouble or lose any rights you normally have.

What if you join the study and then later decide you want to stop?

If you decide you want to stop taking part in the study, tell the study staff as soon as you
can.
•

We will tell you how to stop safely. We will tell you if there are any dangers if you stop
suddenly.

Are there reasons we might take you out of the study later on?
Even if you want to stay in the study, there may be reasons we will need to take you out
of it. You may be taken out of this study:
•

If we find out it is not safe for you to stay in the study. For example, your health may get
worse.

•

If you act in an inappropriate manner in the focus group discussions.

You can get the answers to your questions.
If you have any questions about this study, call Alice Richman at (813) 732-1903.
If you have questions about your rights as a person who is taking part in a study, call USF
Research Compliance at (813) 974-5638.

Consent to Take Part in this Research Study
It’s up to you. You can decide if you want to take part in this study.
I freely give my consent to take part in this study. I understand that this is research. I have
received a copy of this consent form.

________________________
Signature
of Person taking part in study

________________________
Printed Name
of Person taking part in study

___________
Date

Statement of Person Obtaining Informed Consent
I have carefully explained to the person taking part in the study what he or she can
expect.
The person who is giving consent to take part in this study
•

Understands the language that is used.
Reads well enough to understand this form. Or is able to hear and understand
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•

when the form is read to him or her.

•

Does not have any problems that could make it hard to understand what it means
to take part in this study.

•

Is not taking drugs that make it hard to understand what is being explained.

To the best of my knowledge, when this person signs this form, he or she understands:
•

What the study is about.

•

What needs to be done.

•

What the potential benefits might be.

•

What the known risks might be.

•

That taking part in the study is voluntary.

________________________
Signature of Investigator
or authorized research
investigator designated by
the Principal Investigator

_____________________________ __________
Printed Name of Investigator
Date
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Final Pharmacist Pre-Notice Letter*
Date
Inside Address
A few days from now you will receive in the mail a request to fill out a brief
questionnaire for an important research project being conducted by the University of
South Florida.
It concerns the perceptions and experiences of pharmacists in relation to dispensing the
medication emergency contraception.
I am writing in advance because we have found many people like to know ahead of time
that they will be contacted. The study is an important one that will help add to the body
of knowledge on pharmacists and dispensing practices. The study is also anonymous as
your name, pharmacy, or affiliations will be kept confidential and will not be linked to
the study results.
Thank you for your time and consideration. It’s only with the generous help of people
like you that our research can be successful.
Sincerely,
Alice R. Richman
University of South Florida
College of Public Health
*The template for this letter was taken from Dillman (2000).
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Final Pharmacist Informed Consent Form
Researchers at the University of South Florida (USF) study many topics. In this study,
we want to learn more about pharmacists’ perceptions and experiences and how they may
or may not impact emergency contraception dispensing practices.
Title of research study: The Role of Pharmacists and Emergency Contraception: An
Assessment of Pharmacy School Curricula in the U.S. and the Knowledge, Attitudes, and
Dispensing Practices of Florida Pharmacists.
Person in charge of study: Alice R. Richman, MPH, Ph.D. Candidate
Study staff who can act on behalf of the person in charge: Ellen Daley, Ph.D., MPH
Where the study will be done: In the State of Florida
The purpose of this study is to understand pharmacists’ perceptions and experiences
surrounding emergency contraception and to understand how these perceptions are
related to dispensing practices. This study involves sending a questionnaire to
pharmacists registered with the Florida Board of Pharmacy.
Questions on the survey inquire about issues of perceptions about emergency
contraception and your dispensing practices of the medication. Questions also request
some demographic information; however any identifying information including your
name or pharmacy will be kept confidential and all data will be de-identified meaning it
will be rendered anonymous and will not be linked to the study results. The survey
should take you about 10 minutes to complete.
You may decline to take part in this study. You will neither be compensated nor have to
pay anything to participate in this study. Although your participation will not accrue any
immediate benefit to you, your participation in this study will be helpful in understanding
pharmacists’ perceptions and dispensing practices related to emergency contraception
and will advance the state of knowledge in this area. Your participation is greatly
appreciated. There are no known risks to those who take part in this study.
We may publish the results and findings from this study. If we do, we will not use your
name or anything else that would let people know who you are.
Authorized research personnel, employees of the Department of Health and Human
Services, and the USF Institutional Review Board and its staff, and any other individuals
acting on behalf of USF, may inspect the records from this research project.
If you have any questions about this study, call Alice R. Richman at (813) 732-1903 or
Ellen Daley at (813) 974-8518.
If you have questions about your rights as a person who is taking part in a study, call USF
Office of Research Compliance at (813) 974-5638.
Thank you so much for your time and participation.
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Final Cover Letter to Pharmacists*
Inside Address
I am writing to ask your help in a study of pharmacists being conducted by researchers
from the University of South Florida (USF). This study aims to understand Florida
pharmacists’ perceptions of emergency contraception and their dispensing practices.
It’s my understanding that you are a pharmacist practicing in Florida. We are contacting
a random sample of pharmacists in Florida and are requesting that they help us by
completing a brief questionnaire on their perceptions and dispensing practices concerning
emergency contraception.
Results from the survey will be used to understand pharmacists’ perceptions and
dispensing practices related to emergency contraception and will advance the state of
knowledge in this area. Your participation is greatly appreciated.
Your answers are completely anonymous and no identifying information about you will
be collected. This survey is voluntary. However, you can help us very much by taking a
few minutes to share your perceptions about emergency contraception with us.
There is a paper survey attached in this packet for you to fill out and return in the
enclosed and stamped envelope.
If you have any questions or comments about this study, we would be happy to talk with
you. Feel free to call Alice R. Richman at (813) 732-1903 or contact via email at
arichman@health.usf.edu.
Thank you very much for helping with this important study.
Sincerely,
Alice R. Richman
University of South Florida
*The template for this letter was taken from Dillman (2000).
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Final Pharmacist Survey
Thank you for taking the time to complete this survey. Your opinions and responses
are important to us. All responses will remain anonymous. Please complete this
survey and return it in the enclosed self-addressed and stamped envelope.
In order to complete this survey, please circle the number that corresponds to the
answer you choose or if there is no number listed, please write in your answer.
First, I’d like to ask you some questions about your practice and workplace.
1. How many years have you been a practicing registered pharmacist?
____ year/years
2. The type of pharmacy where you work could be best described as (if you have
more than one job, please circle the number that corresponds to your primary type
of pharmacy)
____ 1 Community -- Chain
____ 2 Community -- Independent
____ 3 Hospital
____ 4 Government (e.g., US Public Health Service, military)
____ 5 Indian Health Service
____ 6 Not currently working in a pharmacy
____ 7 Other: Please specify _______________________
3. What is your job title?
____ 1 Staff Pharmacist
____ 2 Pharmacy Manager
____ 3 Other: Please specify _______________________
4. What is your current employment status?
____ 1 Full-time
____ 2 Part-time
____ 3 Retired
5. Does your pharmacy stock any of the following products?
Condoms
____1 Yes
____0 No
Spermicide ____1 Yes
____0 No
Oral contraceptive pills ____1 Yes ____0 No
6. Does your pharmacy stock Plan B?
____ 1 Yes
____ 0 No
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7. Have you ever been asked to fill a prescription of Plan B?
____ 1 Yes
____ 0 No
8. Have you personally ever filled a prescription of Plan B?
____ 1 Yes
____ 0 No (skip to question #10)
9. Approximately how many Plan B prescriptions have you personally filled in the
past 12 months? ____________
10. Have you ever been asked to sell Plan B over-the-counter?
____ 1 Yes
____ 0 No
11. Have you personally ever sold Plan B over-the-counter?
____ 1 Yes
____ 0 No (skip to question #13)
12. Approximately how many times have you sold Plan B over-the-counter in the past
12 months? ____________
13. Would you ever have the opportunity at your workplace to come in contact (sell,
dispense, fill a prescription) of Plan B?
____ 1 Yes
____ 0 No
Next, I would like to ask you about your intention to dispense Plan B to each of the following
groups. Please check the box that corresponds to the answer you choose.
To what extent are you likely to sell Plan B over-the-counter to…
Very
Somewhat Somewhat Very N/A
Unlikely Unlikely
Likely
Likely
14. Women who have experienced
incest or rape.
15. Women who have experienced a
problem with their birth control
method.
16. Women who request the method
after having unprotected sexual
intercourse.
17. A person other than the ultimate
consumer of the product such as
parents or a boyfriend.
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To what extent are you likely to dispense Plan B by prescription to…
Very
Somewhat Somewhat Very N/A
Unlikely Unlikely
Likely
Likely
18. Women who have experienced
incest or rape.
19. Women who have experienced a
problem with their birth control
method.
20. Women who request the method
after having unprotected sexual
intercourse.
21. Sexually active teens under age
18.
Now I’d like to ask you some questions about what you generally know about Plan B.
Please answer these questions to the best of your ability without looking up the answer.
22. How many pills are in a Plan B package?
____ 1 One
____ 2 Two
____ 3 Three
____ 4 Four
____ 5 Five
____ 6 Six
____ 7 Twelve
____ 8 Not Sure
23. According to the Plan B label, Plan B is effective if taken within how many hours
of unprotected intercourse?
____ 1 Up to 12 hours
____ 2 Up to 24 hours
____ 3 Up to 36 hours
____ 4 Up to 72 hours
____ 5 Not Sure
24. Plan B prevents pregnancy via which of the following mechanisms?
____ 1 Inhibition or delay in ovulation
____ 2 Disruption of an implanted embryo
____ 3 Changes in the endometrial lining of the uterus
____ 4 All of the above
____ 5 Not sure
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25. According to the Plan B label, what percentage of the time does Plan B prevent
pregnancy if used properly?
____ 1 <25%
____ 2 25%-49%
____ 3 50%-74%
____ 4 75%-89%
____ 5 >89%
26. Sales of Plan B to eligible consumers may be made by:
____ 1 Pharmacists only
____ 2 Pharmacists or pharmacy technicians only
____ 3 Any member of the pharmacy staff working behind the pharmacy counter,
as long as a pharmacist is on duty
____ 4 Sales clerks, but only if a pharmacist is not on duty
27. A woman asking to buy Plan B in advance of need:
____ 1 Must wait for a contraceptive emergency before buying it
____ 2 Should be advised to take a pregnancy test before taking it
____ 3 May purchase more than one package
____ 4 Can only make a purchase if she is using it for herself
28. When selling Plan B without a prescription to a man, pharmacists:
____ 1 Need to see proof that he is at least 18 years of age
____ 2 Must limit sales to one package
____ 3 Must ask for the name of the person who will be taking the product
____ 4 Are violating the law
Do you think the following statements are true or false?
29. Plan B can cause birth defects if taken by a pregnant woman.
____ 1 True
____ 2 False
____ 3 Not sure
30. Plan B can act as an abortifacient.
____ 1 True
____ 2 False
____ 3 Not sure
31. The sooner a woman takes Plan B, the more effective it will be.
____ 1 True
____ 2 False
____ 3 Not sure
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The next few questions will ask you about how you personally feel about Plan B. Please check
the box that corresponds to the answer you choose.
Completely Somewhat Neither Somewhat Completely
Agree
Agree
Disagree
Disagree
Agree
nor
Disagree
32. Easy availability of
Plan B will
discourage regular
contraceptive use.
33. Easy availability of
Plan B promotes
promiscuity.
34. I feel uncomfortable
dispensing Plan B
because of my
religious/ethical
beliefs.
35. Repeated use of
Plan B is wrong.
36. I feel comfortable
dispensing Plan B to
adult women.
37. I feel comfortable
dispensing Plan B to
adolescents (teens
<18 years old).
38. I feel comfortable
dispensing Plan B to
men.
39. Should Plan B be offered to women who are raped in all hospital emergency
rooms, regardless of hospital affiliation?
____ 1 Yes
____ 2 No
____ 3 Not sure
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The next questions will ask you about your perceptions of what other people think.
The people and groups listed below may be influential in your dispensing decision-making.
Please indicate (by checking the box) how you think the following consider Plan B dispensing
practices, either by prescription or over-the-counter.
Definitely Probably Probably Definitely
Should
Should
Should
Should
Not
Not
40. My partners/business colleagues
think that I _________ dispense
Plan B.
41. The professional organization I am
most active in recommends that
I
dispense Plan B.
42. My supervisor thinks that
I
dispense Plan B.
43. In general, my close friends and
family think that I_________
dispense Plan B.
44. Is there anyone in your pharmacy who refuses to dispense Plan B?
____ 1 Yes
____ 2 No
____ 3 Not sure
____ 4 My pharmacy does not carry Plan B
45. Is there a policy in place at your pharmacy if someone refuses to dispense Plan B?
____ 1 Yes
____ 2 No
____ 3 Not sure
____ 4 My pharmacy does not carry Plan B
Some pharmacists may feel that where they work affects their dispensing practices of Plan B.
The following questions will ask you about your comfort level in dispensing Plan B.
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How easy is it for you to…
Very
Somewhat Somewhat
Difficult Difficult
Easy

Very
Easy

46. Counsel clients about Plan
B.
47. Refuse to dispense Plan B.
48. Educate clients about Plan
B.
49. Dispense Plan B.
The last group of questions will ask some basic questions about you.
50. What is your gender?
____ 1 Female
____ 2 Male
51. How old are you?
____________
52. What pharmacy school did you graduate from?
________________________
53. What year did you graduate from pharmacy school?
____________
54. How would you describe yourself (choose only one)?
____ 1 Religious
____ 2 Spiritual
____ 3 Religious and Spiritual
____ 4 Undecided
____ 5 None of the above
____ 6 Prefer not to respond
55. Which religious group do you most closely identify with (choose only one)?
____ 1 Roman Catholic
____ 2 Baptist
____ 3 Methodist
____ 4 Episcopalian
____ 5 Lutheran
____ 6 Quaker
____ 7 Presbyterian
____ 8 Assembly of God
____ 9 Hindu
____ 10 Buddhist
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____ 11 Jewish
____ 12 Islamic
____ 13 Mormon
____ 14 Non-Denominational
____ 15 None
____ 16 Prefer not to respond
____ 17 Other please specify (___________________)
56. What is your race/ethnicity (choose all that apply)?
____ 1 Caucasian
____ 2 African American
____ 3 Hispanic
____ 4 Asian
____ 5 Other please specify (___________________)
57. What is your current marital status?
____ 1 Married
____ 2 Living with a partner
____ 3 Divorced
____ 4 Separated
____ 5 Widowed
____ 6 Never been married
58. What is your political affiliation?
____ 1 Republican
____ 2Democratic
____ 3 Independent
____ 4 Green Party
____ 5 None/Undecided
____ 6 Other please specify (___________________)
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Pharmacist Thank you/Reminder Postcard*
Date
Last week, a questionnaire seeking your perceptions about emergency contraception was
mailed to you. Your name was randomly drawn from a list of all pharmacists registered
with the Florida Board of Pharmacy.
If you have already completed and returned the questionnaire to us, please accept our
sincere thanks. If not, please do so today. We are especially grateful for your help
because it is only by asking people like you to share your thoughts and experiences that
we can understand pharmacists’ perceptions and practices concerning emergency
contraception in the state of Florida.
If you did not receive a questionnaire, or if it was misplaced, please call Alice R.
Richman (813) 732-1903 and we will get another one in the mail to you today. Also, you
are welcome to go online at www.ultimatesurveyor.com and complete the survey there.

Alice R. Richman
University of South Florida
*The template for this letter was taken from Dillman (2000).
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Panel of Experts Q&A
Questions for Pharmacist Panel of Experts
Combined Interview Responses
1) Male (blue) , 2) Male (purple), 3) Female (green)
Male works at a CVS in Boston, MA
Male who works at Walgreens in Lakeland, Florida
Female works at Kaiser and formally worked with Kroger (Kings Super)
Date: May 26, 2006
General Questions:
1. Is there a National professional society or association that impacts/establishes
policy re: pharmacist practices?
#1: The American Pharmaceutical Association (APhA) has a big impact politically as
they work at the national level but most pharmacies are regulated by their local state
Board of Pharmacies. In fact, pharmacies in general are regulated more by state law
then from national policy.
#2: There are national pharmacy organizations but pharmacist procedures come from
the State Board. Each state has its own Board of Pharmacy. First there are federal
laws created and then each state makes sure the laws are followed.
#3 No, there isn’t one large association that impacts policy but there is APha. Female
thought that the employer can influence policy over anyone else (over both the state
and the national authorities)
Knowledge Questions:
2. When you were in school, what courses taught you the pharmacology of basic
pharmaceuticals? What courses taught you about ethics and legality?
#1: Male didn’t exactly remember which courses taught him basic pharmacology
because he’s been practicing pharmacy since 1975 but he remembers biology,
chemistry, and biochemistry as the courses that covered this material. Also he thinks
that now pharmacy students get this information from courses on biotheraputics and
pharmacology. Male remembers taking a pharmacy law class that taught him about
pharmacy ethics and legality but now he thinks Pharmacy schools offer ethics classes.
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#2: Pharmacotherapy covered the pharmacology of basic pharmaceuticals and he took
2 semesters of pharmacy law that taught ethics and legality. He also mentioned that
information on ethics was worked in to case studies and group assignments from
other classes. He did not take an ethics course.
Pharmacotherapy: teaches which drugs cure which disease
Medical Chemistry: teaches how drugs work chemically
Pharmacology: teaches how drugs work in body
#3: Pharmacology taught her the basic pharmacology of pharmaceuticals and she’s
had no formal ethics class though she thinks that in her pharmacy management class,
they may have discussed ethics. She did take pharmacy law that discussed dispensing
issues. She was in school 20 years ago so she thought it was a little difficult to
remember.
As I also plan to do a curriculum review of the accredited schools of pharmacy in
the U.S., what courses should I be looking for that teach the pharmacology or
mechanism of EC and what courses may teach the ethics or legality of dispensing
or not dispensing a medication?
#1: Male has been out of school for too long to answer this question.
#2: The pharmacology or mechanism of EC was taught in pharmacotherapy and
ethics or legality of dispensing was learned in law class (when it’s okay not to fill) but
Male said that ethics were applied throughout curriculum and he did not have an
ethics class.
#3: She thinks that pharmacology is the course that will teach the mechanism of EC
and pharmacy law may teach the ethics or legality of dispensing EC. When she went
to school, she was just taught about dispensing; now students learn a lot more.
3. How do pharmacists acquire the required CEUs? How many are needed per year?
#1: Male is a pharmacist in Boston, Massachusetts, and he needs 15 per year. And 5
of those 15 credits must be live and 2 must be about pharmacy law. Most CEUs are
good for 2 credits (2 hours) and he can do them on the internet by reading an article
and answering questions or can attend conferences for example. He receives mailings
for different programs offering CEUs and he can find out about CEUs from Journals.
He has noticed that there are a lot on EC dispensing, especially since Massachusetts is
about to have Collaborative Drug Therapy Agreements (CDTA) where a pharmacist
will be able to counsel and prescribe EC at a pharmacy in conjunction with a
physician. He mentioned one CEU course on EC dispensing training offered through
Northeastern University: www.ace.neu.edu/rxce/index.php
268

Appendix R (Continued)
#2: Regular pharmacists need 12 hours/year in Florida. A consulting pharmacist, like
a pharmacist who works in a nursing home checking charts of patients, needs 24
hours/year. 5 credits must be live, 2 credits must involve AIDS or terminal illnesses,
and 1 credit must involve medication errors.
Pharmacists can find CEUs online, from the Hills County Pharmacy Association
Office. Also, national organizations have meetings twice per year and he can get all
live credits for a 2 year period completed in one conference.
(Random note: pharmacists call CEUs, CE’s.)
#3: Pharmacists in Colorado need 12 CEUs per year and these contact hours can be
procured however they want. Colorado doesn’t differ between live and not live.
She procures her CEUs from a Journal she prescribes to called Pharmacist Letter. It
comes out monthly and covers all sorts of issues and then she takes the quiz at the end
and gets her CEU credits. The remainder of her CEUs comes internally from Kaiser.
Here is the information for CEUs for Florida Pharmacists as found on the Florida
Board of Pharmacy Florida Department of Health website
http://www.doh.state.fl.us/mqa/pharmacy/ph ceu.html

Pharmacist: - 30 hours of CE per biennium (two year licensure period) ten
(10) hours must be live, one (1) hour HIV/AIDS, and 2 hours Pharmaceutical
Education on medication errors per biennium (maybe counted toward
required CE hours).
4. What are the typical journals that pharmacists read? In your opinion, do they tend
to read practice or professional journals? Or is there even a distinction made?
a. What kinds of issues are out there being circulated in the field, for
example are there a lot of reproductive, contraception, or reproductive
pharmaceutical related articles?
#1: Typical Journals include Application of Clinical Pharmacy, Pharmacy Times, or
American Druggists. There is no real distinction made between practice or
professional journals and there are not a lot of reproductive or contraception related
articles out there. He guesses that the amount of reproductive related articles is
within the accepted percentage for the Journals. He also noted that he doesn’t read a
lot of Journals and if he does, it’s for CEU credits.
#2: Male says that some pharmacists read the same main medical journals as we do
such as New England Journal of Medicine, AGHP, and American Pharmacist
Association. He says that these Journals are more research based. Then there are
other Journals such as Pharmacy Today and Drug Topics that keep pharmacists up-todate on new drugs and medications. He says that these Journals are sent to Walgreens
for free.
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In terms of reproductive related articles in Journals he said that whatever is typically
in the news is also in the Journals. He remembers seeing a lot of EC related articles
when it almost went OTC in the general news.
#3: Pharmacists typically read Pharmacy Times or the Journal put out by APha.
Pharmacists read both practice and professional journals and she doesn’t think that
there is a distinction made between the two.
Female doesn’t think that there are a lot of reproductive pharmaceutical related
articles out there and since we last spoke she’s kept her eye out for articles on EC and
hasn’t noticed any.
5. How do pharmacists get information on changes to contraception (for example the
upcoming change of birth control pills)? How do pharmacists find out about all
new medications?
#1: Surprisingly, no one ever really tells pharmacists about changes to medication.
He will typically notice a change on a prescription a doctor writes and then if he
doesn’t recognize the prescription or drug he will sometimes tries to self educate
through looking medication up. Some drug salespeople do come by the store but he
doesn’t usually talk to them because they are just pushing their drug. Sometimes,
CVS will send a corporate letter saying what new drugs they will be carrying.
#2: Both changes to medication and new medications are found out through the
following avenues:
i. Package inserts on the new drugs when they arrive at the store
ii. Drug companies will send information to pharmacists
iii. Magazines will talk about new magazines
iv. CEUs may come out on the particular drug or topic
#3: Pharmacists get information on changes to contraception from the following
mechanisms:




Reading Journals
See new prescription that was written
See it through practice

When she worked with Kroger, she found out about new medications through drug
reps and Journals but now that she works for Kaiser it’s a closed formulary so no reps
are allowed.
Attitude Questions:
6. Is there a National policy or code of ethics for pharmacist?
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#1: He thinks that there is something like the Hippocratic Oath for pharmacists but
doesn’t know for sure. He recommends that we search for a code of ethics by state
because everything is deferred to the state level. He also thinks that CVS has its own
code of ethics and he’s going to search for it and send it to me if he can find it.
#2: Yes, there is a code of ethics for pharmacists (he’s going to see if he can find it).
It’s given to pharmacy students when they start the program and when they graduate.
#3: Yes, they say it when students graduate from pharmacy school (she’s going to try
and find it and get back to me).
7. How would you say an individual’s moral or ethical beliefs would impact their
professional practice as a pharmacist?
#1: Male thinks that it’s dependent on where you live. He noted that Boston is very
open and liberal and he doesn’t think that professional opinion affects practice. He
talked about women getting repeat prescriptions of EC and how that bothered him a
little bit but he never has changed his dispensing practices. At the same time, he also
said that there are some people who will not dispense birth control pills or EC.
(These seem to be conflicting statements that on the one hand he says that he doesn’t
think beliefs impact practice but then on the other hand he has heard of people who
will not dispense BCPs).
#2: Male thinks that BC and EC are the only times that moral or ethical beliefs would
impact professional practice but he also mentioned that there is sometimes an issue
with pain killers/relievers and cancer patients but not as much as with BC and EC.
He has never known anyone who refused to fill prescriptions but he has heard of it a
lot around Lakeland. He knows of one Publix in Lakeland doesn’t stock EC because
the pharmacist will not fill EC. So, Publix then sends these customers to Walgreens
to fill the prescription. Because his store has 24 hour access, they have 3 pharmacists
around and available so if one person will not fill it, someone else will.
#3: Female thinks that an individual’s moral or ethical beliefs are impacting practice
more than it use to, that is, you are more likely to see refusal to fill now then before.
She said that it use to be that you got a prescription and you filled it. Now a
pharmacist has the option to refuse based on ethical, moral, or drug based
(contraindications) reasons.
Kaiser has no policy or record and no suggested policy but Kroger did have a policy that
was not accessible to the public. The policy was that if you refuse to fill a prescription,
it’s your responsibility to find someone who would fill it, either within
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your own pharmacy or some other nearby pharmacy. So, for example, Walmart (who
up until recently did not carry EC) would call Kroger with a client asking to fill EC.
She herself has never known anyone to refuse but has heard about it.
Dispensing Practice Questions:
8. What are the general policies on dispensing at pharmacies? Is the policy
corporate or state-driven? Is it accessible to the public?
#1: There is no general policy on dispensing at CVS. Dispensing hasn’t been a real
issue or problem so there’s been no policy created BUT there has been a suggested
method of handling a situation where a pharmacists is uncomfortable filling a
prescription for religious or moral reasons. CVS suggested that if you’re
uncomfortable filling a prescription (for religious or moral reasons), you first see if
someone else is available to fill it (For Male at his CVS, there’s only 1 pharmacist on
duty at any given time so there wouldn’t be anyone to fill it). Then, if there’s no one
else to fill it, you give the client directions to another CVS store where they will fill
it. This is the suggested guideline by CVS as they sent a letter around, but no formal
policy has been set yet.
He also noted that policy is corporate driven and is not accessible to the public.
This is very interesting to me, that they suggest women to go to another pharmacy.
How would this policy be affective in rural areas?
#2: There are no policies on dispensing at Walgreens though he feels that Walgreens
would not be happy if you refuse to fill a prescription especially after hearing about
how pharmacies were sued for it. If the pharmacy doesn’t stock it, then they send
women to another store that does.
Male told me that he doesn’t agree with EC unless in cases of rape. He thinks that his
store gets about 1 or 2 prescriptions of EC per month.
#3: There are no real policies created until there’s a problem. No company policy at
Kaiser but at Kroger there was one. If there is a policy, it’s corporate and not
accessible to the public.
9. How do you think corporate policy affects personal behavior?
#1: Male believes that corporate policy would be a VERY STRONG motivator that
affects personal behavior and he noted that you can not buck the system very long
until you will get thrown out.
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#2: He thinks that fear of losing your job does have a large affect on personal
behavior and he also thinks that if there were no consequences that more people
would refuse to fill it.
#3: She thinks that corporate policy does affect personal behavior by making
pharmacists aware of the need to take care of the client regardless of personal beliefs.
10. What is the recourse or ramifications if you refuse to fill a prescription for a
client? In your opinion, why would a pharmacist not want to fill a prescription?
#1: If you refuse to fill a prescription, you need to find another person or pharmacy to
fill it.
If Males opinion, a pharmacist may not want to fill a prescription based on:
•
Religious Beliefs
•
Moral Beliefs
•
Political Beliefs
#2: Male thinks that if you refuse to fill a prescription for a client that it would
depend on the situation but he thinks that you may lose your job over it. He heard
that Eckerd fired someone for not filling a prescription.
In his opinion, a pharmacist would not fill a prescription due to religious or moral
reasons. Also, if the patient is currently taking one drug and the prescription is for
another drug that could harm the patient if these drugs were taken together, that is
another reason for refusal (harm to the patient or contraindications). An example of
this is that he’s refused Viagra to someone before b/c the combination of his two
medications is known to be lethal.
#3: She thinks that refusing to fill prescriptions may be breaking state law and may
result in a termination of your job but she doesn’t know.
A pharmacist may not want to fill a prescription based on moral or pro-life beliefs.
11. Are all OTC medications placed differently in a pharmacy? Meaning, are all
OTC medications placed in front the counter or are some placed behind the
counter. If some are placed in front and some behind, what distinguishes these
differences?
#1: The only OTC medications required to be behind the counter are tobacco and
Sudafed. However, some medications are placed behind the counter because they are
worth a lot of money and people try to steal them. For example, powdered baby
formula and crest white strips are held behind the counter because of their high ticket
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value and because they will walk right out the door if not held behind the counter.
Male believes if EC ever went OTC that it would be held behind the counter as well.
#2: In the past, all OTC medications were placed in front of the counter but now they
have to keep Sudafed behind the counter. They also place home drug tests behind the
counter because people were stealing them.
#3: Sudafed is the OTC drug required to be behind the counter but sometimes high
priced items such as nicoderm and diabetic supplies will be behind the counter. She
also thinks that if EC with OTC, that it would be held behind the counter b/c it would
be in little packages that would be easy to steal.
Final Questions:
12. In the survey of pharmacists, we will need to ask questions about knowledge,
attitudes, and dispensing practices of EC. Can you help think of ways to ask these
questions most effectively to pharmacists (have some examples ready to help
prompt ideas including existing questions on these variables as well as factors
such as age of recipient, repetition of filling prescription, and OTC status)?
#1: Male said that he would be willing to edit some questions on the survey after we
put it together and provide suggestions if the questions don’t seem to ask what we
think they’re asking.
#2: Male mentioned that he is willing to help with the survey development when we
have some questions for him to look at. He also mentioned, like Male, that if he saw
a woman using EC repeatedly, he may choose to talk to her or to contact her doctor to
have him/her talk to the patient. He also noted that there may have been negative
attitudes towards HIV/AIDS patients thinking that they were promiscuous or dirty
because they had HIV/AIDS but he said that think negative thinking was cleared up.
His email address is: buie933@hotmail.com
#3: If there are what a pharmacist perceives to be too many refills, some pharmacists
personally call the doctor to make sure that’s what they meant to write on the
prescription.
Also if a pharmacist notices that a woman is getting EC twice/month, she has called
her doctor and spoken to the doctor before. (I think Female was telling me that she
herself has called a doctor before to question why a women has been using EC
repeatedly—this finding was in the other interviews and is interesting)
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13. Is it possible that I call you or email you a couple more questions in a few weeks
if I need to?
#1: Yes, Male is more than willing for me to call him with questions anytime.
#2: Yes.
#3: Yes. She’s very interested in seeing the survey.
14. Do you have any questions for me?
#1: No.
#2: No.
#3: No.
Other:
#1:
•
•
•
•
•
•

He noted that pharmacy is very regulated by drug companies and corporations.
Noted that they don’t have access to the internet at work because they run a very
tight system (Condour System)
There are 5,000 CVS stores
Additional website to check out: CVS.net (find CVS learn net) for good pharmacy
information
6 of the top 18 drugs filled are birth control pills
Most prescriptions for EC are filled on Monday and Tuesday (right after the
weekend). He fills around 5 on Monday and 2-3 on Tuesday.

#2:
•

Male Graduated in 2001 but then chose to do a 1-year residency to become more
specialized in community pharmacy. He received his education from University
of Florida (one of the 4 accredited Schools of Pharmacy in Florida).
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Table 54. Description of Survey Variables
Model

Item (Question)

Responses

Level of
Measurement

I.
Background
Variables
Gender
What is your gender?

Female/Male

Nominal

Age

How old are you?

List age

Ratio

Ethnicity

What is your
race/ethnicity
(choose all that
apply)?

____ 1 Caucasian
____ 2 African American
____ 3 Hispanic
____ 4 Asian
____ 5 Other please specify
(___________________)

Nominal

Years in
Practice

How many years
have you been a
practicing registered
pharmacist?

list # of years

Ratio

Type of
Pharmacy

The type of
pharmacy where you
work could be best
described as (if you
have more than one
job, please circle the
number that
corresponds to your
primary type of
pharmacy)

____ 1 Community -- Chain

Nominal

____ 2 Community -Independent
____ 3 Hospital
____ 4 Government (e.g., US
Public Health Service, military)
____ 5 Indian Health Service
____ 6 Not currently working
in a pharmacy
____ 7 Other: Please specify
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____ 1 Married
____ 2 Living with a partner
____ 3 Divorced
____ 4 Separated
____ 5 Widowed
____ 6 Never been married

Nominal

Marital
Status

What is your current
marital status?

Religion

Which religious
group do you most
closely identify with
(choose only one)?

Religiosity

How would you
describe yourself
(choose only one)?

Political
Affiliation

What is your political ____ 1 Republican
affiliation?
____ 2Democratic
____ 3 Independent
____ 4 Green Party
____ 5 None/Undecided
___ 6 Other please specify
(
)

Nominal

Employment
Status

What is your current
employment status?

Nominal

____ 1 Roman Catholic
____ 2 Baptist
____ 3 Methodist
____ 4 Episcopalian
____ 5 Lutheran
____ 6 Quaker
____ 7 Presbyterian
____ 8 Assembly of God
____ 9 Hindu
____ 10 Buddhist
____ 11 Jewish
____ 12 Islamic
____ 13 Mormon
____ 14 NonDenominational
____ 15 None
____ 16 Other please specify
(
)
____ 1 Religious
____ 2 Spiritual
____ 3 Religious and Spiritual
____ 4 Undecided
____ 5 None of the above
6 Prefer not to respond

____ 1 Full-time
____ 2 Part-time
____ 3 Retired
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Nominal

Nominal

Pharmacy
School
Attended

What pharmacy
school did you
graduate from?

Open-ended

Nominal

Year of
Graduation

What year did you
graduate from
pharmacy school?

List year

Ratio

Job Title

What is your job
title?

____ 1 Staff Pharmacist
____ 2 Pharmacy Manager
____ 3 Other: Please specify
_______________________

Nominal

II.
Dispensing
Practices
Does your pharmacy
stock any of the
following products?

Yes/No

Nominal

Does your pharmacy
stock Plan B?

Yes/No

Nominal

Have you personally
ever filled a
prescription of Plan
B?

Yes/No

Nominal

Have you ever been
asked to fill a
prescription of Plan
B?

Yes/No

Nominal

Approximately how
many Plan B
prescriptions have
you personally filled
in the past 12

Open-ended

Ratio

Condoms
Spermicide
Oral contraceptive
pills
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months?

Have you ever been
asked to sell Plan B
over-the-counter?

Yes/No

Nominal

Have you personally
ever sold Plan B
over-the-counter?

Yes/No

Nominal

Approximately how
many times have you Open-ended
sold Plan B over-thecounter in the past 12
months?

Ratio

Would you ever have
the opportunity at
your workplace to
come in contact (sell,
dispense, fill a
prescription) of Plan
B?

Yes/No

Nominal

To what extent are
you likely to sell Plan
B over-the-counter
to…

Women who have experienced
incest or rape.
Women who have experienced
a problem with their birth
control method.
Women who request the
method after having
unprotected sexual intercourse.
A person other than the
ultimate consumer of the
product such as parents or a
boyfriend.

Ordina/Interval

III.
Intention to
Dispense
Plan B

4-point Likert
Scale, with 1 = Very
Unlikely, 2=
Somewhat Unlikely,
3= Somewhat
Likely, 4= Very
Likely, 5=N/A
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Women who have experienced
incest or rape.
Women who have experienced
a problem with their birth
control method.
Women who request the
method after having
unprotected sexual intercourse.
Sexually active teens under age
18.

Ordinal/Interval

How many pills are
in a Plan B package?

____ 1 One
____ 2 Two
____ 3 Three
____ 4 Four
____ 5 Five
____ 6 Six
____ 7 Twelve
8 Not Sure

Nominal

According to the
Plan B label, Plan B
is effective if taken
within how many
hours of unprotected
intercourse?

____ 1 Up to 12 hours
____ 2 Up to 24 hours
____ 3 Up to 36 hours
____ 4 Up to 72 hours
____ 5 Not Sure

Nominal

Plan B prevents
pregnancy via which
of the following
mechanisms?

____ 1 Inhibition or delay in
ovulation
____ 2 Disruption of an
implanted embryo
____ 3 Changes in the
endometrial lining of
the uterus
____ 4 All of the above
5 Not sure

To what extent are
you likely to dispense
Plan B by
prescription to…
4-point Likert
Scale, with 1 =
Very Unlikely, 2=
Somewhat
Unlikely, 3=
Somewhat Likely,
4= Very Likely,
5=N/A
IV.
Knowledge
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Sales of Plan B to
eligible consumers
may be made by:

____ 1 Pharmacists only
____ 2 Pharmacists or
pharmacy technicians only
____ 3 Any member of the
pharmacy staff working behind
the pharmacy counter, as long
as a pharmacist is on duty
____ 4 Sales clerks, but only if
a pharmacist is not on duty

Nominal

According to the
Plan B label, what
percentage of the
time does Plan B
prevent pregnancy if
used properly?

____ 1 <25%
____ 2 25%-49%
____ 3 50%-74%
____ 4 75%-89%
____ 5 >89%

Nominal

A woman asking to
buy Plan B in
advance of need:

____ 1 Must wait for a
contraceptive emergency
before buying it
____ 2 Should be advised to
take a pregnancy test before
taking it
____ 3 May purchase more
than one package
____ 4 Can only make a
purchase if she is using it for
herself

Nominal

When selling Plan B
without a
prescription to a
man, pharmacists:

____ 1 Need to see proof that
he is at least 18 years of age
____ 2 Must limit sales to one
package
____ 3 Must ask for the name
of the person who will be
taking the product
4 Are violating the law

Nominal
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Do you think the
following statements
are true or false?
True
False
Not Sure

Emergency contraceptive pills
cause birth defects if taken by a
pregnant woman.
Emergency contraception can
act as an abortifacient.
The sooner a woman takes
emergency contraception, the
more effective it will be.

Nominal

V. Attitudes
--Easy availability of
emergency contraception will
discourage regular
contraceptive use.
--Easy availability of
emergency contraception
promotes promiscuity.
--I feel uncomfortable
dispensing Plan B because of
my religious/ethical beliefs.
--Repeated use of emergency
contraception is wrong.
5-point Likert
--I feel comfortable dispensing
Scale, with 1 =
Plan B to adult women.
Completely
--I feel comfortable dispensing
Disagree, 2=
Somewhat Disagree, Plan B to adolescents (teens
<18 years old).
3= Neither Agree
--I feel comfortable dispensing
nor Disagree, 4=
Plan B to men.
Somewhat Agree,
5= Completely
Agree

Ordinal/Interval

Should emergency
contraception be
offered to women
who are raped in all
hospital rooms,
regardless of hospital
affiliation?

Nominal

The next few
questions will ask
you about how you
personally feel about
emergency
contraception.
Please check the box
that corresponds to
the answer you
choose.

____ 1 Yes
____ 2 No
____ 3 Not sure

VI.
Subjective
Norms
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The next questions
will ask you about
your perceptions of
what other people
think.
The people and
groups listed below
may be influential in
your dispensing
decision-making.
Please indicate (by
checking the box)
how you think the
following consider
emergency
contraception
dispensing practices,
either by prescription
or over-the-counter.

59. My partners/business
colleagues think that I
dispense Plan
B.
60. The professional
organization I am most
active in recommends that
I
dispense Plan
B.
61. My supervisor thinks that
I_________ dispense Plan
B.
62. In general, my close
friends and family think
that I_________ dispense
Plan B.

5-point Likert scale
1=Definitely should
not, 2=Probably
should not, 3=
Probably should,
4=Definitely should)
Is there anyone in
your pharmacy who
refuses to dispense
Plan B?

____ 1 Yes
____ 2 No
____ 3 Not sure
____ 4 My pharmacy does not
carry Plan B

Is there a policy in
place at your
pharmacy if someone
refuses to dispense
Plan B?

____ 1 Yes
____ 2 No
____ 3 Not sure
____ 4 My pharmacy does not
carry Plan B

VII.
Perceived
Behavioral
Control
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Ordinal/Interval

Some pharmacists
may feel that where
they work effects
their dispensing
practices of Plan B.
The following
questions will ask
you about your
comfort level in
dispensing Plan B.

Counsel clients about Plan B.
Refuse to dispense Plan B.
Educate clients about Plan B.
Dispense Plan B.

How easy is it for
you to…
4-point Likert scale
with N/A option
1=Very Difficult, 2=
Somewhat Difficult,
3= Somewhat Easy,
4= Somewhat Easy,
5= N/A
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Ordinal/Interval

Appendix T
Focus Group Topical Guide
1) Introduction
Good morning, evening, afternoon and welcome to our session. Thank you for taking
the time to join our discussion. Your assistance is important; the ideas you share today
will help us understand the perceptions about emergency contraception among
pharmacy students. My name is Alice Richman and assisting me today is Lisa Nugent.
2) Purpose
I am a doctoral student at the University of South Florida and I am conducting research
on pharmacists and access to emergency contraception. I am trying to understand what
pharmacy students learn about emergency contraception in their pharmacy school
classes.
We are interested in all of your thoughts and comments. There are no right or wrong
answers but rather differing points of view. Please feel free to share your point of view
even if it differs from what others have said. Before we begin, let me remind you of
some groundrules…
3) Procedure & Ground Rules
Group discussion – so don’t wait to be called on, but please speak one at a time so I can
get your opinions on the tape.
Audiotape: we’re tape recording the session b/c we don’t want to miss any of your
comments. Although we may use your first names in the discussion, no names will be
attached to comments. You may be assured of complete confidentiality.
No right or wrong answers: want both positive and negative comments
Please feel free to disagree with each other, respectfully of course, and ask the group
questions.
If you have to use the bathroom, please feel free to get up at any time during our
discussion.
About 1 hour
4) Questions
Opening Question
Tell us your first name and why you want to be a pharmacist? (5 min)
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Appendix T (Continued)
Introductory Question:
When I say emergency contraception which is also sometimes referred to as the
morning after pill, what is the first thing that comes to your mind?
Warm up:
What have you learned about emergency contraception that you think is important for
people to know?
Probe Questions: What is it? How does it work? Who should use it? When should
people take it? Mechanism of action? Purpose?
Warm up:
Where have you gotten information this information?
Probe Questions: could be a range of people and places: in school, from pharmacy
practice experience, pharmacy representatives, magazines, from friends, teachers,
parents? Where else have you learned about it?
Key Question:
Thinking back to the courses you have taken in your Pharm D program, what do you
remember learning about emergency contraception?
Things I am looking for: Timing of administration? Mechanism of action? Purpose?
Elective or required?
Key Question:
Think back to any instruction you received on emergency contraception in your
pharmacy school classes. Were you aware of any attitudes towards the medication by
the instructor?
Positive/negative/neutral
Key Question:
How do you feel about dispensing emergency contraception?
Probe Questions: There are a number of circumstances where EC is thought to be
controversial: feelings about dispensing to adolescents, rape victims, women whose birth
control fails, women who use it repeatedly.
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Appendix T (Continued)
Key Question:
Do you feel any differently about dispensing emergency contraception than you do
dispensing any other medications?
Probe Question if they feel negatively: Where do your feelings about dispensing come
from?
Key Question:
The Food and Drugs Administration (FDA) recently approved for emergency
contraception to be administered over-the-counter to women 18 years of age and over
in the U.S. What do you think about this decision?
Key Question:
Does that (OTC status) change your views about it?
Key Question:
Some pharmacists have refused to dispense emergency contraception. How do you feel
about this?
Key Question:
Should moral or religious views guide dispensing of pharmaceutical products? What
about dispensing of emergency contraception?
Recap
Brief summary of key issues. How well does that description capture what we have
talked about? Have we missed anything? Any other comments?
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Appendix T (Continued)
Initial Paper & Pencil Survey for Focus Groups
1. Did you take any classes in your Pharm D program which taught you about
emergency contraception? (please check a box)
 Yes
 No (skip to question 9)
 Not sure (skip to question 9)
2. Which classes taught you about emergency contraception? (please list below)
Please also check the box if these classes were required or offered as an elective.
 required
elective
 required
elective
 required
elective
3. In your estimation, how much time would you say was spent on learning about
emergency contraception in a given class?

4. What types of instructional methods were used to teach you about emergency
contraception in your pharmacy school classes? (e. g. lectures, course readings,
power point discussions, videos, course discussions)

5. Of the instructional methods that taught you about emergency contraception in
your pharmacy school classes, which method/s did you learn the most from and
why?
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6. Was there any information concerning emergency contraception that you wished
you had learned or had more detailed instruction on?

7. Have your pharmacy school classes discussed the new over-the-counter status of
emergency contraception?
 Yes
 No
 Not sure
8. Have your pharmacy school classes discussed the dispensing issues (e. g.
pharmacists refusals to dispense) surrounding emergency contraception?
 Yes
 No
 Not sure
9. Do you think you will dispense emergency contraception upon becoming a
pharmacist?
 Yes
 No
 Not sure
10. Do you think pharmacists are well enough informed to confidently dispense
emergency contraception?
 Yes
 No
 Not sure
Thank you for completing this survey!!
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Appendix U (p. 290-293)
List of 91 pharmacy schools that received Dean’s survey*
Alabama
Kentucky
The University of Toledo
College of Pharmacy
Auburn University
University of Kentucky
2801 West Bancroft Street
Harrison School of
College of Pharmacy
Mail Stop #608
Pharmacy
725 Rose Street
Toledo, OH 43606
2316 Walker Building
Pharmacy Building
419-530-1904
Auburn , AL 36849
Lexington, KY 40536-0082
334-844-8348
859-257-2736
Oklahoma
University of Oklahoma
College of Pharmacy
The University of Louisiana PO Box 26901
at Monroe
Oklahoma City, OK 73190
College of Pharmacy
405-271-6485
700 University Avenue
Monroe, LA 71209
Southwestern Oklahoma
318-342-1600
Arizona
State University
College of Pharmacy
The University of Arizona Xavier University of
100 Campus Drive
College of Pharmacy
Louisiana
Weatherford, OK 73096
1295 N. Martin Avenue
College of Pharmacy
580-774-3760
PO Box 210202
1 Drexel Drive
Tucson, AZ 85721
New Orleans, LA 70125
Oregon
520-626-1427
504-520-7500
Oregon State University
Maryland
College of Pharmacy
Midwestern University
College of Pharmacy 203 Pharmacy Building
University
of
Maryland
Corvallis, OR 97331
Glendale
19555 North 59th Avenue School of Pharmacy
541-737-3424
20
North
Pine
Street
Glendale, AZ 85308
Baltimore, MD 21201
Pennsylvania
623-572-3500
410-706-7651
Duquesne University
Arkansas
Massachusetts
Mylan School of Pharmacy
University of Arkansas for
306 Bayer Learning Center
Massachusetts
College
of
Pittsburgh, PA 15282
Medical Sciences
Pharmacy and Health Scien 412-396-6380
College of Pharmacy
4301 West Markham - #522 School of Pharmacy-Boston
179 Longwood Avenue
Little Rock, AR 72205
Lake Erie College of
Boston,
MA
02115-5896
501-686-5557
Osteopathic Medicine
617-732-2781
LECOM School of Pharmacy
1858 West Grandview
Samford University
McWhorter School of
Pharmacy
800 Lakeshore Drive
Birmingham, AL 35229
205-726-2820

Louisiana
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Massachusetts College of
Pharmacy and Health Scien
University of California,
School of PharmacySan Diego
Worcester
Skaggs School of Pharmacy 19 Foster Street
& Pharmaceutical Science Worcester, MA 01608
9500 Gilman Drive, MC
508-890-8855
0657
La Jolla, CA 92093-0657
Northeastern University
858-822-4900
Bouve College of Health
Sciences, School of Pharma
University of California at 360 Huntington Avenue
San Francisco
206 Mugar Hall
School of Pharmacy
Boston, MA 02115
521 Parnassus Avenue
617-373-3380
Clincial Sciences, Room C156
Michigan
San Francisco, CA 94143
415-476-2733
Ferris State University
College of Pharmacy
Loma Linda University
220 Ferris Drive
Big Rapids, MI 49307
School of Pharmacy
West Hall
231-591-2254
11262 Campus Street
Loma Linda, CA 92350
The University of Michigan
909-558-1300
College of Pharmacy
428 Church Street
Ann Arbor, MI 48109
University of the Pacific
Thomas J. Long School of 734-764-7312
Pharmacy & Health Science
3601 Pacific Avenue
Wayne State University
Stockton, CA 95211
Eugene Applebaum College
209-946-2561
of Pharmacy and Health Sc
259 Mack Avenue
Detroit, MI 48201
University of Southern
California
313-577-1574
School of Pharmacy
Minnesota
1985 Zonal Avenue
Los Angeles, CA 90089University of Minnesota
9121
College of Pharmacy
323-442-1369
5-130 Weaver-Densford Hall
Touro University-California 308 Harvard Street SE
Minneapolis, MN 55455
School of Pharmacy
1310 Johnson Lane, Mare
California
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Boulevard
Erie, PA 16509-1025
814-866-6641
University of the Sciences in
Philadelphia
Philadelphia College of
Pharmacy
600 South 43rd Street
Philadelphia, PA 19104
215-596-8870
University of Pittsburgh
School of Pharmacy
1104 Salk Hall
3501 Terrace Street
Pittsburgh, PA 15261
412-624-2400
Temple University of the
Commonwealth of Higher Ed
School of Pharmacy
3307 North Broad Street
Philadelphia, PA 19140
215-707-4990
Wilkes University
Nesbitt School of Pharmacy
84 West South Street
Wilkes-Barre, PA 18766
570-408-4280
Puerto Rico

University of Puerto Rico
School of Pharmacy
PO Box 365067
San Juan, PR 00936
787-758-2525
Rhode Island

University of Rhode Island
College of Pharmacy
41 Lower College Road

Island
Vallejo, CA 94592
707-638-5200

612-624-1900

Western University of
Health Sciences
College of Pharmacy
College Plaza, 309 East
Second Street
Pomona, CA 91766
909-469-5214

The University of
Mississippi
School of Pharmacy
Thad Cochran Research
Center
Room 1026, PO Box 1848
University, MS 38677
662-915-7265

Mississippi

Colorado

Fogarty Hall
Kingston, RI 02881
401-874-2614
South Carolina

South Carolina College of
Pharmacy
MUSC Campus
280 Calhoun Street, PO Box
250141
Charleston, SC 29425-2301
843-792-8450

Missouri

University of Colorado at
Denver & Health Sciences
School of Pharmacy
C238
4200 East Ninth Avenue
Denver, CO 80262
303-315-5055
Connecticut

The University of
Connecticut
School of Pharmacy
69 North Eagleville Road
Unit 3092
Storrs, CT 06269
860-486-2129
District of Columbia

Howard University
School of Pharmacy
College of Pharmacy,
Nursing & AHS
2300 4th Street NW
Washington, DC 20059
202-806-5431
Florida

University of Missouri Kansas City
School of Pharmacy
5005 Rockhill Road
Kansas City, MO 64110
816-235-1609
St. Louis College of
Pharmacy
4588 Parkview Place
St. Louis, MO 63110
314-367-8700
Montana

The University of Montana
Skaggs School of Pharmacy
32 Campus Drive #1512
Missoula, MT 59812
406-243-4621
Nebraska

Creighton University
School of Pharmacy and
Health Professions
2500 California Plaza
Omaha, NE 68178
402-280-2950

University of Florida
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South Carolina College of
Pharmacy
USC Campus
Columbia, SC 29208
803-777-4151
South Dakota

South Dakota State
University
College of Pharmacy
Pharmacy Building - Room
125
Box 2202C
Brookings, SD 57007
605-688-6197
Tennessee

University of Tennessee
College of Pharmacy
847 Monroe Avenue, Suite
226
Memphis, TN 38163
901-448-6036
Texas

University of Houston
College of Pharmacy
141 Science & Research 2

College of Pharmacy
PO Box 100484, JHMHC
101 South Newell Drive,
#4334
Gainesville, FL 32611
352-273-6601

University of Nebraska
College of Pharmacy
986000 Nebraska Medical
Center
Omaha, NE 68198
402-559-4333

Florida Agricultural and
Mechanical University
College of Pharmacy and
Pharmaceutical Sciences
333 New Pharmacy
Building
Tallahassee, FL 32307-3800
850-599-3301

Nevada

Nova Southeastern
University
College of Pharmacy
Health Professions Division
3200 South University
Drive
Fort Lauderdale, FL 33328
954-262-1300
Palm Beach Atlantic
University
School of Pharmacy
901 South Flagler Drive
West Palm
Beach, FL 33416
561-803-2700
Georgia

University of Southern
Nevada
College of Pharmacy
11 Sunset Way
Henderson, NV 89014
702-990-4433
New Jersey

Rutgers, the State University
of New Jersey
Ernest Mario School of
Pharmacy
160 Frelinghuysen Road
Piscataway, NJ 08854-8020
732-445-2675

Building
Houston, TX 77204
713-743-1300
The University of Texas at
Austin
College of Pharmacy
1 University Station A1900
Austin, TX 78712
512-471-3718
Texas Southern University
College of Pharmacy and
Health Sciences
3100 Cleburne
Houston, TX 77004
713-313-7559
Texas Tech University
Health Sciences Center
School of Pharmacy
1300 S. Coulter Street
Amarillo, TX 79106
806-354-5463
Utah

New Mexico

University of New Mexico
College of Pharmacy
MSC09 5360
1 University of New Mexico
Albuquerque, NM 87131
505-272-3241

University of Utah
College of Pharmacy
30 South 2000 East
Room 201
Salt Lake City, UT 84112
801-581-6731
Virginia

The University of Georgia
College of Pharmacy
Green Street
Athens, GA 30602
706-542-1911
Mercer University
College of Pharmacy and
Health Sciences
3001 Mercer University

New York

University at Buffalo
School of Pharmacy and
Pharmaceutical Sciences
126 Cooke Hall - Box
601200
Buffalo, NY 14260-1200
716-645-2823
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Hampton University
School of Pharmacy
Kittrell Hall
Hampton, VA 23668
757-727-5071
Shenandoah University
Bernard J. Dunn School of
Pharmacy

Drive
Atlanta, GA 30341
678-547-6304
South University
School of Pharmacy
709 Mall Boulevard
Savannah, GA 31406
912-201-8120
Idaho

Idaho State University
College of Pharmacy
Stop 8288
921 S. 8th Avenue
Pocatello, ID 83209
208-282-2175

Long Island University
Arnold & Marie Schwartz
College of Pharmacy and He
75 DeKalb Avenue
Brooklyn, NY 11201
718-488-1234
St. John's University
College of Pharmacy and
Allied Health Professions
8000 Utopia Parkway
Jamaica, NY 11439
718-990-1415
Union University
Albany College of Pharmacy
106 New Scotland Avenue
Albany, NY 12208
518-694-7200

Illinois

University of Illinois at
Chicago
College of Pharmacy (M/C
874)
833 South Wood Street
Suite 145
Chicago, IL 60612
312-996-7240

North Carolina

Campbell University
School of Pharmacy
PO Box 1090
205 Day Dorm Road, Room
101
Buies Creek, NC 27506
910-893-1685

1775 N. Sector Court
Winchester, VA 22601
540-665-1282
Virginia Commonwealth
University
School of Pharmacy
MCV Campus - Box 980581
410 North 12th Street
Richmond, VA 23298
804-828-3006
Washington

University of Washington
School of Pharmacy
H-364 Health Science
Building
Box 357631
Seattle, WA 98195
206-543-2030
Washington State University
College of Pharmacy
PO Box 646510
105 Wegner Hall
Pullman, WA 99164
509-335-5901
West Virginia

Midwestern University
Chicago College of
Pharmacy
555 31st Street
Downers Grove, IL 60515
630-971-6417
Southern Illinois University
Edwardsville
School of Pharmacy
200 University Park Drive
Campus Box 2000
Edwardsville, IL 62026
618-650-5150

University of North Carolina
School of Pharmacy
Beard Hall, CB#7360
Chapel Hill, NC 27599
919-966-1121
Wingate University
School of Pharmacy
Campus Box 3087
Wingate, NC 28174
704-233-8331
North Dakota

North Dakota State
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West Virginia University
School of Pharmacy
Room 1136 HSN, Health
Science Center
PO Box 9500
Morgantown, WV 26506
304-293-5101
Wisconsin

University of Wisconsin Madison
School of Pharmacy
777 Highland Avenue

Indiana

Butler University
College of Pharmacy and
Health Sciences
4600 Sunset Avenue
Indianapolis, IN 46208
317-940-9322

University
College of Pharmacy,
Nursing, and Allied Sciences
123 Sudro Hall
1401 Albrecht Boulevard
Fargo, ND 58105
701-231-6469
Ohio

Purdue University
School of Pharmacy and
Pharmaceutical Sciences
Heine Pharmacy Building
575 Stadium Mall Drive
West Lafayette, IN 47907
765-494-1368

University of Cincinnati
James L. Winkle College of
Pharmacy
3225 Eden Avenue
PO Box 670004
Cincinnati, OH 45267-0004
513-558-3784

Madison, WI 53705-2222
608-262-1416
Wyoming

University of Wyoming
School of Pharmacy
Department 3375
1000 E. University Avenue
Laramie, WY 82071
307-766-6120

Iowa

Drake University
College of Pharmacy and
Health Sciences
2507 University Avenue
Des Moines, IA 50311
515-271-2172
The University of Iowa
College of Pharmacy
115 South Grand Avenue
Iowa City, IA 52242
319-335-8794

Ohio Northern University
College of Pharmacy
525 South Main
Ada, OH 45810
419-772-2275
The Ohio State University
College of Pharmacy
217 Parks Hall
500 West 12th Avenue
Columbus, OH 43210
614-688-4756

Kansas

University of Kansas
School of Pharmacy
1251 Wescoe Hall Drive
Malott Hall #2056
Lawrence, KS 66045-7582
785-864-3591
*List of pharmacy schools taken from American Association of Colleges of Pharmacy (AACP)
website www.aacp.org The listing includes colleges and schools of pharmacy whose professional
degree programs have been granted full or candidate accredited status by the Accreditation
Council for Pharmacy Education (ACPE) and whose requests for membership have been
approved by the AACP House of Delegates.
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Appendix V
Second follow-up letter to Deans
About two weeks ago we sent you a survey via email. We are asking Deans of the
schools of pharmacy in the U.S. about the curricula that addresses instruction on
emergency contraception.
As of today, we have not received a completed survey from you. I realize that we all
have busy schedules; however we are hoping for at least a 50% response rate on this brief
3-question survey. As we mentioned before, answers are confidential and will be
combined with others before disseminating the results. In case the previous questionnaire
has been deleted from your email account, we have included it again and hope you will
respond.
Should you have any questions or concerns, feel free to contact me (Alice Richman) or
Ellen Daley at the contact information provided below. Thank you for your cooperation.
Alice R. Richman
USF College of Public Health
Phone: (813) 732-1903
Email: arichman@health.usf.edu

Ellen Daley, Ph.D.
USF College of Public Health
Phone: (814) 974-8518
Email: edaley@health.usf.edu

(Link to Survey Inserted Here)
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Appendix W (p. 297-298)
List of course titles containing emergency contraception course content
Questions on Deans Survey:
You answered yes that your School does offer required courses that provide content on
emergency contraception. Would you please list the titles of these courses in the box
below.
You answered yes that your School does offer elective courses that provide content on
emergency contraception. Would you please list the titles of these courses in the box
below
Answers provided for required courses that contain emergency contraception content:
Women's Health (a combination course with Men's Health).
1) Pharmacologic Basis of Therapeutics III: The endocrinology section of this basic
science course includes a lecture that addresses the mechanism of action of emergency
contraceptives, the period of time during which they can be effectively used, and their
side effects.
2) Early Practice Experience I: As part of this early clinical course, the students obtain
certification from the State in emergency contraception. They learn about prescriptive
authority, and are trained to counsel patients appropriately.
Professional Skills Development II
Health Assessment and Pharmacotherapy II
Integrated Science and Therapeutics II. It's part of a 2-hr contraception lecture.
Therapeutics - Women's Health
Syllabi not available at this time.
PHA 5930--Issues in Contemporary Pharmacy Practice.
Clinical Therapeutics
IPDM (Integrated Pharmacology & Disease Management III Endocrinology/Gastroenterology
Princles of Pharmacotherapy 1: Selfcare and Alternative Medicine
Princles of Pharmacotherapy 8: Special Populations
Ethics and Professional Responsibility
Pharmacotherapy II
Pharmacy Ethics
It is in one of our Pharmacotherapy courses
It is contained within a pathophysiology and therapeutics course that has a section on
women's health. The syllabus only states that the topic of contraception is covered.
see printed out syllabus -- reproductive health course.
There are a couple of lectures in Pharmacy 505 which is a pharmacy practice course
titled Pharmaceutical Care and a case discussion in pharmacy 514 - Pharmacy Ethics.
Pharmacotherapy 4: contemporary topics 2hours, 5th year spring semester class
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Phrm 6206 includes endocrine and reproductive medicine.
Material Covered in Over-the-Counter Medications Course under OTC Contraception.
Not specifically mentioned in the syllabus.
Integrated Sequence 4
To the best of my knowledge, I believe we are teaching this in these courses.
PHA 551 Endocrine Disorders
PHA 502 Pharmacy Law and Ethics
PHA 566 Women's Health
Therapeutics I
It is taught in our Self Care course in the lecture covering the prevention of unintended
pregnancy. I apologize for not being able to attach the syllabus.
In PHR 920 (Communication and Behavior in Pharmacy Practice) from a social
behavioral aspect, in PHR 930 (Legal, Ethical and Access Issues in Pharmacay), in
PHR 933 (Pharmacological Basis for Therapeutics: Endocrine Systems) from a
pharmacologic perspective and in PHR 946 (Advanced Pharmacotherapy I) in the
block on "women's health" from a pharmacological and therapeutic perspective. The
course syllabi are not very descriptive of the topics - they only indicate "contraception"
or "Plan B".
Integrated Therapeutics III Course and Laboratory offers review of material regarding
emergency contraception. It may also be discussed in the mandatory Healthcare Ethics
class.
PHP 414 - Therapeutic Core /Endocrinology/Women's Health
PHP 518 - Self Care 1
PHP 519 - Elective - Self Care 2
Pathophysiciology and Therapeutics III under Women's Health
NonPrescriptions Drug Products under contraception
Possibly in phamacology, not sure
I know we teach this but I dont know specifics on courses since several have changed
recently.
Topic is covered in our Pharmacotherapy- Disease State management course. The topic
is not listed in the syllabus- it is discussed as part of the contraception discussion
Answers provided for elective courses that contain emergency contraception content:
Overview of Contraceptive Management; I'll send the syllabus via email attachment
"Women's Health"
Women's Health
PHP 519 - Self Care 2

298

Appendix X (p. 299-313)
Panel of Experts Interview Guide for Review of Pharmacists’ Questionnaire
You are being asked to be part of a special panel of experts that will review a
questionnaire to make sure it is valid. The survey you are reviewing will be administered
to Florida pharmacists and it is designed to measure emergency contraception knowledge,
attitudes, and dispensing practices of pharmacists who practice in the state of Florida.
Your honest input and feedback is essential to producing a valid instrument and I want to
personally thank you for your participation.
This review will inquire about five six main topics:
(1) level of knowledge about emergency contraception,
(2) personal attitudes held about emergency contraception and about emergency
contraception dispensing,
(3) perceived social pressures around issues of dispensing,
(4) perceived behavioral control over the behavior of dispensing emergency
contraception,
(5) emergency contraception dispensing practices and (6) basic demographics and
background questions.
Directions:
First, rate each question on the instrument according to the extent to which you
think it looks as if it is measuring the designated topic (i.e., face validity), with 1 = this
item does not look as if it has anything to do with measuring the topic, and 7 = this item
looks very much as if it is on-target with measuring the topic. Please explain your ratings
that are below 5, that is, items that you do not think look as if they are measuring the
designated topic. What would you do, if anything, to fix them?
Second, are there important aspects of the designated topic that the instrument is
not measuring (i.e., content validity)?
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Topic 1: Knowledge about Emergency
Contraception

Rating
1234567

Q1: How many pills are dispensed in Plan
B® packaging? ____
Q2: Emergency contraception or Plan B® is
effective if taken within how many hours of
unprotected intercourse?
____ 1 Up to 24 hours
____ 2 Up to 36 hours
____ 3 Up to 72 hours
____ 4 Up to 120 hours
____ 5 Not Sure
Q3: The mechanism of action of emergency
contraception is most similar to (please
choose one):
____ 1 Spermicides
____ 2 Oral Contraceptives
____ 3 Mifepristone (RU-486)
____ 4 Not Sure
Q4: If used properly, emergency
contraception or Plan B® prevents
pregnancy what percentage of the time?
____ 1 <25%
____ 2 25%-49%
____ 3 50%-74%
____ 4 75%-89%
____ 5 >89%
Q5: To what extent do you think the
following statements are true or false?
Repeated use of emergency contraceptive
pills can pose health risks.
____ 1 True
____ 2 False
Q6: To what extent do you think the
following statements are true or false?
Emergency contraceptive pills cause birth
defects if taken by a pregnant woman.
1 True
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Explain ratings <5,
what would you do to
fix them?

____ 2 False
Q7: To what extent do you think the
following statements are true or false?
Emergency contraception can act as an
abortifacient.
____ 1 True
____ 2 False
Q8: To what extent do you think the
following statements are true or false?
The sooner a woman takes emergency
contraception, the more effective it will be.
____ 1 True
____ 2 False
Q9: To what extent do you think the
following statements are true or false?
Plan B® is the same as the abortion pill
(RU-486).
____ 1 True
____ 2 False
Q10: To what extent do you think the
following statements are true or false?
Emergency contraception can protect against
HIV and other sexually transmitted
infections (STIs).
____ 1 True
____ 2 False

Are there important aspects of the topic emergency contraception knowledge that the
instrument is not measuring (i.e., content validity)?
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Topic 2: Attitudes about Emergency
Contraception

Rating
1234567

Q1: ____ I feel the benefits of emergency
contraception outweigh the risks.
1=Completely Disagree
2=Somewhat Disagree
3=Not sure
4=Somewhat Agree
5=Completely Agree
Q2: ____ Emergency contraception will
discourage regular contraceptive use.
1=Completely Disagree
2=Somewhat Disagree
3=Not sure
4=Somewhat Agree
5=Completely Agree
Q3: ____ Emergency contraception will
promote promiscuity.
1=Completely Disagree
2=Somewhat Disagree
3=Not sure
4=Somewhat Agree
5=Completely Agree
Q4: ____ I feel uncomfortable prescribing
emergency contraception for religious/ethical
reasons.
1=Completely Disagree
2=Somewhat Disagree
3=Not sure
4=Somewhat Agree
5=Completely Agree
Q5: ____ Repeated use of emergency
contraception by adolescents is wrong.
1=Completely Disagree
2=Somewhat Disagree
3=Not sure
4=Somewhat Agree
5=Completely Agree
Q6:

I feel comfortable dispensing
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what would you do to
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emergency contraception to women.
1=Completely Disagree
2=Somewhat Disagree
3=Not sure
4=Somewhat Agree
5=Completely Agree
Q7: ____ I feel comfortable dispensing
emergency contraception to adolescents.
1=Completely Disagree
2=Somewhat Disagree
3=Not sure
4=Somewhat Agree
5=Completely Agree
Q8: In general, I think that dispensing
emergency contraception for clients is…
____ 1 Good
____ 2 Positive
____ 3 Beneficial
____ 4 Harmful
____ 5 Negative
____ 6 Bad
Q9: What is the maximum number of times
emergency contraception should be given to
one individual woman over her lifetime?
____ 1 0 times
____ 2 1 time
____ 3 2-5 times
____ 4 6-10 times
____ 5 10+ times
____ 6 Not sure

Are there important aspects of the topic emergency contraception attitudes that the
instrument is not measuring (i.e., content validity)?
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Topic 3: Emergency Contraception
Dispensing Practices (includes both
intention to dispense and actual dispensing
practices)
Q1: Does your pharmacy dispense any forms
of emergency contraception (e. g. Plan B®)?
____ 1 Yes
____ 2 No
Q2: Have you ever been asked to fill a
prescription of emergency contraception?
____ 1 Yes
____ 2 No
Q3: Have you personally ever filled a
prescription of emergency contraception?
____ 1 Yes
____ 2 No
Q4: Approximately how many emergency
contraceptive pill prescriptions have you
personally filled in the past 12 months?
____________
Q5: Have you ever been asked to dispense
emergency contraception over-the-counter?
____ 1 Yes
____ 2 No
Q6: Have you personally ever dispensed
emergency contraception over-the-counter?
____ 1 Yes
____ 2 No
Q7: Approximately how many times have
you dispensed emergency contraceptive pills
over-the-counter in the past 12 months?
____________
Q8: To what extent are you likely to dispense
emergency contraception over-the-counter
to…
Women who have experienced incest or rape
1=Very Unlikely
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Rating
123456
7

Explain ratings <5,
what would you do to
fix them?

2=Unlikely
3=Not sure
4=Likely
5=Very Likely
Q9: To what extent are you likely to dispense
emergency contraception over-the-counter
to…
Women who have experienced a problem
with their birth control method
1=Very Unlikely
2=Unlikely
3=Not sure
4=Likely
5=Very Likely
Q10: To what extent are you likely to
dispense emergency contraception over-thecounter to…
Sexually active 18, 19, and 20 year olds
1=Very Unlikely
2=Unlikely
3=Not sure
4=Likely
5=Very Likely
Q11: To what extent are you likely to
dispense emergency contraception over-thecounter to…
Women who request the method after having
unprotected sexual intercourse
1=Very Unlikely
2=Unlikely
3=Not sure
4=Likely
5=Very Likely
Q12: To what extent are you likely to
dispense emergency contraception over-thecounter to…
Men requesting emergency contraception
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over-the-counter for their partner
1=Very Unlikely
2=Unlikely
3=Not sure
4=Likely
5=Very Likely
Q13: To what extent are you likely to
dispense emergency contraception by
prescription to…
Women who have experienced incest or rape
1=Very Unlikely
2=Unlikely
3=Not sure
4=Likely
5=Very Likely
Q14: To what extent are you likely to
dispense emergency contraception by
prescription to…
Women who have experienced a problem
with their birth control method
1=Very Unlikely
2=Unlikely
3=Not sure
4=Likely
5=Very Likely
Q15: To what extent are you likely to
dispense emergency contraception by
prescription to…
Sexually active teens under age 18
1=Very Unlikely
2=Unlikely
3=Not sure
4=Likely
5=Very Likely
Q16: To what extent are you likely to
dispense emergency contraception by
prescription to…
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Women who request the method after having
unprotected sexual intercourse
1=Very Unlikely
2=Unlikely
3=Not sure
4=Likely
5=Very Likely
Are there important aspects of the topic emergency contraception dispensing practices
that the instrument is not measuring (i.e., content validity)?

Topic 4: Perceived Social Pressures
Concerning Dispensing Practices of
Emergency Contraception
Q1: My partners/colleagues think that I
_________ dispense emergency contraception.
1=Definitely Should Not
2=Probably Should Not
3=Neutral
4=Probably Should
5=Definitely Should
Q2: My professional organization recommends
that I_________ dispense emergency
contraception.
1=Definitely Should Not
2=Probably Should Not
3=Neutral
4=Probably Should
5=Definitely Should
Q3: My boss thinks that I
emergency contraception.
1=Definitely Should Not
2=Probably Should Not
3=Neutral
4=Probably Should
5=Definitely Should

dispense
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Rating
123456
7
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Q4: My corporation or pharmacy thinks that
dispense emergency contraception.
I
1=Definitely Should Not
2=Probably Should Not
3=Neutral
4=Probably Should
5=Definitely Should
Q5: In general, most people or groups that are
important to me think that I
dispense emergency contraception.
1=Definitely Should Not
2=Probably Should Not
3=Neutral
4=Probably Should
5=Definitely Should
Q6: My clients or customers thinks that
I_________ dispense emergency contraception.
1=Definitely Should Not
2=Probably Should Not
3=Neutral
4=Probably Should
5=Definitely Should
Are there important aspects of the topic perceived social pressures concerning dispensing
practices of emergency contraception that the instrument is not measuring (i.e., content
validity)?

Topic 5: Perceived Ease or Difficulty
(comfort level) with Dispensing Emergency
Contraception
Q1: How easy would it be for you to…
____ Counsel clients about emergency
contraception
1=Very Difficult
2=Difficult
3=Not sure
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4=Easy
5=Very Easy
Q2: How easy would it be for you to…
____ Dispense emergency contraception
1=Very Difficult
2=Difficult
3=Not sure
4=Easy
5=Very Easy
Q3: How easy would it be for you to…
____ Refuse to dispense emergency
contraception
1=Very Difficult
2=Difficult
3=Not sure
4=Easy
5=Very Easy
Q4: How easy would it be for you to…
____ Educate clients about emergency
contraception
1=Very Difficult
2=Difficult
3=Not sure
4=Easy
5=Very Easy
Q5: How comfortable are you talking about
emergency contraception with customers?
1=Very Uncomfortable
2=Somewhat Uncomfortable
3=Somewhat Comfortable
4=Very Comfortable
Are there important aspects of the topic perceived ease or difficulty (comfort level) with
dispensing emergency contraception that the instrument is not measuring (i.e., content
validity)?

309

Note: This last section titled ‘Demographic & Background Questions’ is a little different
as each topic is listed for each question in blue.
Topic 6: Demographic & Background
Rating
Explain ratings
Questions
1234567
<5, what would
you do to fix
them?
Topic Measuring: Years in Practice
Q1: How many years have you been in practice
(registered as a pharmacist)?
____ year/years
Topic Measuring: Type of Pharmacy
Q2: The type of pharmacy where you work could
be best described as (if you have more than one
job, please circle the number that corresponds to
your primary type of pharmacy)
____ 1 Retail
____ 2 Independent
____ 3 Chain
____ 4 Hospital
____ 5 Nuclear
____ 6 Government
____ 7 VA
____ 8 Academia
____ 9 HIS
____ 10 Home Infusion
____ 11 Other: Please specify
_______________________
Topic Measuring: Employment Status
Q3: What is your current employment status?
____ 1 Full-time
____ 2 Part-time
____ 3 Retired
Topic Measuring: Pharmacy Availability of Birth
Control Products
Q4: Does your pharmacy carry any of the
following birth control products?
Condoms

1 Yes

0 No
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Spermicide ____1 Yes
____0 No
Oral contraceptive pills ____1 Yes ____0 No
Topic Measuring: Gender
Q5: What is your gender?
____ 1 Female
____ 2 Male
Topic Measuring: Age
Q6: How old are you?
____________
Topic Measuring: School of Attendance
Q7: Where did you go to school to become a
pharmacist?
________________________
Topic Measuring: Year of Graduation
Q8: What year did you graduate school to become
a pharmacist?
____________
Topic Measuring: Religion
Q9: If you had to choose only one, which would it
be?
____ 1 Religious
____ 2 Spiritual
____ 3 Religious and Spiritual
____ 4 Undecided
____ 5 None of the above
____ 6 Not religious or Spiritual
Topic Measuring: Religious Identity
Q10: If you had to choose one, which religious
group do you most closely identify with?
____ 1 Roman Catholic
____ 2 Baptist
____ 3 Methodist
4 Episcopalian
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____ 5 Lutheran
____ 6 Quaker
____ 7 Presbyterian
____ 8 Assembly of God
____ 9 Hindu
____ 10 Buddhist
____ 11 Jewish
____ 12 Islamic
____ 13 Mormon
____ 14 Neo-Pagan/Wicca
____ 15 Non-Denominational
____ 16 Not Religious
____ 17 Other
Topic Measuring: Ethnicity
Q11: What is your ethnicity?
____ 1 Caucasian
____ 2 African American
____ 3 Hispanic
____ 4 Asian
____ 5 Multi-Racial
____ 6 Other please specify
(___________________)
Topic Measuring: Marital Status
Q12: What is your marital status?
____ 1 Married
____ 2 Living with a partner
____ 3 Divorced
____ 4 Separated
____ 5 Widowed
____ 6 Never been married
Topic Measuring: Ethnicity
Q13: To what extent are you likely to dispense
emergency contraception by prescription to…
Women who have experienced incest or rape
1=Very Unlikely
2=Unlikely
3=Not sure
4=Likely
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5=Very Likely
Topic Measuring: Political Affiliation
Q14: What is your political affiliation?
____ 1 Republican
____ 2Democratic
____ 3 Independent
____ 4 None/Undecided
Are there important aspects of the questions asked in this last section titled Demographic
& Background Questions that the instrument is not measuring (i.e., content validity)?

Thank you for your time. Please save your answers and follow the directions outlined in
the email provided.
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